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Clinical picture and muscle involvement
Facioscapulohumeral muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common hereditary 
muscular disorder [1] with an estimated prevalence of 1:8,500 in the Netherlands [2]. The 
disease is characterized by progressive fatty infiltration and weakness of eventually all 
skeletal muscles. Recently it was demonstrated that FSHD is associated with a contraction 
of D4Z4 repeats on chromosome 4q35 [3], leading to lost repression of DUX4, a protein 
that exerts toxic effects on muscle cells [4]. However, even though the most important 
genetic events for the disease seem to be identified (Box 1), a causative treatment is not 
yet available [5, 6]. 
 During the last decades, clinical research in FSHD has focused on the symptomatic 
treatment of muscles weakness. Three large randomized controlled trials (RCTs) were 
conducted to evaluate the effects of strength training with or without medication 
(albuterol or salbutamol) [8-10], but no significant and clinically relevant effects on muscle 
strength were found. Recently, however, an aerobic training study revealed small 
improvements in quadriceps strength and reduced rates of fatty infiltration of quadriceps 
muscles [11] after 4 months (3 times a week) cycling exercises. These results indicate that 
physical training may be beneficial for the preservation of muscles in FSHD, but they need 
to be replicated before more definitive conclusions can be drawn. Until we are able to 
stop the progressive affliction of skeletal muscles, the main focus of rehabilitation 
treatment in patients with FSHD will be on providing them with strategies and aids to 
overcome their progressive disabilities.
Pattern of muscle involvement 
In FSHD, muscle weakness generally starts in the facial and shoulder muscles. In approximately 
70% of the patients, muscle weakness progresses beyond the shoulders. According to the 
literature, the progression and distribution of clinical muscle weakness over time follows a 
characteristic pattern in the majority of the patients [1, 12, 13]. Tibial anterior and abdominal 
muscles are often the first muscles to become involved following shoulder weakness. In a 
later stage, weakness of the pelvic muscles and the calves is observed. About 20% of the 
patients eventually become wheelchair bound. The typical pattern of muscle involvement 
is mainly based on clinical observations of muscle weakness. However, scoring of muscle 
weakness through clinical manual muscle testing (MMT) [14] focuses on muscle groups 
instead of individual muscles. Hence, individual muscle affliction may be overlooked in 
the clinic. Hence, imaging studies are required to identify the pattern of involvement of 
individual muscles. 
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Individual variability in muscle involvement 
Approximately 70% of the patients with FSHD show muscle weakness according to the 
characteristic pattern [30]. Different patterns of muscle involvement are seen in the 
remaining patients [31]. For example, camptocormia has been described in a small group 
as a result of back extensor weakness, whereas the typical pattern is characterized by a 
progressive lumbar (hyper)lordosis throughout the course of the disease [32]. In 20% of 
the patients with progression beyond shoulder weakness, pelvic and thigh involvement 
precedes affliction of the abdominals and foot elevators. A last example of atypical 
presentation are wasted quadriceps in patients with intact hamstrings, whereas in most 
patients the hamstrings muscles are affected earlier than the quadriceps. These differences 
in pattern of muscle involvement, even within families [1, 31, 33], indicate that genetic 
defect size is not the only determinant of this involvement. Variability between the sexes 
has also been described. Men generally show a higher penetrance of the disease [34] and 
greater clinical severity than women, when corrected for age and genetic defect size [35, 
36]. Overall, the mechanisms behind the characteristic pattern of muscle involvement and 
the causes of pattern variation remain unclear. 
Asymmetric muscle involvement 
A certain degree of asymmetric muscle involvement is typically observed in patients with 
FSHD. Asymmetry in muscle weakness can readily be noticed in the face when smiling or 
around the shoulders upon active elevation of the arms, but it is also present in the muscles 
of the extremities [37, 38]. A preference for right-sided weakness has been observed, but the 
mechanisms underlying this preference are still unknown. Various hypotheses have been 
proposed to explain this observation, including overwork weakness [39] and handedness 
[37, 40], whereas other authors have ascribed the asymmetry to an intrinsic disease process 
[41] or an intrinsic genetic mechanism [42]. Due to the relatively small number of left- 
handed persons with FSHD, it remains difficult to test any hypothesis, leaving the cause of 
the asymmetric muscle involvement as yet undetermined.
Box 1  (Epi)genetics of facioscapulohumeral muscular dystrophy (FSHD)
Breakthroughs during the last decades:
· 1990: Discovery of defect gene location on chromosome 4q35. [15-18]
· 1992: FSHD is associated with shorter EcoRI fragments (<28kb) at 4q35. [19-21]
· 1997: Development of a  reliable blood-DNA test for FSHD. [22-24]
· 2007- 2010: It was discovered that FSHD is related to up-regulated DUX4 transcript 
levels. [3, 25-27]
· 2013: Gene SMCHD1 is a modifier of disease severity. [28, 29]
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Clinical assessment of disease severity 
Disease severity in FSHD is generally assessed with Ricci’s Clinical Severity Scale (CSS) [7] 
(Box 2), which is based on MMT. This scale reflects the present functional status of a 
patient, but does not take into account the rate of disease progression. Disease duration 
and age of onset are other important aspects of clinical severity, which are - to a certain 
extent - associated with the genetic defect size, the D4Z4 repeat length [7, 36, 43-46]. 
Although the CSS serves as the standard measure of clinical severity in FSHD, the use of 
MMT to assess muscle strength is rather unreliable, particularly among multiple evaluators. 
Besides, the CSS disregards the variability in muscle involvement between patients as it 
follows the ‘typical pattern’ of muscle weakness. Furthermore, in stages 3 to 4, it focuses 
on the degree of pelvic and proximal leg muscle weakness as well as on the ability to get 
up from a chair with or without support, functional aspects which are not 1:1 related in 
many patients due to individual differences in use of compensatory strategies. As a result, 
a substantial proportion of patients cannot be unequivocally assessed with the CSS. Thus, 
Box 2  Clinical Severity Scale [7]
0.5 Facial weakness
1 Mild scapular involvement without limitation of arm abduction; no awareness of 
disease symptoms is possible
1.5 Moderate involvement of scapular and arm muscles or both (arm abduction >60° 
and strength ≥3 in arm muscles); no involvement of pelvic and leg muscles
2 Severe scapular involvement (arm abduction <60° on at least one side); strength 
<3 in at least one muscular district of the arms; no involvement of pelvic and leg 
muscles
2.5 Tibioperoneal weakness; no weakness of pelvic and proximal leg muscles
3 Mild weakness of pelvic and proximal leg muscles or both (strength ≥4 in all these 
muscles); able to stand up from a chair without support
3.5 Moderate weakness of pelvic and proximal leg muscles or both (strength ≥3 in all 
these muscles); able to stand up from a chair with monolateral support
4 Severe weakness of pelvic and proximal leg muscles or both (strength <3 in at 
least one of these muscles); able to stand up from a chair with double support; 
able to walk unaided
4.5 Unable to stand up from a chair; walking limited to several steps with support; 
may use wheelchair for most activities 
5 Wheelchair bound
Muscle strength is evaluated by using Manual Muscle Testing (Medical Research Council Scale).
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lack of inter-observer reliability, individual variability in muscle involvement, and individual 
variation in use of compensation strategies all limit the use of a generic clinical score for 
grading functional severity such as the CSS, particularly for research purposes.  
Muscle imaging
Muscle imaging studies are increasingly used in neuromuscular disorders to characterize 
the severity and pattern of muscle involvement [47]. In FSHD, studies have been conducted 
using computer tomography (CT) or magnetic resonance imaging (MRI) in small groups of 
patients [37, 38, 48], revealing the involvement of muscles that cannot be reliably tested 
clinically. For example, affliction of the m. semimembranosus cannot be detected when 
the adjacent hamstrings are still intact [38]. Furthermore, involvement of the m. iliopsoas 
is a matter of debate. One study found iliopsoas affliction in more than one third of the 
investigated subjects [37], whereas another study reported that none of the patients 
showed iliopsoas involvement [38].These are only a few examples of issues that can be 
addressed in larger muscle imaging studies. Muscle imaging, with either quantitative or 
semi-quantitative scoring of fatty infiltration, gives a more objective measure of disease 
severity and progression than clinical examination. It allows a more reliable determination 
of the number of muscles involved, but also of the extent of fatty infiltration within the 
affected muscles. These aspects are the ultimate measures of disease severity that are 
sensitive for even minor negative or positive changes. 
 Although it is well known that individual differences in pattern and progression exist, 
muscle imaging is still not routinely used to identify the individual pattern of muscle 
involvement in the clinic. Objective monitoring of progression of muscle involvement 
through repeated imaging almost never occurs, even though this would be useful to 
understand the problems that are experienced by individual patients and could support 
tailor-made rehabilitation strategies (Box 3). 
Postural control and mobility
Posture
Postural problems are frequently experienced by patients with FSHD as soon as trunk and/
or lower extremity muscles become involved. A lumbar hyperlordosis often occurs as an 
effect of trunk muscle weakness, with a strong impact on body posture and balance. This 
lumbar hyperlordosis seems to be more severe in persons with a low age of onset [49, 50]. 
Sometimes spinal fusion is considered to stabilize or correct a severe back deformity in 
wheelchair-bound persons [49, 50]. Why lumbar hyperlordosis develops in persons with 
FSHD is not fully clarified. It may be due to different mechanisms [49, 50], but the most 
accepted theory is that the increase in lordotic angle is caused by weakness of the 
abdominal muscles relative to the (stronger) back extensor muscles [1, 12]. 
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 Persons with FSHD have worse static balance control and plantar foot pressure 
distribution is often shifted anteriorly in mildly affected patients compared to controls [51]. 
Early weakness of the ankle dorsiflexors may be an important underlying cause, as these 
muscles are essential to withstand backward body perturbations during an ankle strategy 
[52]. Thus, a forward shift of the centre of foot pressure may be a useful compensatory 
strategy, given the fact that the calf muscles are often less affected [51]. Distal leg muscle 
weakness appeared to have the largest influence on sagittal-plane postural instability due 
to interference with the ankle strategy [53]. The effects of (additional) trunk muscle 
weakness on postural instability are unknown, which led to one of the key questions 
addressed in this thesis. 
Mobility
In the course of FSHD, mobility and other functional skills become progressively affected. 
Indeed, the CSS is inversely related to the physical functioning domains of quality of life 
scores [54]. Gait impairments gradually occur as a result of leg, pelvic and trunk muscles 
involvement. Persons with FSHD have a reduced walking speed probably as a result of 
decreased ankle power [55]. Another typical deviation is the presence of bilateral drop 
foot as a result of early weakness of the foot elevators. Other gait deviations may occur as 
well, especially in patients with higher CSS scores, such as increased trunk range of motion 
in the sagittal-plane [51, 56]. Whether increased trunk sway reflects a primary impairment 
or must be regarded as a compensation strategy to control the movements of the centre 
of mass has yet to be determined. Dynamic postural stability during gait has not yet been 
specifically studied in persons with FSHD. Although greater changes in spatiotemporal 
parameters were associated with lower Berg Balance Scores [51], the mechanisms behind 
this association remain unclear. A better understanding of the gait deviations in persons 
with FSHD is an important goal of the studies reported in this thesis, particularly to 
disentangle primary impairments from compensatory mechanisms.   
Falls
When muscle weakness is present at several body segments, complex alterations of static 
(standing) and dynamic (walking) balance occur that increase the risk of falls compared to 
healthy persons of similar age [57]. Both leg and trunk muscle weakness, together with the 
resulting deformation of spinal posture, probably contribute to this postural instability 
and fall risk. It has been shown that 65% of persons with FSHD report a fall at least once a 
year, whereas this was merely 13% for healthy control subjects of the same age [58]. 
Frequent fallers showed increased trunk movements during several functional tasks 
compared to infrequent fallers and controls. Falls occurred mainly in the home situation. 
Patients reported the largest number of falls while climbing stairs or rising from a chair. It 
was also found that falls mainly occurred in the forward direction [58]. However, it 
remained unclear what fall mechanisms played a role and which muscle weakness was 
CHAPTER 1
14
most critical for the increased occurrence of falls. An association between falls and walking 
stairs and standing on heels was found based on questionnaires, which may indicate that 
a combination of muscle strength and dynamic balance determines the fall risk. One of 
the aims of this thesis is to contribute to the identification of specific muscles and 
mechanisms associated with postural instability and increased fall risk.
Rehabilitation
Rehabilitation treatment for patients with FSHD is based on a combination of optimizing 
residual functions and providing compensation for functional limitations. Moderate 
weight or resistance training has been shown to be safe in patients with muscle disease 
[59], but it does not have a similar effect on muscle strength as in healthy persons [60]. 
Only very limited beneficial effects of strength training in specific muscles of patients with 
FSHD were found in a large randomized controlled trial [8]. However, persons with FSHD 
may experience improvement of strength, physical activity and reduction of fatigue as a 
result of aerobic training [11, 38]. Aerobic exercise may also decrease the rate of fatty 
infiltration in the trained muscles of persons with FSHD [11, 61]. Interestingly, lifestyle 
improvement through cognitive behavioral therapy (CBT) has also been shown to improve 
physical activity, reduce chronic fatigue and decelerate the rate of muscle fatty infiltration 
in FSHD [11], while CBT has a beneficial influence on quality of sleep, quality of life and 
social participation as well.
Limited results are available on the effects of assistive devices on daily functioning of 
patients with FSHD. Foot-orthosis (FO) and ankle-foot-orthosis (AFO) may significantly 
improve walking performance, balance and quality of life [62], but the effects of such 
interventions strongly depend on individual needs, physical impairments, and learned 
compensatory strategies. For example, AFOs may support weakened foot elevators but 
hamper the function of the calf muscles at the same time. Another example is the use of 
semi-rigid trunk corsets to support weakened abdominal and back extensor muscles. 
Although some patients profit from such an orthosis during normal standing and walking, 
they are often hindered by it during more dynamic activities such as rising from a chair, 
bending, and reaching. Probably, the development of a lumbar hyperlordosis is not merely 
a direct consequence of trunk muscles weakness, but also the end-result of compensatory 
mechanisms to keep the body upright despite weakness of trunk and pelvic muscles. 
Thus, the development of optimal rehabilitation strategies calls for a good understanding 
of all aspects and mechanisms underlying postural deformity, decreased postural control 
and walking capacity in persons with FSHD (Box 3).
From a reversed perspective, patients with FSHD constitute a good clinical model to study 
the functional consequences of specific muscle weakness [57], because they rarely suffer 
from proprioceptive problems, muscle contractures, or other motor deficits such as loss of 
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motor selectivity, spasticity, rigidity or dystonia. In addition, replacement of a muscle by 
fatty tissue occurs generally fast [61], as a result of which many muscles can be considered 
to be either ‘affected’ or ‘non-affected’. In this perspective, it may be more informative to 
study differences between persons with FSHD than to assess group differences between 
patients and healthy control subjects. 
Box 3  Case report
A 45-year-old man with genetically confirmed FSHD1 (D4Z4 repeat: 28 kb) visited the 
outpatient clinic of our rehabilitation department. His disease onset was around the 
age of 18 years and he was known for many years with moderate weakness of the facial 
and shoulder girdle muscles and with mild leg muscle weakness. He complained of 
progressive problems while walking since one-and-a-half year. He was easily fatigued 
after just a couple of hundred meters walking and tended to lose balance in the forward 
direction frequently. Being a paramedic on an ambulance, he had noticed that walking 
was much easier and less fatiguing when pushing a stretcher. 
On clinical examination he was able to slowly raise the arms at shoulder level and he 
could move his lower extremity joints well against gravity in all directions. In addition, 
he was able to get up from a supine position to sitting with straight legs using his 
abdominal muscles. However, he was unable to fully and actively extend his spine. His 
spontaneous posture showed a kyphosis from the lumbar to the cervical region that 
could be corrected passively and largely disappeared when lying supine. 
On MR imaging of the trunk and pelvis his abdominal and pelvic muscles showed only 
few abnormalities, but his back extensors showed massive bilateral fatty infiltration 
across their entire length with sparing of the quadrates lumborum muscles only. 
Based on clinical examination, the possibility of serious back extensor affliction with relatively 
spared abdominal and pelvic muscles was considered. This ‘atypical’ presentation was 
confirmed by the MRI scans, which could explain his recent complaints and progressive 
disability. Supported by the knowledge of individual muscle involvement, the decision 
was made to order a tailor-made trunk corset providing support to the anterior chest, 
middle back, and lower abdomen using a 3-point principle. With this corset the patient 
was able to walk for much longer distances without getting fatigued and experienced 
a decreased tendency to fall. Most importantly, he became less dependent on pushing 
a stretcher to maintain his walking performance at work.
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Methods used in this thesis
Muscle imaging
Valid and reliable quantification of individual muscle involvement in patients with muscle 
disease requires muscle imaging using ultrasound, MRI or CT [47, 63, 64]. CT images are 
derived from differences in absorption of ionizing radiation between different types of 
tissue. Although the quality of the images has improved throughout the last decades, the 
use of a fairly high dose of radiation is a drawback for both research and clinical purposes. 
MRI makes use of a strong magnetic field and radio waves to form images. The technique 
is based on differences in the rate at which proton nuclear spins in different compounds 
or environments return to their equilibrium state after being excited by the magnetic field. 
This can be detected with a higher resolution than obtained with CT imaging. Because of 
the harmless effect of MRI and the possibility to perform quantitative measurements on 
the images, this method is increasingly popular both scientifically and clinically. However, 
MR imaging is relatively time consuming and expensive. Ultrasound imaging is based on 
the delay and amount of reflected sound sent out by a transducer. The advantage of 
ultrasound is that imaging of muscle contractions is possible. In addition, it is fast and 
relatively inexpensive. A disadvantage is that the resolution and quality of the images is 
less than those provided by CT or MRI.        
 In this thesis both CT and MR imaging are used to determine individual muscle involvement 
in patients with FSHD. With regard to the CT scans, individual muscle fatty infiltration is 
determined using a semi-quantitative scale [65]. Fatty infiltration on the MRI scans is scored 
by semi-quantitative grading or by calculation of the proportional area of remaining 
muscle tissue. 
Figure 1 Examples of a transversal CT image (left) and a MR image of the left thigh, from two 
different subjects of the current study.
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Gait analysis 
In the studies of this thesis, analysis of full body movement is performed using a 3D Vicon 
motion analysis system (Vicon MX, Oxford Metrics, Oxford, UK). Body segments are marked 
by attachment of several reflective markers, of which the location can be determined in 
three dimensions by cameras that emit and record infra-red light. From the orientation of 
the segments relative to each other, joint kinematics are calculated in time. The additional 
use of two AMTI force plates (Advanced Medical Technology Inc. Watertown MA. USA) 
embedded in a 10m walkway allows the recording of ground reaction forces in three 
directions, and to subsequently calculate joint moments and powers based on inverse 
dynamics. The movements of the centre of mass are calculated based on full body 
kinematics to obtain information about dynamic postural stability.
Dynamic posturography
Dynamic posturography is an umbrella term for a variety of techniques that employ 
physical perturbations of stance. In this thesis, postural perturbations are imposed with a 
motorized platform that can suddenly be moved by powerful torque motors: the Radboud 
Falls Simulator (RFS) (figure 2). This platform can translate in all directions and rotate in all 
Figure 2 Radboud Falls Simulator.
CHAPTER 1
18
directions except in the transversal plane.  The use of the RFS assures standardized delivery 
of perturbation direction and intensity. The fact that an acceleration phase is followed by 
a sufficiently long phase of constant velocity prevents mechanical stabilization by the 
platform due to its deceleration. In this thesis, balance responses are evoked by platform 
translations in the forward and backward directions to focus on sagittal-plane balance 
control, since falls in FSHD mainly occur in the forward direction [58]. Postural control is 
quantified by analyzing the stepping threshold being the highest intensity of perturbation 
that can be sustained without stepping. In addition, kinematic responses are studied with 
the above-mentioned 3D movement analysis system.
 
Aims and research questions
The general aim of the research presented in this thesis is to increase our insight into the 
mechanisms underlying the balance and mobility problems in patients with FSHD, in 
particularly related to their increased fall risk. More specifically, it is aimed to establish 
relationships between individual muscle involvement and functional performance. An 
additional goal is to improve our understanding of the pattern and asymmetry of muscle 
involvement in patients with FSHD and to contribute to a better functional assessment of 
these patients. 
The following research questions are subsequently addressed:
1. What is the total body pattern of individual muscle involvement in FSHD and is the 
degree of muscle involvement associated with genetic defect size?
2. Which muscle weakness is most critical for loss of sagittal-plane postural control in 
FSHD?
3. What is the association of ankle plantarflexor involvement with gait propulsion in 
FSHD and what compensatory gait strategies are used?
4. To what extent is dynamic postural stability during normal level walking and 
obstructed walking affected in FSHD?
5. What is the added clinical value of anti-gravity tests next to conventional tests for 
assessment of functional capacity in FSHD? 
Outline
In chapter 2 the pattern of selective muscle fatty infiltration is described using semi- 
quantitative CT scans in a large group of patients with FSHD. Frequency and severity of 
individual muscle involvement from the neck and the trunk to the upper and lower 
extremities is analyzed in a group of 70 patients that previously participated in a 
randomized controlled trial investigating the effects of strength training and albuterol on 
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muscle strength. Emphasis is placed on the identification of various patterns of muscle 
involvement, and the asymmetry herein, as well as on the relationship of fatty infiltration 
with muscle strength and genetic defect size. 
 Subsequently, in a selected group of 10 FSHD patients with a large between-subjects 
variability in disease severity, MRI muscle involvement, balance, gait and clinical functioning 
are studied. Relationships between MRI-determined individual muscle involvement and 
several measures of functional performance are described in the following chapters. In 
chapter 3 postural stability is challenged using the RFS and kinematic responses are 
studied. Muscles most critical for loss of balance control in the sagittal plane are identified. 
In chapter 4 underlying mechanism of gait propulsion are determined during walking at 
comfortable and maximum speed, with a focus on ankle plantarflexor involvement and 
possible use of compensatory hip flexion and/or hip extension power. Dynamic gait 
stability is analyzed in chapter 5 during both unobstructed level walking and obstacle 
crossing. Differences between mild and moderately affected patients are assessed. 
Chapter 6 focuses on the added value of four ‘anti-gravity’ performance tests (sit-to-
stance, stance-to-sit, step-up and step-down) next to conventional clinical tasks, such as 
the 10-Meter Walk Test and the Timed Up and Go Test. Chapter 7 concludes this work by 
a summary and general discussion of the studies described in this thesis, including 
suggestions for future avenues.
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Abstract
To better understand postural and movement disabilities, the pattern of total body 
muscle fat infiltration was analyzed in a large group of patients with facioscapulohumeral 
muscular dystrophy. Additionally, we studied whether residual D4Z4 repeat array length 
adjusted for age and gender could predict the degree of muscle involvement. Total body 
computed tomography scans of 70 patients were used to assess the degree of fat 
infiltration of 42 muscles from neck to ankle level on a semi-quantitative scale. Groups of 
muscles that highly correlated regarding fat infiltration were identified using factor 
analysis. Linear regression analysis was performed using muscle fat infiltration as the 
dependent variable and D4Z4 repeat length and age as independent variables. A pattern 
of muscle fat infiltration in facioscapulohumeral muscular dystrophy could be constructed. 
Trunk muscles were most frequently affected. Of these, back extensors were more 
frequently affected than previously reported. Asymmetry in muscle involvement was 
seen in 45% of the muscles that were infiltrated with fat. The right-sided upper extremity 
showed significantly higher scores for fat infiltration compared to the left side, which 
could not be explained by handedness. It was possible to explain 29% of the fat infiltration 
based on D4Z4 repeat length, corrected for age and gender. Based on our results we 
conclude that frequent involvement of fat infiltration in back extensors, in addition to the 
abdominal muscles, emphasizes the extent of trunk involvement, which may have a 
profound impact on postural control even in otherwise mildly affected patients.  
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Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a common form of muscular dystrophy, 
with a clinical presentation of progressive weakness in the muscles of the face, shoulder 
girdle, upper arm, trunk and lower limbs [1]. The extent of muscle abnormalities can be 
variable both between subjects and between different muscles of the body [2-4]. Disease 
progression is also variable, with asymptomatic patients suffering from the least severe 
form and patients with infantile onset and early wheelchair dependency from the most 
progressive form [2, 4]. Disease severity is thought to be partly related to the genetic 
defect, i.e. the length of the residual D4Z4 repeat array [5-7]. 
Previously, we have shown that falling is a major problem in FSHD [8, 9]. In this paper we 
investigate the pattern of total body muscle fat infiltration to better understand which 
muscles might be critical for causing postural instability. Until now, the pattern of muscle 
involvement in FSHD has been described mainly by the clinical manifestations of muscle 
weakness [6, 10, 11]. However, not all muscles can be selectively evaluated using physical 
testing. Muscle imaging, on the other hand, enables the selective assessment of all body 
muscles including those that are hard to assess clinically. 
Only two studies have described the pattern of muscle involvement in groups of up to 
24 patients with FSHD in relation to genetic defect size [3, 12]. These studies yielded 
contradicting results regarding the most frequently involved muscles and associations 
with genetic defect size and muscle function. Wang et al. [12] found that the hamstrings 
were the most severely affected muscles in the lower limbs, whereas Olsen et al. [3] 
reported that the tibialis anterior as well as the hamstring muscle semimembranosus were 
most specifically affected. Furthermore, associations between computed tomography 
(CT) grades for fat infiltration and D4Z4 fragment size reported by Wang et al. [12] were not 
corroborated by Olsen et al. [3]. Asymmetry scores reported by both studies were 
comparable but low considering the clinical observations of characteristic asymmetric 
muscle involvement [10, 11, 13, 14]. Unfortunately, Olsen et al. [3] only assessed muscle 
involvement of the lower extremity.
Because of the few and inconsistent results, this study reports the results of CT muscle 
imaging from neck to ankle level in a large group of 70 well characterized FSHD patients 
using a systematic approach [15]. To better understand postural and movement disabilities 
in FSHD, we aimed to analyze the pattern of individual muscle involvement. We also 
aimed to determine the extent of asymmetry and to relate the degree of muscle 
involvement to muscle strength as well as to genetic defect size, corrected for age and 
gender.  
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Subjects
Seventy patients with FSHD who participated in a previously published randomized controlled 
trial were included in this study [15]. They were recruited via the Dutch Neuromuscular 
Diseases Association and the Neuromuscular Centre Nijmegen. The diagnosis FSHD was 
genetically confirmed as all included patients, or a first-degree relative, had a D4Z4 contraction 
at 4q35 with EcoRI fragments smaller than 38 kb after double digestion with BlnI [16, 17]. 
Self-reported handedness was derived from a questionnaire. The study was approved by 
the Committee on research involving Human Subjects in Nijmegen, The Netherlands. 
Informed consent was obtained from all subjects.
Computed tomography 
CT scans were made in a systematic way [18] to analyze changes in total body muscle 
volume as part of the previously reported trial [15]. Since most body muscles were 
visualized, baseline CT scans from this trial are valuable sources to assess the pattern of 
individual muscle involvement in FSHD. None of the participants had undergone any 
intervention at the time of the baseline scans. All data were collected before 2001. In short, 
subjects were scanned lying supine with their arms alongside the body. The first scan fell 
at an arbitrary position ranging from 0 till 9 cm caudally from the top of the scalp, followed 
by systematic equidistant sections (10 cm) in the transverse plane throughout the 
rostrocaudal axis of the body. 
 Fat infiltration was scored by a research assistant (RvA) who had been extensively 
trained to grade muscle involvement on CT scans. Of all 70 available CT scans fat infiltration 
was determined for  42 muscles on both the left and right body side, using the semi- 
quantitative four-point scale of Schwartz et al. [19]. Muscles were graded as: 1. normal 
appearance; 2. ‘early moth-eaten’ appearance (i.e. scattered areas of reduced attenuation); 3. 
‘late moth-eaten’ appearance with many discrete areas of reduced attenuation and some 
confluent zones of abnormality; 4. ‘washed out’ appearance either with large confluent 
zones of low attenuation or complete replacement of the muscle by fatty tissue, with a rim 
of fascia remaining. Muscles were graded based on the most affected slice. Reliability of 
scoring was tested by blindly re-testing all muscles in a random sample of 10 subjects; an 
intraclass-correlation coefficient (ICC) of 0.95 was found. Examples of CT slices at shoulder, 
upper leg and lower leg regions are displayed in Figure 1.
Muscle strength testing
For comparison of fatty infiltration grades with muscle strength, the Maximum Voluntary 
Isometric Strength (MVIC) was assessed. Strength assessments were performed at the 
same day as the CT scans were made. Measurements were performed on a Quantitative 
Muscle Assessment testing system [15]. Shoulder abductors, elbow flexors, elbow extensors, 
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knee extensors, knee flexors and ankle dorsal flexors were assessed. Muscles were tested 
on both body sides in a standardized way by one well-trained neurology resident (EvdK). 
The highest force (kg) of two maximal isometric contractions during 3-4 seconds was 
used for data analysis.   
Statistical methods 
Because of the non-linearity of the four-point scale, the CT grades were dichotomized into 
‘fat infiltration’ (grades 2-4) versus no ‘fat infiltration’ (grade 1). The grades of identical 
muscles at the right and the left side of the body were combined into one score. Fat 
infiltration was considered present if either side was affected. To identify the total body 
pattern of muscle fat infiltration, ‘factors’  were identified consisting of muscles that were 
highly correlated regarding the presence of fat infiltration. This was done by factor analysis 
using principal axis factoring as the extraction method. The varimax rotation with Kaiser 
normalization was used to simplify the interpretation of the factors. Extraction of the 
factors was based on the Kaiser’s criterion for Eigenvalues being equal to or greater than 
1.5. Cronbach’s alpha was used to calculate the internal consistency of the constructed 
factors [20]. Muscles with more than 10 missing values were not included in the factor 
analysis. 
Figure 1  On the left side, a visual representation of the factors (muscle groups ordered by degree 
of fatty infiltration) from red (most frequently affected) to yellow (least frequently affected). On the 
right side examples of three computed tomography (CT) slices at shoulder, upper leg, and lower 
leg level showing fatty infiltration in the mm. longissimus pars thoracale (1) , mm. rectus femoris (2), 
hamstrings (3) and mm. tibialis anterior (4).
Set G 
Set F 
Set C 
Set E 
Set B 
Set A 
Set D 
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 Fat infiltration of an individual muscle was defined as ‘asymmetric’ if fat infiltration 
was found on one side while the contralateral side showed normal muscle tissue. The 
asymmetry score was graded as follows: +1, if fat infiltration was only found on the right 
side; 0, in the case of fat or no fat infiltration on both sides; -1, if fat infiltration was only 
found on the left side. The percentage asymmetry of three body parts (upper extremities, 
trunk and lower extremities) was calculated as the sum of the asymmetry scores of the 
muscles divided by the number of muscles of that body part (x100). A one sample t-test 
was used to separately test the percentage asymmetry of the total body as well as of each 
body part for statistical significance (i.e., difference from zero). The two samples t-test was 
used to test the difference in the percentage asymmetry between right handed and left 
handed patients, again for each body part separately. Additionally, asymmetry scores 
were calculated for differences in the degree of fat infiltration between the left and right 
body side, reflected by all differences in CT grades. 
 A linear regression model was constructed to study the influence of residual D4Z4 
repeat length (kb) on the percentage of muscles with fat infiltration in each body part, 
adjusted for age (years) and gender (0 represents the male gender, 1 the female gender). 
The percentage fat infiltration of a body part was calculated as the number of muscles 
with fat infiltration divided by the number of muscles of that particular body part (x100).  
 To evaluate whether a higher CT grade was associated with decreased muscle 
strength, Spearman correlations coefficients were calculated. Shoulder abduction strength 
was correlated to CT grades of the m. deltoideus, elbow flexion strength to the m. biceps 
brachii, elbow extension strength to the m. triceps brachii, ankle dorsiflexion to the m. 
tibialis anterior, knee extension to the quadriceps muscles, and knee flexion strength to 
the CT grades of the hamstrings.
Results
Subjects
Patient characteristics are displayed in table 1. The group of 70 patients consisted of 45 
men and 25 women with a mean (± SD) age of 38 (± 11) years. The average (± SD) D4Z4 
repeat length was 26 (± 6) kb. A wide range of disease severity was present; e.g., two 
patients showed only facial muscle weakness, whereas four patients made use of a 
wheelchair. All patients were able to walk ten meters, 37 of them made use of ankle-foot 
orthoses or orthopedic shoes. The self-reported handedness was right-sided for 63 and 
left-sided for 6 patients. One patient did not report preferred handedness. 
Muscle involvement 
Table 2 shows the percentage of subjects with fat infiltration on either side of the body for 
all 42 muscles assessed. In some patients it was not possible to properly assess smaller 
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muscles; these were treated as missing values. Large differences in the frequency of fat 
infiltration were identified between individual muscles. In the upper extremity the deltoid 
muscle (68%) was most frequently affected, followed by the biceps brachii muscle (57%). 
In the trunk, more than half of the muscles were infiltrated with fat in nearly all patients 
(≥85%). The trapezius muscle (97%) and the m. latissimus dorsi (94%) were most frequently 
affected. The m. semimembranosus was the most frequently affected muscle of the lower 
extremity (89%), followed by the anterior tibial muscle with 71%.
Factor analysis
Factor analysis was performed using 37 of the 42 muscles. Five muscles were excluded 
from the analysis because of too many missing values (Table 2). The analysis resulted 
in seven factors explaining 61% of the total variance (based on 29 muscles). Each of the 
seven factors represents a group of muscles that match regarding the presence of fatty 
infiltration. Table 3a shows the muscles assigned to each specific factor. High Cronbach’s 
alpha values were found for all factors (0.54 – 0.96), indicating good internal consistencies. 
Table 3b shows the ordering of the factors based on frequency of involvement (of at least 
one muscle within the factor). The four most frequently involved factors (muscle groups) 
were afflicted in more than 90% of the subjects. In figure 1 the pattern of muscle fat 
infiltration is visualized. This figure shows the most frequently involved muscles in red, 
while the least frequently involved muscles is displayed in yellow.
Asymmetry
Table 4 shows the percentage asymmetric fat infiltration by body part. We found that the 
muscles of the right upper extremity were, as a percentage, significantly more often 
infiltrated with fat compared to the left side (Δ7.0% (95% CI: 2.4; 11.6)). A similar result 
was found for the right-handed patients only (Δ7.4% (95% CI: 2.4; 12.4)). Nevertheless, the 
mean CT grade was not significantly different for the upper extremity muscles on either 
body side. For the left-handed patients no difference in the frequency or degree of fatty 
Table 1  Patient characteristics.
Male / Female, n   45 / 25
Dominant hand (R/L) 63 / 6
Age, year     38  ± 11
Height, cm 180  ± 9 
Weight, kg     76  ± 13
D4Z4 fragment size, kb   26  ± 6
Values for age, length, weight and D4Z4 fragment size are means ± SD
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Table 2   The percentage of subjects with muscle fat infiltration at either the left or  
the right body side. Muscles are ordered based on their somatotopic location 
(from upper to lower extremity) and frequency of involvement. 
n
Percentage  
of muscles 
 infiltrated with fat 
Upper extremity
    m. deltoideus 68 68
    m. biceps brachii 70 57
    m. triceps brachii 70 43
    forearm flexors / pronators 68 19
    forearm extensors / supinators 68 18
Trunk
    m. trapezius 68 97
    m. latissimus dorsi / m. teres major 70 94
    m. obliquus ext-int-transv abdominis 68 90
    m. rhomboideus 63 89
    m. pectoralis major/minor 70 89
    m. serratus anterior 70 89
    m. rectus abdominis 69 86
    m. longissimus (pars thoracalis) 70 85
    m. longissimus (pars lumbalis/iliocostalis) 70 59
    m. subscapularis 59 17
    m. sternocleidomastoideus 57 14
    m. infraspinatus 63 14
    m. iliopsoas 69 14
    neck extensors 70 10
    neck flexors(m. longus capitis /m. longus colli) 40 5
Lower extremity
    m. semimembranosus 70 89
    m. tibialis anterior 70 71
    m. semitendinosus 70 70
    m. adductor longus / magnus 70 67
    m. biceps femoris 70 67
    m. rectus femoris 70 64
    m. gluteus minimus 69 61
    m. extensor digitorum / hallucis longus 70 60
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infiltration between the right and left upper extremity was found (Δ3.3% (95% CI: -5.2; 12.0)). 
The percentage of individual muscle involvement for upper extremity muscles is described 
in table 5. Of all muscles infiltrated with fat, 23% showed asymmetric involvement. When 
asymmetry was calculated taking into account also the differences in CT grades, a whole 
body asymmetry score of 45% was found.
Muscle strength 
Table 6 shows the average strengths of the muscles grouped by CT grade for both the left 
and the right side of the body. For nearly all movements strong and significant (inverse) 
correlations were found between CT muscle involvement and muscle strength on both 
sides of the body. Only for shoulder abduction and deltoid CT grade, correlations lower 
than rs=0.45 were found.  
Table 2   Continued. 
n
Percentage  
of muscles 
 infiltrated with fat 
Lower extremity
    m. vastus lateralis 70 56
    m. gastrocnemius (pars mediale) 70 56
    m. peroneus longus / brevis 70 50
    m. adductor brevis / m. pectineus 70 47
    m. vastus medialis 70 47
    m. vastus intermedius 70 44
    m. soleus 70 43
    m. gracilis 69 42
    m. gluteus medius 69 38
    m. tensor fasciae latae 70 37
    m. sartorius 70 31
    m. tibialis posterior 70 31
    m. gastrocnemius (pars laterale) 70 31
    m. gluteus maximus 69 25
n: number of patients with a valid right or left muscle CT grade
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Table 3a   Sets of muscles determined by factor analysis. 
A. B. C. D. 
m. iliopsoas m. gastrocnemius 
medialis
m. adductor longus/
magnus 
m. triceps brachii
m. gluteus maximus m. gastrocnemius 
lateralis
m. semimembranosus forearm flexors /  
pronators 
m. gluteus medius m. soleus m. semitendinosus forearm extensors/
supinators 
m. tensor fascia latae m. peroneus longus / 
brevis
m. biceps femoris m. subscapularis *
m. sartorius m. extensor digitorum /
hallucis longus
m. rectus femoris m. infraspinatus *
m. gracilis 
m. vastus intermedius
m. vastus medialis
E. F. G. 
m. serratus anterior m. latissimus dorsi m. trapezius 
m. longissimus lumbalis / 
iliocostalis 
m. longissimus thoracalis m. rectus abdominis 
m. gluteus minimus m. rhomboideus * m. tibialis anterior 
The sets of muscles determined by factor analysis. Within the sets, muscles are categorized by body location 
in the craniocaudal direction.
*  these muscles were omitted from factor analysis because of too few valid data, but are expected to be part 
of the set of muscles indicated.
Table 3b   The Eigenvalue, explained variance, Cronbach’s α and the frequency of 
involvement of the sets of muscles based on factor analysis, organized by 
frequency of involvement. Colors refer to the body mapping of Figure 1.
EV Var (%) n Cα Pi (%)
G 1.5 3.8 3 0.54 99
F 1.8 4.5 2 0.64 94
C 2.5 6.2 5 0.82 91
E 2.1 5.2 3 0.60 90
B 3.3 8.2 5 0.79 76
A 11.1 27.7 8 0.96 74
D 2.2 5.5 3 0.73 51
EV,  Eigenvalue of the factor. Var, explained variance of the sets of muscles. n, the number of muscles within the 
set. Cα, Cronbach’s alpha. Pi, percentage of patients with fat infiltration in at least one muscle within the set. 
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D4Z4 constriction and muscle fat infiltration
Corrected for age and gender, we found statistically significant (inverse) relations between 
the D4Z4 repeat length and the percentage of fat infiltrated muscles of the trunk (R2 = 0.19 
(β -0.8, 95% CI: -1.5; -0.2)), of the lower extremity (R2 = 0.34 (β -1.7, 95% CI: -2.7; -0.7)) and, 
consequently, also of the total body (R2 = 0.29 (β -1.3, 95% CI: -2.1; -0.5)). No significant 
relation was found between the D4Z4 repeat length and fat infiltration of the upper 
extremity. Thus, the percentage variance of muscle involvement explained by the 
regression model was 34% for the lower extremity and 19% for the trunk (Table 7). Overall, 
compared to men of the same age with a similar D4Z4 repeat length, females had a 10.9% 
higher percentage of total body muscle involvement. 
Table 5   The percentage of subjects with upper extremity muscle fat infiltration  
at the right, left, both and either side of the body, respectively. Muscles are 
ordered based on frequency of involvement (either left or right). 
Percentage of muscles infiltrated with fat
n Right (%) Left (%) Both (%) Either (%)
Upper extremity
    m. deltoideus 68 56 56 44 68
    m. biceps brachii 70 53 37 33 57
    m. triceps brachii 70 37 33 27 43
    forearm flexors / pronators 68 16 12 9 19
    forearm extensors / supinators 68 16 9 7 18
n: number of patients with a valid right or left muscle CT grade
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Table 6   Average Maximum Voluntary Isometric Contraction (MVIC) in kg, during a spe-
cific movement, of muscles with normal aspect of muscle tissue (CT grade 1), 
of muscles with fatty infiltration (CT grade 2-4), and of muscles with different 
grades of fatty infiltration separately, for both body sides. Spearman correla-
tion coefficients (rs) between muscle CT grade and MVIC are calculated.
MVIC
Upper extremity
I: Shoulder abduction II: Elbow flexion III: Elbow extension
CT muscle aspect L  R L R L R
meansd;n meansd;n meansd;n meansd;n meansd;n  meansd;n
Normal 9.63.9;30 7.94.0;29 17.36.3;42 21.46.3;31 11.24.1;45 11.23.7;42
Fatty infiltration 
(grade 2-4)
6.14.3;37 6.34.4;37 12.66.2;26 10.67.8;37    5.94.8;23    5.64.7;26
grade 2 6.44.4;33 7.15.1;25 15.14.0;16 15.06.6;17    9.63.5;10    8.53.9;12
grade 3 4.02.8;4 4.61.5;11 12.43.6;6 13.46.6;8    4.74.0;9    5.54.0;9
grade 4 - 2.9-;1    2.30.5;4    2.41.1;12    0.30.7;4    0.00.0;5
rs -0.41** -0.27*  -0.66**  -0.75** -0.64** -0.68**
Lower extremity
CT muscle aspect
IV: Knee flexion V: Knee extension VI: Ankle dorsiflexion
L R L R L R
meansd;n meansd;n meansd;n meansd;n meansd;n meansd;n
Normal 14.66.4;12 16.27.4;17 35.812.5;29 38.914.0;24 18.26.2;25 18.97.5;20
Fatty infiltration 
(grade 2-4) 
grade 2
  
9.76.7;56
 
9.56.9;51 22.711.7;39 22.612.6;44
   
9.28.1;43
  
8.27.9;48
15.35.9;18 15.56.2;15 31.07.3;22 31.910.0;22 15.18.1;18 13.97.8;20
       grade 3 11.85.3;12 11.75.9;10 18.310.6;6   21.78.5;11 6.84.5;9 5.74.4;8
grade 4   5.13.7;26    4.93.9;26 11.57.0;11    9.25.6;11 4.05.0;16 3.85.7;20
rs  -0.67** -0.66** -0.71** -0.75** -0.68** -0.68**
The muscles recruited for the different movements were: I: deltoideus, II: biceps brachii, III:triceps 
brachii, IV: hamstrings, V: quadriceps, VI: tibialis anterior.
* Significant at the level of p<0.05
** Significant at the level of P<0.01
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Discussion
To better understand the frequently occurring postural and movement disabilities [9], 
we aimed to identify the total body pattern of skeletal muscle fat infiltration in a large group 
of patients with genetically confirmed FSHD. We also studied associations of the degree 
of muscle involvement with muscle strength and genetic effect size. We demonstrated 
a pattern of muscle fat infiltration with relatively frequent involvement of the back extensors. 
In addition, a high percentage of asymmetry was found with more frequent involvement 
of the right body side. Muscle strength was strongly associated with CT muscle involvement, 
except for shoulder abduction. Overall, we found 29% explained variance of muscle 
involvement by D4Z4 repeat length, corrected for age, which indicates that other than 
genetic factors must influence disease severity as well.
Based on factor analysis, groups of muscles (‘factors’) were identified that highly correlated 
regarding the presence of fat infiltration. Because of the progressive nature of FSHD, 
we assume that the frequency of involvement of these factors represents the inverse 
sequence at which the muscles become involved during the course of the disease. 
We were able to sketch a total body pattern of muscle fat infiltration in FSHD, not taking 
into account the facial muscles (figure 1). The most frequently involved muscle group that 
was identified (‘factor G’) consisted of the trapezius, rectus abdominis, and the tibialis 
Table 7   The regression formula to calculate the estimated muscle fat infiltration 
from the D4Z4 repeat length, age and gender, for the total body, the upper 
extremity, the trunk and the lower extremity. A linear regression model was 
constructed for each body part separately, showing significant contributions 
of D4Z4 length and age to lower extremity, trunk and total body muscle 
 i nvolvement, and an effect of female gender on total body muscle involvement.
Intercept D4Z4 length 
(kb)
Age 
(years)
Gender 
(female)
R square 
(%)
β (95%CI) β (95%CI) β (95%CI)
Total body 50 - 1.3 (-2.1; -0.5) 0.91 (0.43; 1.38) 10.9 (0.8; 21.0) 29
Upper extremity 53 - 0.5 (-1.9; 0.9) - 0.07 (-0.86; 0.73) 12.0 (-5.0; 29.1) 4
Trunk 72 - 0.8 (-1.5; -0.2) 0.56 (0.064; 1.06) 7.8 (-0.2; 15.8) 19
Lower extremity 39 - 1.7 (-2.7; -0.7) 1.34 (0.76; 1.92) 12.0 (-0.4; 24.4) 34
CI: Confidence Interval
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anterior with individual frequencies of involvement of 97%, 86% and 71%, respectively. 
These results support the clinical experience thatthese muscles are among the earliest 
affected by FSHD [11, 21, 22]. The combination of these muscles in the same factor indicates 
that if one of these muscles is involved, it is likely that the other muscles are also affected, 
which contrasts with previous studies that described involvement of these muscles in a 
temporal order [6, 10, 11, 21, 22].
The next group of muscles that could be identified was ‘factor F’ with a frequency of 
involvement of 94%. This factor consisted of the latissimus dorsi and the thoracic part of 
the longissimus muscle, which revealed individual frequencies of involvement of 94% and 
84%, respectively. Surprisingly, no study has previously reported such frequent 
involvement, which may be related to the difficulty encountered when clinically testing 
these trunk muscles individually. In the present study, a similar testing problem is reflected 
in the weak association between shoulder abduction and CT grade of the  m. deltoideus, 
which may be caused by the difficulty to exert abduction force when scapula stabilization 
is poor, even though the m. deltoideus may be unaffected. 
The third group (‘factor C’) was formed by all three hamstring muscles, the rectus femoris, 
and the adductor longus/magnus with an overall frequency of 91% involvement. 
Individual frequencies of involvement ranged from 64% to 89%. The high percentage of 
semimembranosus affliction has previously been reported [3, 12], however, the strong 
relationship between all hamstrings muscles, the rectus femoris and the adductors is a 
novel finding. 
The last group with a high frequency of overall involvement (90%) was ‘factor E’, which 
consisted of the serratus anterior (89%), the lumbar part of the longissimus (59%), and the 
gluteus minimus (61%). The frequent serratus anterior involvement is well known and 
affects the stabilization of the scapula [11]. The strong relationship with both the lumbar 
longissimus and gluteus minimus indicates that these muscles are also relatively frequently 
affected. Again, the involvement of these latter muscles may be overlooked because they 
are harder to test individually. Indeed, manual muscle testing may not be reliable for 
muscles that act together in moving a joint [3, 21].
From individual muscle involvement frequencies (table 2), it is apparent that the trunk 
muscles were most frequently affected, with half of the muscles showing fat infiltration in 
more than 85% of the subjects. The abdominal muscles and the thoracic part of the back 
extensors showed similar frequencies of involvement (85-90%), which seems to be in 
contrast with previous studies reporting that the rectus abdominis muscle becomes 
involved much earlier than the back extensors [21]. Frequent back muscle involvement 
accompanied by abdominal weakness may be an important determinant underlying 
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postural instability in patients with FSHD [9, 23, 24]. A remarkable finding was the high 
percentage of involvement of the oblique and transverse  abdominal muscles (90%), next 
to the rectus abdominis (86%), which indicates that abdominal involvement is widespread.
 
Interestingly, while all muscles involved in stabilization of the trunk were affected in more 
than half of the patients, the m. iliopsoas was spared in most patients, suggesting late 
involvement or perhaps even ‘insensitivity’ of this muscle to fat infiltration by FSHD. This 
finding is in line with the results of Olsen et al.[3], but seems to be in contrast with those 
of Wang et al. [12]. However, the latter authors reported that subjects with m. iliopsoas 
involvement suffered from the infantile form of FSHD, which is characterized by early 
disease onset, rapid progression, and early wheelchair dependency [25, 26]. Unlike trunk 
instability, dropped head has been documented as an infrequent sign of axial weakness in 
FSHD [27], which is supported by our finding that neck extensors were involved in only 
10% of the subjects.
Remarkably, some muscles were relatively frequently affected, but could not be assigned 
with other muscles to one specific factor. These muscles are, therefore, not visualized in 
figure 1. One typical muscle was the pectoralis major/minor that was affected in 89% of all 
patients. This finding is coherent with the fact that loss of pectoralis muscle volume and 
function has frequently been noted as one of the earliest clinical signs of FSHD [11, 21]. 
Other notable muscles were the m. deltoideus and the m. rhomboideus being affected in 
68% and 89% of all patients, respectively. The latter muscle could not be assigned to 
‘factor F’ due to a lack of valid data (see table 3a). A relatively high explained variance and 
Eigenvalue were found for ‘factor A’, which consisted of many of the pelvic and anterior 
thigh muscles. This finding points toward a relatively strong correlation of involvement, 
which should not be confused with a high frequency of fat infiltration. In fact, most pelvic 
and anterior thigh muscles were affected in less than 50% of the patients. 
Regarding asymmetry at the level of individual muscles, we found a relatively large 
proportion (45%) of asymmetric fat infiltration, which is in contrast with three previous 
imaging studies that reported asymmetric involvement in merely 11% [27] of the whole 
body, 15% [3]  and 18% [12] of the lower extremity, and 27% of upper extremity muscles 
[12]. This discrepancy may be due to the fact that previous studies evaluated relatively 
small groups , or focused on a specific subgroup of patients [3, 12, 27]. In our study, fat 
infiltration favored the right body side, especially in the upper extremities, which is 
consistent with previous observations [11, 14]. Although it has been postulated that 
asymmetry of muscle fat infiltration is related to handedness of FSHD patients [11, 28, 29], 
we were not able to confirm this hypothesis. We found that left-handed patients showed 
similar fat infiltration grades for the right upper extremity muscles compared to the left. 
Additionally, there was no significant difference in asymmetry between right- and 
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left-handed patients. Previously, a study by Tawil et al. [28] also found differences in muscle 
strength between the left and right body side unrelated to handedness. Overall, the 
proportion of left-handed patients seems too small to draw definitive conclusions about 
the cause of asymmetric muscle involvement favoring the right side. Further research is 
needed to determine whether muscle fat infiltration in FSHD is more severe on the right 
body side due to genetic, function-related, and/or anatomical/developmental mechanisms.
 
We found merely a weak association between total amount of fatty infiltration of the body 
muscles and residual D4Z4 repeat length, corrected for age and gender (rs = -0.29). 
Previously, inconsistent associations were found between D4Z4 repeat length and muscle 
strength or clinical severity score [5, 6, 30, 31], while strong associations were found 
between D4Z4 repeat length and age of onset (rs > 0.80) [7, 25, 31-33]. One study has found 
associations between D4Z4 repeat length and fatty infiltration grades of the upper and 
lower extremities, which were based on a small group (n = 24) and not adjusted for age 
and gender (upper limb: rs = 0.55, p = 0.007, lower limb: rs = 0.68,  p < 0.0001) [12], whereas 
another study did not find any correlation with lower extremity muscle involvement [3]. 
We now report significant associations of D4Z4 repeat length with trunk and lower 
extremity muscles affliction based on total body muscle involvement. Nevertheless, the 
overall explained variance of muscle involvement by residual D4Z4 repeat length was 
limited, which implies that there must be other than the known genetic factors that 
determine the degree of muscle fat infiltration in FSHD. Perhaps the recently identified 
chromatin modifier of D4Z4, SMCHD1, of which mutations also cause increased expression 
of DUX4, plays a role in determining the genotype-phenotype association [34, 35]. Finally, 
although penetrance of FSHD is higher in males compared to females [31, 36, 37], our 
results counterintuitively reveal that among affected persons the detrimental effect of a 
certain D4Z4 repeat length on fat infiltration and associated muscle weakness is stronger 
in females compared to males of the same age with a similar D4Z4 repeat length. 
Study limitations 
Although both CT and MRI scans are widely used methods to assess muscle fat infiltration 
in neuromuscular diseases, MRI is nowadays preferred since it allows objective quantitative 
assessment of fat infiltration and because patients are not exposed to radiation [1, 38, 39]. 
Still, CT is a well standardized method to assess the aspect and shape of muscles allowing 
operator-independent evaluation of fatty degeneration of superficial as well as deep 
muscle groups [18, 38, 40]. A limitation of the present study is the semi-quantitative 
method that was used to assess muscle fat infiltration. Although patchy replacement of 
muscle tissue was incorporated in the scale, the fact that the most affected part of the 
muscle was used for grading may have led to an overestimation of the degree of fat 
infiltration in muscles that were only locally affected. For example, we found a high 
percentage of deltoid involvement, while only one patient showed full replacement of 
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deltoid muscle tissue by fat (grade 4) on one body side. Since a CT grade of 2 in the deltoid 
muscle did not lead to a large decrease in shoulder abduction strength (table 6), a 
discrepancy may exist between clinical experience and the frequency of m. deltoideus 
involvement in the current study. Another limitation is the cross-sectional design, which 
did not allow to establish temporal relationships. Longitudinal, quantitative muscle imaging 
studies are required to reliably establish the sequence of muscle involvement in FSHD. 
Conclusion
The current study presents the pattern of fat infiltration based on CT scans of 42 different 
muscles in 70 patients with facioscapulohumeral muscular dystrophy. Muscle groups 
were identified based on comparable frequency of involvement using factor analysis. The 
results indicate that back extensors were relatively frequently affected by FSHD, in addition 
to the abdominal muscles, which may explain the postural control problems in these 
patients. Involvement of trunk and leg muscles correlated with the size of the genetic 
defect, but more so in women than in men. Significant asymmetry of muscle involvement 
was observed in the upper extremities indicating right-sided predominance, independent 
of handedness. These novel findings, obtained from a large and relatively unselected 
study sample, can be used to improve clinical management of patients with FSHD, for 
instance with regard to restoring postural control and mobility and for prescribing 
functional exercises.
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Abstract
Background. Although it is known that muscle weakness is a major cause of postural 
instability and leads to an increased incidence of falls in patients with neuromuscular disease, 
the relative contribution of lower extremity and trunk muscle weakness to postural instability 
has not been studied well. 
Methods. We determined the relationship between muscle fatty infiltration and sagittal- 
plane balance in ten patients with facioscapulohumeral muscular dystrophy. Sagittal-plane 
platform translations were imposed in forward and backward direction on patients with 
facioscapulohumeral muscular dystrophy and healthy controls. Stepping thresholds were 
determined and kinematic responses and centre-of-mass displacements were assessed 
using 3 dimensional motion analysis. In the patients, magnetic resonance imaging was 
used to determine the amount of fatty infiltration of trunk and lower extremity muscles. 
Findings.  Stepping thresholds in both directions were decreased in patients compared 
to controls. In patients, significant correlations were found for fatty infiltration of ventral 
muscles with backward stepping threshold and for fatty infiltration of dorsal muscles 
with forward stepping threshold. Fatty infiltration of the rectus abdominis and the back 
extensors explained the largest part of the variance in backward and forward stepping 
threshold, respectively. Centre-of-mass displacements were dependent on intensity and 
direction of perturbation. Kinematic analysis revealed predominant ankle strategies, except 
in patients with lumbar hyperlordosis. 
Interpretation. These findings indicate that trunk muscle involvement is most critical 
for loss of sagittal-plane postural balance in patients with facioscapulohumeral muscular 
dystrophy. This insight may help to develop rehabilitation strategies to prevent these 
patients from falling. 
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Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary myopathy that 
causes weakness of the face, shoulder girdle, trunk and leg muscles due to progressive 
fatty infiltration [1-3]. Although nearly all muscles of the trunk and lower extremities can 
be affected, individual muscle involvement varies greatly between patients [2, 4]. 
Generally, disease progression is slow, but as soon as a muscle becomes affected the 
process towards total muscle fattening occurs relatively fast [5]. The degree of fatty 
infiltration shows a high correlation with both muscle strength and the Ricci [6] clinical 
severity score [5, 7, 8]. As a consequence, patients with FSHD suffer from postural instability 
and show a high incidence of falls, mainly in the forward and backward direction [9, 10]. 
Since FSHD does not cause disturbances of muscle tone, motor coordination, sensibility, 
or loss of joint range of motion, it constitutes a good model to examine the influence of 
specific patterns of muscle weakness on the control of posture and balance [11, 12]. 
In a previous study from our group, Horlings and coworkers have included patients with 
distal spinal muscular atrophy (SMA; predominantly distal weakness of arms and legs) and 
patients with limb-girdle muscular dystrophy (LGMD; predominantly proximal weakness 
of trunk, arms and legs) as models to investigate the contribution of proximal versus distal 
leg muscle weakness to postural instability. By contrasting responses to balance 
perturbations, it was demonstrated that participants with distal weakness had larger 
sagittal-plane Centre-of-Mass (CoM) displacements compared to those with proximal 
weakness. Hence, loss of distal leg muscle strength seemed to be a critical factor in 
sagittal-plane instability [12]. However, in this study, the contribution of trunk muscle 
weakness to postural instability was not addressed, although trunk muscles play a critical 
role in the recovery from balance perturbations [13-17]. 
In persons with FSHD, it is well known that abdominal muscles are afflicted relatively early 
in the course of the disease, whereas back extensor muscles were not believed to show 
major involvement [1, 18]. In a recent study, however, it was demonstrated that the back 
extensor muscles did exhibit substantial fatty infiltration in many FSHD patients (85%) as 
well, including people in early disease stages [7]. We expect that this frequent involvement 
of the back extensors, in addition to the abdominal muscles, will greatly affect core 
stability with, consequently, profound impact on postural control. Similarly, a previous 
study also suggested a possible association between trunk muscle weakness in people 
with FSHD and decreased control of upper body movement during walking [19]. 
Only in healthy subjects, the effects of lumbar extensor versus ankle plantar flexor weakness 
on balance recovery following a forward postural perturbation have been contrasted by 
inducing localized muscle fatigue by repetitive movement. The maximum perturbation 
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that could be withstood without stepping was not significantly affected by localized 
muscle fatigue in either muscle group, but CoM excursions increased in both conditions 
[20]. Although it is unknown whether fatigue-induced muscle weakness is similar to 
FSHD-related loss of strength, we assume that the weakness of ~30% as induced in the 
paper of Davidson et al., was only minor compared to the loss of muscle strength that 
patients with FSHD experience (e.g. almost 50% lower quadriceps strength in ambulatory 
FSHD patients than in controls [21]). Hence, the specific effects of (severe) leg versus trunk 
muscle weakness on postural stability have not been thoroughly investigated.
The aim of this study was to determine whether the affliction of trunk or lower limb muscles is 
ultimately most critical for the loss of postural control by studying the responses to sagittal-plane 
balance perturbations in patients with FSHD. We hypothesized that trunk muscle involvement 
would be more critical than lower extremity muscle involvement for sagittal-plane balance 
control. To this aim we performed radiological assessments of muscle fat infiltration (FI) 
in ten patients with FSHD of different disease severity as well as balance assessments with 
full-body kinematic recordings of these FSHD patients and ten healthy control subjects. 
Methods
Participants
Ten adults with genetically confirmed FSHD, based on blood DNA testing, were recruited 
via the rehabilitation and neurology departments of our university hospital during a 
period of six months. We aimed to include a range of disease severities; from patients who 
did not yet experience postural problems during activities of daily life on the one end of 
the spectrum to severely affected patients who were barely able to walk at the other end. 
Specific exclusion criteria were: the presence of other neurological diseases affecting muscle 
strength, balance or sensibility; contra-indications for physical exercise; metal implants 
(contra-indication for MRI); and pregnancy. Ten healthy controls of similar age and gender 
were also included. This study was approved by the local medical-ethical committee. All 
subjects gave written informed consent.
Procedure
During an intake visit a physiatrist checked the inclusion and exclusion criteria and 
determined the clinical severity score (CSS) as described by Ricci et al. [6] for each patient. 
To grade balance performance in the patients, the Berg Balance Scale (BSS) was used. 
Following the intake visit, the radiological assessments were performed on the same day. 
The balance assessments in the movement laboratory were done within 8 weeks after 
the intake. Healthy controls did not undergo radiological assessments and were only tested 
in the movement laboratory. 
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Radiological assessments
The patients were examined with a 3.0 Tesla (T) MR system (Skyra; Siemens, Erlangen, 
Germany) using the body coil. Imaging of the trunk and lower extremity was performed 
using transverse and coronal turbo spin echo T1weighted sequences. Transverse images 
were obtained from four different regions; sequences of ten slices each of the trunk at the 
level of vertebra L4, the pelvis between the symphysis and the anterior superior iliac spine, 
the upper leg at 15 centimeters proximal to the apex of the patella, and the lower leg at 15 
centimeters below the patella (TR 750, TE 9.4, turbo factor 3, matrix 256x256, slice thickness 
5mm, slice gap 1mm). In these regions, also coronal imaging was performed from the 
anterior to posterior side of the body (TR 650, TE 10, turbo factor 2, matrix 512x512, slice 
thickness 5 mm, slice gap 0.5mm). The degree of FI was scored by one experienced 
musculo skeletal radiologist (JR) on a modified four-point scale for 70 muscles (35 on each 
body side) within the regions covered by MRI. This semi-quantitative score correlates 
inversely to muscle strength [22]. The FI of the muscles was graded as: 1. normal 
appearance, with a homogeneous low signal intensity of the muscle; 2. early ‘moth-eaten’ 
appearance (i.e. scattered areas or beginning confluence of high signal intensity consistent 
with fat; less than fifty percent of muscle affected); 3. scattered areas of high signal 
intensity as well as confluent zones of hyperintensity; more than fifty percent of muscle 
affected; 4. ‘washed-out’ appearance consistent with complete replacement of the muscle 
by high signal intensity fat and connective tissue, with a rim of fascia remaining (end-stage 
disease). The presence of muscle atrophy was not considered in the semi-quantitative 
scoring system, given the large variation in muscle size even in healthy subjects. Because 
of the minor differences between left and right, for each muscle the FI score was calculated 
as the average of the MRI FI scores of the left and right body side. For each patient, the 
number of muscles with an average FI score ≥ 2 was determined. 
A lumbar hyperlordosis is often seen in patients with FSHD [23, 24] and may affect the 
kinematic response of the body to a perturbation. Therefore, weight-bearing total spine 
conventional radiographs were made in both the anterior-posterior and lateral direction 
to assess the spinal curvature. The lumbar lordosis was measured in the sagittal plane as 
the angle between the inferior endplate of vertebra L5 and the superior endplate of 
vertebra L1 (Cobb’s angle) [25]. 
Balance assessments
To quantify the maximum sustainable balance perturbation we used an instrumented 
movable platform to perform standardized balance perturbations (Radboud Falls Simulator). 
Subjects were exposed to anterior and posterior translations with an acceleration period 
of 300ms, a constant-speed period of 500ms, and a deceleration period of 300ms. An 
anterior translation causes a backward perturbation and a posterior translation a forward 
perturbation of the body. Prior to the perturbations, subjects held their hands on their 
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waist. Subjects wore a safety harness attached with a cable to a sliding rail at the ceiling 
that allowed frictionless movement. They were instructed to try their hardest to overcome 
the perturbations while keeping their feet in place. A trial was considered successful if the 
subject recovered balance without stepping or grabbing the surrounding handrails. 
 One first trial in both directions was performed to familiarize subjects with the type 
of perturbations. Thereafter, perturbations were administered according to a defined trial 
sequence, which existed of backward and forward perturbations in an unpredictable 
order. Three trials were included for each level of intensity, starting at an intensity of 0.25m/s2, 
with subsequent increments of 0.25m/s2. After return of the platform to the starting 
position, the delay for a subsequent perturbation ranged between four and eight seconds. 
When all three trials failed at a particular intensity level in either direction, three additional 
trials were performed at 0.125 m/s2 above the highest successful intensity to define a 
more accurate threshold. The definitive stepping threshold in each direction was defined 
as the maximum acceleration intensity that could be sustained at least once without 
stepping or grabbing for support. 
Data analysis
Kinematic data were acquired using an eight-camera Vicon motion analysis system (Vicon 
MX, Oxford Metrics, Oxford, UK). The Helen Hayes model was used together with the 
Vicon full body PlugInGait model (BodyBuilder, Vicon Motion Systems, Lake Forest, CA). 
Marker position data was recorded with a sample frequency of 100 Hz and processed with 
the Vicon Clinical Manager model (VCM) to calculate CoM positions. Displacement of 
the CoM was corrected for platform movement. Maximal CoM displacement in the 
perturbation direction was calculated within 800ms after platform translation onset 
(MATLAB 7.0, Mathworks, Natick, MA, USA). This was done for all subjects at two levels 
of perturbation intensity: at a ‘low’ intensity and at the ‘maximum’ intensity (stepping 
threshold). To obtain an evident kinematic response and a successful trial for the majority 
of the patients without taking a step, the ‘low’ perturbation intensity level was lower in 
backward direction (0.25m/s2) compared to forward (0.50m/s2) [26]. 
Statistical analysis
Stepping thresholds were analyzed using a two-way ANOVA with group (FSHD vs. control) 
as a between-subjects factor and perturbation direction (forward vs. backward) as a 
 within-subjects factor. The associations between the stepping thresholds and the FI 
scores of individual muscles that have their main action in the sagittal plane were evaluated 
with Spearman’s correlation coefficients. For both perturbation directions, relevant 
muscles for which the FI score correlated with the stepping threshold (rs > -0.60; p < 0.1) were 
entered as independent variables in a linear regression model with stepping threshold 
as the dependent variable using the enter method. A three-way ANOVA was used for analysis 
of CoM excursions with group (FSHD vs. control) as a between-subjects factor and 
BALANCE CONTROL IN FSHD
53
3
perturbation direction (forward vs. backward) and intensity (low vs. maximum) as between- 
subjects factors. An α-level of p = 0.05 was used for all analyses. Whole-body kinematic 
responses were described qualitatively due to the small sample size and the varying 
patterns of responses. Kinematic responses were visualized during the acceleration and 
constant velocity phase of the perturbation with an interval of 50ms.
Results
Subjects
Table 1 shows the demographic and clinical characteristics of the FSHD patients as well as 
their performance on the clinical tests. Patients and controls were of comparable age 
(FSHD: 52 ± 8.4y; Control: 53 ± 9.0y), weight (FSHD: 78.8 ± 14.7kg; Control: 79.0 ± 9.6kg), and 
height (FSHD: 1.78 ± 0.07m; Control: 1.76 ± 0.07m).  
Radiological assessments
All patients showed FI of the trunk and/or lower extremity muscles on MRI. There was a 
wide range in the number of muscles infiltrated with fat as well as in the degrees of FI. 
Spine radiographs revealed a wide range of lumbar-lordosis angles (table 1).
Table 1   Individual patient characteristics and results of clinical tests. And mean (SD) 
values of age, height and weight for the whole group of patients.
Age
(years)
Height 
(cm)
Weight 
(kg)
Gender CSS 
(Ricci)
Lumbar 
lordosis
angle (°)
BBS
score
1 68 180 110 Male 4.5 10.3 33
2 55 175 65 Male 4 0 51
3 63 187 77 Male 4 41 42
4 48 172 69 Female 4 48 48
5 52 178 79 Male 3.5 28 54
6 56 179 79 Female 3 28 54
7 45 190 80 Male 3 47 56
8 46 170 59 Female 3 59 55
9 45 183 95 Male 3 34 54
10 43 170 75 Male 3 31 55
FSHD 52 (8) 1.78 (0.07) 79 (15)
CCS: Clinical Severity Score, BBS: Berg Balance Scale
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Balance assessment
Figure 1a shows the average stepping thresholds of the patients and the controls in 
both directions. Stepping thresholds were significantly lower in the FSHD patients compared 
to the controls (F1,36 = 23.1, p < 0.01), while stepping thresholds were significantly higher in 
the forward compared to the backward direction (F1,36 = 24.5, p < 0.01). There was no 
interaction effect between group and perturbation direction (F1,36 = 0.44, p = 0.51). 
Table 2 shows the median FI grades of all muscles predominantly acting in the sagittal 
plane and their correlation with the stepping thresholds. With regard to backward 
perturbation, FI grades of the rectus abdominis (RA), rectus femoris (RF) and tibialis 
anterior (TA) met the pre-set statistical criterion  (rs > -0.60, p < 0.1) and were entered as 
independent variables in a linear regression model. This model yielded an explained 
Figure 1  a. Mean stepping thresholds in patients with FSHD (light grey bars) and in healthy controls 
(dark grey bars) during backward and forward perturbations. * represent significant difference (p<0.01) 
b. Mean CoM excursions in patients with FSHD (light grey bars) and in healthy controls (dark grey bars) 
during backward and forward perturbations at ‘low’ intensity (0.25m/s2 and 0.50m/s2 resp.) and at 
stepping threshold. * represent significant difference (p < 0.05)
Backward Forward
Pl
at
fo
rm
 a
cc
el
er
at
io
n
0
0.5
1
1.5
2
a. Stepping threshold (m/s2)
low intensity stepping threshold
Ba
ck
w
ar
d 
   
 F
or
w
ar
d
-100
-50
0
50
100
150
200
b. CoM displacement (mm)
Controls
FSHD
BALANCE CONTROL IN FSHD
55
3
variance of 92% (p < 0.001). Only the contribution of the RA was statistically significant 
(β = -0.19, p < 0.01; explained variance of RA alone: 61%); the other muscles did not add to 
the explained variance (TA (β = -0.046, p = 0.27), RF (β = -0.044, p = 0.24)). With regard to 
forward perturbations, FI grades of the erector spinae (ES), quadratus lumborum (QL) and 
gastrocnemius medialis (GM) met the statistical criterion to be entered as independent 
variables in a linear regression model. Since the ES and QL are functionally intertwined 
and their degree of FI was strongly intercorrelated (rs = 0.80, p < 0.01), the FI grades of these 
muscles were averaged into a combined variable “back extensors”. A model with back 
extensors and GM explained 66% of the variance (p = 0.022) of the forward stepping 
Table 2   Median and range of FI of all muscles assessed on transversal and  
coronal MRI images of patients, and Spearman correlation coefficients of FI 
with backward and forward stepping threshold.
FI
Median
FI
Range
Backward step-
ping threshold
Forward stepping 
threshold
rs p rs p
m. rectus abdominis 3 [1.25; 4] -0.92  0.000* -0.40 0.247
m. obliquus externus abdominis 2.5 [1; 4] -0.34 0.334 -0.24 0.512
m. erector spinae 2 [1; 4] -0.31 0.390 -0.69 0.029*
m. quadratus lumborum 2 [1; 4] -0.34 0.340 -0.87 0.001*
m. iliopsoas 1 [1; 2] -0.26 0.470 -0.32 0.375
m. gluteus maximus 2 [1;25] 0.13 0.715 -0.10 0.780
m. rectus femoris 2.5 [1; 4] -0.62 0.056 -0.58 0.081
m. vastus medialis 2 [1; 3.5] 0.56 0.095 0.24 0.499
m. vastus lateralis 2 [1; 4] 0.49 0.148 0.22 0.543
m. vastus intermedius 1.75 [1; 4] 0.36 0.306 -0.17 0.632
m. sartorius 2 [1; 4] -0.23 0.523 0.11 0.760
m. biceps caput longum/breve 2.5 [1.5; 4] -0.39 0.270 0.13 0.715
m. semitendinosis 2.75 [1; 4] -0.57 0.084 -0.39 0.272
m. semimembranosis 3.25 [1; 4] -0.33 0.355 0.15 0.671
m. tibialis anterior 2 [1; 4] -0.72 0.019* -0.59 0.074
m. gastrocnemius medialis 3 [1; 4] -0.74 0.014* -0.61 0.063
m. gastrocnemius lateralis 1.75 [1; 4] -0.54 0.108 -0.52 0.120
m. soleus 1.25 [1 ;3] -0.24 0.505 -0.35 0.319
rs: Spearman correlation coefficient; FI: fatty infiltration
* Significant correlation p<0.05
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Figure 2  Stick figures representing sagittal-plane body motion in response to forward (A) and 
backward (B) perturbations for four typical subjects. Lines represent segment positions with 50ms 
intervals during 800ms after perturbation onset with the darkest line representing the latest position. 
From left to right the figures represent: a typical control; a typical patient without trunk muscle 
involvement; a patient with trunk muscle involvement without lumbar hyperlordosis; a patient with 
trunk muscle involvement and lumbar hyperlordosis. BE: Back extensor, RA: Rectus abdominis.
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threshold. The contribution of the back extensors was significant (β = -0.26, p = 0.028) in 
contrast to the GM (β = -0.08, p = 0.31). The back extensors alone explained 61% of the 
variance in stepping threshold (β = -0.30, p < 0.01).
Centre of Mass excursions 
Nine patients (90%) successfully withstood the low-intensity level and were included in 
the analysis of low-intensity CoM excursion. Figure 1b shows the CoM excursions at the 
low and maximum intensity for backward and forward perturbations. Both groups 
revealed significantly larger CoM excursions at the maximum compared to the low 
intensity level (main effect intensity: F1,70 = 103.5, p < 0.01) as well as following forward 
compared to backward perturbations (main effect direction: F1,70 = 43.1, p < 0.01). However, 
group differences depended on perturbation intensity (group*level interaction effect: 
F1,70 = 11.4, p < 0.01); at the low intensity, patients showed larger CoM excursions, whereas 
at the maximun intensity they showed smaller CoM excursions than controls, similarly for 
both directions of perturbation. 
Kinematic responses
Figure 2 shows stick figures of the kinematic responses of several typical subjects to a 
low-intensity forward (0.5 m/s2) and backward perturbation (0.25 m/s2). Following forward 
perturbations, both the control subject, the patient without back extensor involvement, and 
the patient with back extensor involvement (without lumbar hyperlordosis) demonstrate a 
similar inverted-pendulum-like response with increasing body sway, whereas the patient 
with back extensor involvement and lumbar hyperlordosis shows marked hip flexion. 
Also for backward perturbations, the control subject, the patient without RA involvement, 
and the patient with RA involvement (without lumbar hyperlordosis) show an inverted- 
pendulum-like response with incremental body sway. Yet, the patient with RA involvement 
and lumbar hyperlordosis shows a less typical kinematic pattern with anterior trunk 
displacement.
Discussion
The aim of this study was to determine whether the affliction of trunk or lower limb 
muscles is most critical for the loss of postural control in patients with various severities of 
FSHD; a disease characterized by progressive and distributed fatty infiltration in nearly all 
muscles of the trunk and lower limbs. The capacity to withstand both forward and 
backward balance perturbations was found to be clearly affected in the patients with 
FSHD compared to healthy control subjects of similar age, weight and height. Overall, 
the degree of FI of the trunk muscles (rectus abdominis and back extensors) showed 
the strongest correlation with postural instability. Remarkably, the lower extremity muscles 
CHAPTER 3
58
did not substantially contribute to explaining stepping thresholds in either direction of 
perturbation, even though the degree of FI was similar compared to the trunk muscles. 
In addition, the abnormalities in the kinematic responses of the body to balance perturbations 
appeared to be dependent mainly on trunk muscle involvement and lumbar-lordosis angle. 
As FI and muscle weakness are generally strongly correlated [5, 7, 8], our results suggest 
that trunk muscle weakness is the main factor leading to loss of postural stability in 
patients with FSHD. This finding seems to be in contrast with previous studies that pointed 
at an important contribution of lower leg muscle weakness to impaired sagittal-plane 
balance control in these patients [12, 27]. These studies, however, did not consider 
weakness of the trunk muscles. Indeed, the vast majority of studies that reported 
detrimental effects of leg muscle weakness on postural control have focused on conditions 
merely affecting the lower extremities [11, 28]. Thus, our results do not contradict previous 
findings, as we also found that weakness of the calf muscles and tibialis anterior was 
associated with lower stepping thresholds. They rather provide evidence for the notion 
that involvement of the trunk muscles is even more critical for postural stability compared 
to the leg muscles in patients with FSHD. 
In addition to the lower stepping thresholds in FSHD patients compared to controls, we 
observed that the patients needed to step at smaller CoM excursions, whereas they 
demonstrated greater CoM excursions than controls during feet-in-place responses at low 
intensity perturbations. These findings indicate that the patients were less able to control 
their CoM over their base of support under various circumstances. Our results are in line 
with those reported by Davidson et al. (2009) who contrasted the effects of exercise- 
induced localized muscle fatigue of the calves and the back extensors on the recovery 
from postural perturbations. They too observed larger CoM displacements when 
weakness of either the calves or back muscles was induced. However, they reported no 
effect of muscle fatigue on the stepping thresholds, which was likely due to the rather 
modest degree of muscle weakness induced (25%-30% of maximum voluntary 
contraction) and to the use of relatively large increments in perturbation intensity. Our 
patients presumably had more severe muscle weakness, which resulted in a substantially 
reduced capacity to recover balance without stepping. 
The inverted-pendulum-like kinematic responses indicate that patients without trunk 
muscle involvement used a predominant ankle strategy in response to both forward and 
backward perturbations [14]. This suggests that their trunk was sufficiently stable and their 
lower leg muscles still strong enough to control an ankle strategy. The presence of trunk 
muscle involvement led to increased body sway in both directions but, when there was 
also lumbar hyperlordosis, a different kinematic pattern was observed with increased 
movements at the hips indicating impaired ‘core stability’ (figure 2). It is likely that this 
BALANCE CONTROL IN FSHD
59
3
pattern reflects a passive rather than an active response strategy, relying on the stretching 
forces within joint ligaments, since hyperlordosis in FSHD is typically related to trunk 
muscle weakness [29] and trunk muscles play an essential role in active hip strategies [14]. 
Remarkably, after both forward and backward perturbations, patients with lumbar 
hyperlordosis demonstrated hyperflexion of the trunk, which may be related to a structural 
inability to extend their trunk (either passively or actively).
A limitation of this study is the small sample size and the fact that many muscles were 
affected in each of the patients with FSHD despite large differences in disease severity. 
Still, the variability in FI grades both within and between patients appeared to be sufficient 
to identify involvement of the trunk muscles as most critical for loss of postural stability. 
The validity of this finding is exemplified by one participant with severe abdominal 
affliction (FI = 4) and minor involvement of the tibialis anterior (FI = 1-2) who had a very 
low stepping threshold in the backward direction (0.375m/s2). Conversely, his forward 
stepping threshold was very high (1.25m/s2), even though he had severe calf muscle 
involvement (FI = 3), because his back muscles were only mildly affected (FI = 1-2).
 Another limitation is the focus of our study being restricted to sagittal-plane balance. 
Although it has been reported that patients with FSHD primarily fall in the forward and 
backward directions [10], future studies should aim to determine whether trunk muscle 
involvement is most critical for loss of frontal-plane balance as well. 
In conclusion, the present study shows that trunk muscle involvement appears to be most 
critical for the loss of sagittal-plane balance in patients with FSHD. In addition, the presence 
of lumbar hyperlordosis contributed to aberrant kinematic responses. These findings 
point towards the critical role of trunk muscles and ‘core’ stability in human postural 
control. For patients with FSHD who suffer from imbalance or recurrent falls, it is important 
to pay attention to the presence of trunk muscle weakness. In some cases, it may be 
valuable to prescribe strength training to enhance core stability. If this is not successful, 
a semi-rigid lumbar corset may provide some lower trunk stability without impeding 
activities of daily living. However, further research is necessary to identify the optimal 
treatment procedures in FSHD patients with trunk muscle weakness.
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Abstract
Facioscapulohumeral muscular dystrophy is a slowly progressive hereditary disorder 
resulting in fatty infiltration of eventually most skeletal muscles. Weakness of trunk and leg 
muscles causes problems with postural balance and gait, and is associated with an 
increased fall risk. Although drop foot and related tripping are common problems in 
patients with facioscapulohumeral muscular dystrophy, gait impairments are poorly 
documented. The effect of ankle plantarflexor involvement on gait propulsion has never 
been addressed. In addition to ankle plantarflexion, gait propulsion is generated through 
hip flexion and hip extension. Compensatory shifts between these propulsion sources 
occur when specific muscles are affected. Such a shift may be expected in patients with 
facioscapulohumeral muscular dystrophy since the calves may show early fatty infiltration, 
whereas iliopsoas and gluteus maximus muscles are often spared for a longer time. In the 
current study, magnetic resonance imaging was used to assess the percentage of 
unaffected calf, iliopsoas and gluteus maximus muscles. Joint powers were analyzed in 
ten patients with facioscapulohumeral muscular dystrophy at comfortable and maximum 
walking speed to determine the contribution of ankle plantarflexor, hip flexor and hip extensor 
power to propulsion. Associations between muscle morphology, power generation and 
gait speed were assessed. Based on multivariate regression analysis, ankle plantarflexor 
power was the only factor that uniquely contributed to the explained variance of comfortable 
(R2 = 80%) and maximum (R2 = 86%) walking speed. Although the iliopsoas muscles were 
largely unaffected, they appeared to be sub-maximally recruited. This submaximal 
recruitment may be related to poor trunk stability, resulting in a disproportionate effect of calf 
muscle affliction on gait speed in patients with facioscapulohumeral muscular dystrophy.
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Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common hereditary 
neuromuscular disorders with a prevalence of 1:15,000 – 1:20,000 persons [1, 2]. Although 
weakness typically starts in the muscles of the face and shoulder girdle, FSHD is characterized 
by progressive fat infiltration of eventually almost all skeletal muscles. Weakness of the 
trunk and lower extremity muscles, which is present in more than half of the patients [3], 
causes problems with postural balance and gait and is related to an increased risk of recurrent 
falls [4-8]. A typical gait impairment in FSHD is caused by early weakness of ankle dorsiflexors [6, 
9], leading to foot drop and an increased risk of tripping. This is often compensated by 
exaggerated hip and knee flexion to prevent tripping-related falls. However, recently, we were 
able to show that ankle plantarflexors are also involved in 56% of the people with FSHD [3], 
yet gait impairments due to ankle plantarflexor weakness in FSHD have been not yet been 
studied. Plantarflexor weakness may not only cause difficulties with the propulsion of gait, 
but has also been associated with an increased fall risk in healthy elderly [10, 11]. The latter 
finding was related to a reduced capacity to recover from a trip due to a lack of 
compensatory push-off power. 
It has been reported that comfortable walking speed in FSHD is on average 20% reduced 
compared to healthy controls [4, 6, 7], even in persons without clinically detectable lower 
extremity weakness [6]. Although walking speed was associated with hip flexion, knee 
extension and ankle dorsiflexion strength assessed by manual muscle testing [4], only one 
study has investigated gait kinetics in people with FSHD [6]. This study revealed that ankle 
kinetics were different from controls, which was related to typical drop-foot problems [6]. 
During normal walking, propulsion can be attributed to concentric activity of the ankle 
plantarflexors, hip flexors and hip extensors. As a consequence, the calf, iliopsoas and 
gluteus maximus muscles together constitute the main determinants of walking speed in 
healthy persons, of which the calf muscles are known to contribute most [12-15]. Previous 
studies have described a shift in the contribution to walking speed from ankle plantarflexor 
to hip flexor power in the case of impaired function or pain in the lower legs [16, 17]. 
We hypothesize that people with FSHD and calf muscle weakness also tend to rely on 
such a trade-off phenomenon to maintain their preferred walking speed, since particularly 
the iliopsoas muscle appears to be preserved even in patients with a very long disease 
duration [3]. If so, people with FSHD would be able to compensate the functional 
consequences of calf muscle weakness for a relatively long time. 
Hence, the aim of the current study was to examine the associations of walking speed 
with ankle plantarflexor, hip flexor and hip extensor power and relate these to the degree 
of fatty infiltration of the calf, iliopsoas and gluteus maximus muscles in FSHD. The reason 
for using quantitative fatty infiltration based on magnetic resonance imaging (MRI) as a 
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measure of muscle involvement is that the validity of manual muscle testing may be 
questioned particularly in patients with very localized muscle disease such as in FSHD [6, 
9, 18, 19]. In contrast, it has been shown that muscle MRI is a sensitive tool to estimate the 
amount of individual muscle fatty infiltration [20], which highly correlates to quantitative 
muscle assessment in people with FSHD [3, 21]. 
 
Methods
Participants
A sample of ten adults with genetically confirmed FSHD type I or II was recruited via the 
rehabilitation and neurology departments of our university clinic. We purposely included 
a wide range of disease severities, from patients who did not yet subjectively experience 
lower extremity muscle weakness at the one end, to severely affected patients who were 
barely able to walk anymore on the other hand. Specific exclusion criteria were: the 
presence of other neurological diseases affecting ambulation, severe cardiopulmonary 
disease, metal implants (contra-indication for MRI) and pregnancy. During an intake visit a 
physiatrist checked the inclusion and exclusion criteria and determined the clinical 
severity score (CSS) as described by Ricci et al. (Table 1) [22]. In addition, body weight and 
height were determined. At the same day the radiological assessments were performed. 
The gait assessments in the movement laboratory were done within 8 weeks after the 
intake. This study was approved by the local ethics committee. All subjects gave written 
informed consent.
Radiological assessments
The patients were examined with a 3.0 Tesla (T) MR system (Skyra; Siemens, Erlangen, 
Germany) using the body coil. Imaging was performed using transverse turbo spin echo 
T1-weighted sequences of the lower body and trunk. Ten transverse images were obtained 
in four different regions: the trunk at the level of vertebra L4, the pelvis between the 
symphysis and the anterior superior iliac spine, the upper leg at 15 centimeters proximal 
to the apex of the patella and the lower leg at 15 centimeters below the patella (TR 750, TE 
9.4, turbo factor 3, matrix 256x256, slice thickness 5mm, slice gap 1mm). 
 Software of Siemens (InveonTM Research Workplace 4.0) was used for quantification of 
muscle involvement of 36 muscles within the scanned regions. For each muscle, we identified 
the transversal slice that captured the largest cross-sectional area and manually traced the 
original edges of the muscles. Within these edges, the amount of remaining muscle tissue 
was obtained by calculating the surface area of a region of interest with a window width 
of 200 gray-scale units, which excluded both edema and fat tissue. This window level was 
adapted according to the brightness of the image. The proportion of remaining muscle 
tissue (PMT) was calculated as the cross-sectional area of the remaining muscle tissue 
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divided by the cross-sectional area of the original muscle edges. Asymmetry values were 
calculated as the absolute difference in PMT-value between the left and right body side.
Gait assessments
Subject walked barefoot wearing shorts and a sleeveless top. Reflective markers were 
placed on the skin according to the PlugInGait full-body model (BodyBuilder, Vicon 
Motion Systems, Lake Forest, CA). Kinematic data were acquired using a six-camera Vicon 
motion analysis system (Vicon MX, Oxford Metrics, Oxford, UK) with a sample frequency 
of 100Hz. Two AMTI (Advanced Medical Technology Inc. Watertown MA. USA) force plates, 
embedded in a ten-meter walkway, were used to record ground reaction forces at a 
sample frequency of 2400 Hz.
The subjects were instructed to walk over the walkway at their comfortable (Vcomf) and 
at their maximum (Vmax) walking speed. Once subjects were accustomed to walking on 
the walkway, three trials of both walking speeds were recorded, starting with comfortable 
walking. No information was given regarding the presence or position of the force plates 
to prevent any adaptations of step length or walking speed to their location. 
Table 1   Ricci Clinical Severity Scale
0.5 Facial weakness
1 Mild scapular involvement without limitation of arm abduction; no awareness of disease 
symptoms is possible
1.5 Moderate involvement of scapular and arm muscles or both (arm abduction MRC >60° and 
strength MRC ≥3 in arm muscles); no involvement of pelvic and leg muscles
2 Severe scapular involvement (arm abduction <60° on at least one side); strength MRC <3 in 
at least one muscular district of the arms; no involvement of pelvic and leg muscles
2.5 Tibioperoneal weakness; no weakness of pelvic and proximal leg muscles
3 Mild weakness of pelvic and proximal leg muscles or both (strength MRC ≥4 in all these 
muscles); able to stand up from a chair without support
3.5 Moderate weakness of pelvic and proximal leg muscles or both (strength MRC ≥3 in all these 
muscles); able to stand up from a chair with monolateral support
4 Severe weakness of pelvic and proximal leg muscles or both (strength MRC <3 in at least one 
of these muscles); able to stand up from a chair with double support; able to walk unaided
4.5 Unable to stand up from a chair; walking limited to several steps with support; may use 
wheelchair for most activities
5 Wheelchair bound
Muscle strength was evaluated by using the clinical Manual Muscle Testing Scale (Medical Research Council) 
CHAPTER 4
68
 Marker data was filtered with a low-pass fourth-order Butterworth filter with a cut-off 
frequency of 6 Hz and processed with the Vicon Clinical Manager model (VCM) to calculate 
full body kinematics and joint moments. Force plate data was filtered with a fourth-order 
Butterworth filter with a cut-off frequency of 6 Hz. Gait cycle events were detected based 
on force plate and marker position data. 
 Walking speed was calculated by dividing the traveled distance of the center of mass 
during two strides by the time passed in this timeframe. The mean walking speed was 
calculated by taking the average of three trials for both comfortable and maximum 
velocity. Ankle and hip powers were calculated as the product of the joint moment and 
the joint angular velocity. Peak hip extensor power (H1), generated mainly by the gluteus 
maximus, was determined during early stance. Peak ankle plantarflexor power (A2), 
generated by the calf, and hip flexor power (H3), generated mainly by the iliopsoas, were 
determined during late stance [12-14, 23]. Mean peak powers of three trials were calculated; 
values for left and right side were averaged. A2, H1 and H3 peak powers were normalized 
for body mass. 
Statistical analysis
A paired two-tailed t-test was used to test the differences in walking speed and joint 
powers between Vcomf and Vmax. For correlation and regression analysis, the walking 
speed values were normalized by dividing them by body height. Bivariate correlations of 
walking speed with peak joint power and corresponding PMT-values were determined 
using Pearson correlation coefficients and a 2-tailed test of significance. Variables that 
showed a significant correlation (r > 0.40) with walking speed were entered in a linear 
regression analysis to identify their relative contribution to its variance. To adjust for 
multiple testing an α-level of p < 0.01 was used.
Results
Patients
The ten subjects (7 males, 3 females) completed all assessments. Their age ranged from 
43 to 68 years (mean ± SD, 52.1 ± 8.4y) and the time since diagnosis from 3 to 31 years 
(14 ± 10y). Table 2 shows the individual characteristics and measures of gait performance.
Radiological results
MRI scans revealed that of the 36 trunk and lower extremity muscles that were scored, 
fatty infiltration was observed in all muscles in the most severely affected patient, whereas 
the least affected patient had only minor fatty infiltration in a small proportion of the 
muscles. Table 3 shows the PMT-values of the trunk and lower extremity muscles, in 
addition to PMT-values of the calf, iliopsoas and gluteus maximus muscles individually. 
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Table 2  Individual patient characteristics and walking velocities. 
Age 
(y)
Height 
(m)
Weight 
(kg)
Gender CSS 
(Ricci)
Vcomf 
(km/h)
Vmax 
(km/h)
Vmax 
(km/h/BH)
P1 68 1.80 110 Male 4.5 0.71 0.71 0.4
P2 48 1.72 69 Female 4 2.35 3.90 2.3
P3 55 1.75 65 Male 4 3.69 4.74 2.7
P4 63 1.87 77 Male 4 3.12 3.96 2.1
P5 52 1.78 79 Male 3.5 3.22 3.81 2.1
P6 46 1.70 59 Female 3 4.60 5.41 3.2
P7 56 1.79 79 Female 3 4.22 6.15 3.4
P8 45 1.83 95 Male 3 4.23 6.43 3.5
P9 43 1.70 75 Male 3 4.70 6.10 3.6
P10 45 1.90 80 Male 3 4.86 6.32 3.3
Mean 52±8 1.78±0.07 79±15 3.57±1.29 4.75±1.77 2.66±0.98
CCS: clinical severity score, Vcomf: Comfortable walking velocity, Vmax: Maximum walking velocity.
Table 3  Radiological assessments
Trunk Lower 
extremity
Calf Iliopsoas Gluteus 
maximus
PMT asym PMT asym PMT asym PMT asym PMT asym
P1 13 1 18 6 2 4 49 2 45 18
P2 73 1 52 1 72 6 93 4 78 8
P3 73 3 71 19 53 74 94 1 77 32
P4 67 14 44 11 40 8 97 0 75 10
P5 86 7 65 12 39 50 93 7 78 6
P6 63 1 67 19 86 1 91 5 90 1
P7 73 9 51 3 62 1 94 3 78 4
P8 82 4 62 4 61 1 91 0 74 5
P9 77 1 80 3 96 0 89 3 78 3
P10 75 9 67 17 60 15 94 1 88 4
M(std) 68(20) 5(5) 58(18) 9(7) 57(26) 16(25) 89(14) 3(2) 60(18) 7(6)
Proportion of remaining muscle tissue (PMT, %) and asymmetry (%) of the trunk and the lower extremity, and of the 
calf, iliopsoas and gluteus maximus muscles individually. Mean (M) and standard (std) deviations are given.
CHAPTER 4
70
Lower extremity muscles showed PMT-values ranging from 18-80%, while trunk muscles 
showed a larger range (13-86%) with values lower than 80% in 80% of the subjects. 
Nevertheless, asymmetry values never exceeded 19%. There were large inter-individual 
differences in PMTcalf (2-96%). The PMTgmax showed moderate variability (49-97%) with 
decreased values in most patients, whereas PMTpsoas showed low variability with only two 
patients having a value less than 90%. Because only 3 of the 30 individual muscle pairs 
(10%) showed asymmetry larger than 18%, average PMT-values of the right and left side of 
the body were used for further analysis. 
Gait analysis
Comfortable walking speed was 3.57km/h, which was 29% lower than reported in 
literature for healthy controls of similar age [24]. Participants walked 32% faster during the 
trials at maximum compared to comfortable speed (t = 5.75, p < 0.01), which corresponded with 
a 28% higher A2 power and a 66% increase in H3 power (A2: t = 4.35, p < 0.01 H3: t = 4.57, 
p < 0.01). H1 peak power was not significantly higher at maximum speed (H1: t = 2.16, 
p = 0.06). Figure 1 shows representative trials of each participant at maximum gait velocity.
Bivariate correlations
Bivariate correlations between walking speeds, joint powers and PMT-values are displayed 
in figure 2. Walking speed was significantly correlated to A2 power at Vcomf (A2: r = 0.91, 
p < 0.001) and to A2 and H3 power at Vmax (A2: r = 0.94, p < 0.001; H3: r = 0.78, p < 0.01). 
No significant correlation was found between H1 power and Vcomf or Vmax. PMTcalf was 
strongly correlated with walking speed (Vcomf: r = 0.82, p < 0.01; Vmax: r = 0.84, p < 0.01) 
and with A2 power (Vmax: r = 0.77, p < 0.01), whereas no correlation was found between 
PMTpsoas and walking speed or H3 power. PMTgmax was associated with both walking 
speed values (Vcomf: r = 0.84, p < 0.01; Vmax: r = 0.80, p < 0.01), but not with H1 power. 
Figure 2 shows that the observed correlations of PMTgmax with walking speed were mainly 
determined by one subject.
Multivariate analysis
For comfortable walking speed, regression analysis with A2 power,  PMTcalf, and PMTgmax 
explained 81% of the variance (Vcomf: R2 = 81%, p = 0.001; βA2 = 0.57, p = 0.07; βPMTcalf = 
0.25, p = 0.34; βPMTgmax = 0.18, p = 0.53). Backward stepwise exclusion resulted in A2 power 
being the only remaining factor (R2 = 80%). For maximum walking speed, the model 
including A2 power, H3 power, PMTcalf, and PMTgmax explained 84% of the variance (Vmax: 
R2 = 84%, p = 0.008; βA2 = 0.69, p = 0.06; βH3 = -0.03, p = 0.94; βPMTcalf = 0.27, p = 0.35; 
βPMTgmax = 0.07, p = 0.84). Again, A2 power was the only factor remaining when a backward 
stepwise exclusion was applied (R2 = 86%). 
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Figure 1  Ankle and hip power profiles of a representative trial at maximum velocity for all subjects 
separately (P1-P10) as well as for a control subject, normalized for step cycle (data collected in our lab). 
A2: Ankle plantarflexion peak during late stance
H1: Hip extension peak during early stance
H3: hip flexion peak around toe-off.
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Figure 2  Bivariate scatter plots of peak ankle (A2) and hip (H1 and H3) power generation, walking 
speed, and percentage remaining muscle tissue of the calf (PMTcalf), iliopsoas (PMTpsoas) and gluteus 
maximus (PMTgmax) muscles. Blue plots represent correlations for comfortable walking speed, red 
plots for maximum walking speed. Only significant correlation coefficients are displayed. 
BH = body height.
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Discussion
In the current study, we tested the hypothesis that compensatory hip power is recruited 
to maintain walking speed in persons with FSHD and ankle plantarflexor weakness. 
Correlations of walking speed with ankle plantarflexor and hip flexor and extensor power 
were assessed and related to calf, iliopsoas and gluteus maximus muscle involvement 
based on quantitative MRI scores. Walking speed was strongly associated with A2 power, 
but not with H1 power. H3 power was only associated with maximum walking speed. In 
contrast to A2 power, in a multivariate model, H3 power no longer contributed to the 
explained variance in walking speed, despite the fact that the calves were substantially 
(PMT-value < 70%) affected in 70% of the patients and the iliopsoas muscles were largely 
spared. These results suggests that, unlike the calves, the preserved iliopsoas muscles 
were sub-maximally recruited, which does not support the hypothesis that intact hip 
flexors are maximally used for compensation of reduced ankle plantarflexion power. 
Furthermore, the lack of association between H1 power and walking speed suggests that 
the hip extensors did not provide effective compensation either, even though the gluteus 
maximus showed a PMT-value lower than 70% in only one patient. Interestingly, the 
relatively large increase in H3 power (66%) compared to the 28% increase in A2 power 
from walking at comfortable to maximum walking speed reveals that our patients were 
able to use their hip flexors for instantaneous up regulation of walking speed. Similar 
values have been observed in healthy elderly [25] and in patients with stroke [26], 
indicating that the hip flexors have a relatively large reserve capacity. However, our data 
suggest that persons with FSHD do not spontaneously make use of their maximum hip 
power, since the comfortable walking speed was only 3.57km/h. 
  
The strong correlations of PMTcalf with A2 power and walking speed are indicative of the 
notion that the calves are optimally recruited for gait propulsion. In contrast, involvement 
of the hip muscles was not associated with hip power, while only PMTgmax was associated 
with walking speed. Because this latter result could be attributed to one patient only and 
because PMTgmax was not associated with H1 power, it seems to be spurious rather than 
meaningful. If our patients would have used their hip muscles to compensate for calf 
muscle weakness, those with low PMTcalf-values would have been better able to maintain 
their walking speed by stronger recruitment of the intact hip flexors or extensors, perhaps 
with the exception of one patient with PMT-values of the iliopsoas and gluteus maximus 
of merely 40-50% (P1 in Table 3). If this compensation had taken place, the observed 
correlation between PMTcalf and walking speed had been lower and a significant 
contribution of H3 and/or H1 power to the explained variance in walking speed had been 
found in the multivariate regression analysis. Hence, the overall pattern of results suggest 
that the FSHD patients in this study possessed residual propulsive capacity in their hip 
muscles that remained unexploited for maintaining walking speed.
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The lack of effective compensation by the hip flexors in patients with FSHD seems to be in 
contrast with other patient groups suffering from weakness or inefficacy of the calf 
muscles [12, 16, 27-29]. Eek et al. [27] reported decreased ankle plantarflexion power in 
patients with cerebral palsy during normal walking, while a significantly increased hip 
extension power area was found (despite reduced hip muscle strength). In patients with 
diabetic polyneuropathy, hip flexion power during walking at comfortable speed was 
found to be larger than ankle plantarflexion power [16]. Finally, as an extreme example of 
ineffective calf muscles, patients with ankle arthrodesis exhibited a large increase in hip 
flexion power indicating a complete shift from a ‘push-off’ towards a ‘pull-off’ strategy 
[29]. Thus, the question is justified why the patients with FSHD in this study did not 
maximally exploit their residual hip power to compensate for reduced ankle plantarflexor 
power. We propose that this lack of compensation may be related to lack of trunk stability. 
 Indeed, trunk stability may be compromised in the case of weakness of the back 
extensors and abdominal muscles [7, 8, 30]. In contrast with earlier descriptions, we have 
shown in a previous study using whole-body computed tomography (CT) that, in addition 
to the rectus abdominis, the back extensors can be involved in a relatively early stage of 
FSHD [3]. In the current study as well, trunk muscle involvement was substantial as the 
mean PMT-value of the trunk was 68%. In a parallel study of the same patient group, we 
found that trunk muscle involvement was most critical for loss of sagittal-plane balance, 
even more than leg muscle affliction [8]. In this perspective, it is possible that maximal use 
of hip power to preserve comfortable walking speed may critically challenge dynamic 
balance, especially when gait speed is not constant. Interestingly, similar submaximal hip 
muscle recruitment to compensate for reduced ankle plantarflexion power has been 
observed in stroke survivors, which was also thought to be related to dynamic balance 
impairments [17, 31]. 
Since a loss of trunk stability cannot readily be resolved, an important clinical implication 
of our results seems to be that residual ankle plantarflexion power should be optimally 
preserved in patients with FSHD. Since many patients are prescribed ankle-foot orthoses 
(AFOs) for the compensation of drop foot [32], maximal effort is warranted to support 
ankle dorsiflexion while maintaining the possibility to plantarflex the ankle joints during 
walking. This approach would imply the use of dynamic AFOs with a spring-like dorsiflexion 
support, allowing active plantarflexion during push-off.    
Strengths and limitations
To our knowledge, the present study is the first to evaluate the association between 
individual muscle involvement assessed by MRI and functional muscular recruitment in 
terms of power generation and resulting walking speed. An obvious limitation is its small 
sample size, which was related to the explorative nature of the study, the relatively high 
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burden on participants, and the limitations in available resources. By no means, the 
included subjects can be regarded as representative of the whole FSHD population, but 
they do reflect the wide variety of FSHD patients that are typically seen in an academic 
hospital. The clinical variability within the selected patients was large enough to find 
strong correlations between calf muscle morphology, ankle plantarflexion power and 
walking speed. Future studies with larger patient samples should corroborate our findings 
and strive to elucidate which mechanisms underlie the submaximal use of hip flexor 
capacity for gait propulsion in patients with FSHD. 
CHAPTER 4
76
References
1. Padberg GW. Facioscapulohumeral disease 1982, Leiden University: Leiden.
2. Flanigan KM, et al. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumer-
al dystrophy. Neuromuscul Disord, 2001. 11(6-7): p. 525-9.
3. Rijken NHM, et al. Skeletal muscle imaging in Facioscapulohumeral Muscular Dystrophy, Pattern and asymmetry of 
individual muscle involvement Neuromuscular Disorders, DOI: 10.1016/j.nmd.2014.05.012.
4. Aprile I, et al., Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment. Eur J 
Phys Rehabil Med, 2012. 48(3): p. 393-402.
5.  Horlings CG, et al. A weak balance: the contribution of muscle weakness to postural instability and falls. Nat Clin 
Pract Neurol, 2008. 4(9): p. 504-15.
6. Iosa M, et al. Mobility assessment of patients with facioscapulohumeral dystrophy. Clin Biomech (Bristol, Avon), 
2007. 22(10): p. 1074-82.
7. Iosa M, et al. Control of the upper body movements during level walking in patients with facioscapulohumeral 
dystrophy. Gait Posture, 2010. 31(1): p. 68-72.
8. Rijken NHM, et al.  Trunk muscle weakness is most critical for the loss of balance control in patients with Facioscapu-
lohumeral dystrophy. Clin Biomech, Accepted. 
9. Olsen DB, et al. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol, 
2006. 253(11): p. 1437-41.
10.  Pijnappels M, et al. Tripping without falling; lower limb strength, a limitation for balance recovery and a target for 
training in the elderly. J Electromyogr Kinesiol, 2008. 18(2): p. 188-96.
11.  Pijnappels M, et al. Identification of elderly fallers by muscle strength measures. Eur J Appl Physiol, 2008. 102(5): 
p. 585-92.
12.  Riad J, Haglund-Akerlind Y and Miller F, Power generation in children with spastic hemiplegic cerebral palsy. Gait 
Posture, 2008. 27(4): p. 641-7.
13.   Winter DA. Biomechanical motor patterns in normal walking. J Mot Behav, 1983. 15(4): p. 302-30.
14.  Winter DA. Changes in gait with aging. Can J Sport Sci, 1991. 16(3): p. 165-7.
15.  Perry J. Gait Analysis: Normal and Pathological Function. 1992: NY: Slack Inc. 542.
16.  Mueller MJ, et al. Differences in the gait characteristics of patients with diabetes and peripheral neuropathy 
compared with age-matched controls. Phys Ther, 1994. 74(4): p. 299-308; discussion 309-13.
17.  Nadeau S, et al. Plantarflexor weakness as a limiting factor of gait speed in stroke subjects and the compensating 
role of hip flexors. Clin Biomech (Bristol, Avon), 1999. 14(2): p. 125-35.
18. Sookhoo S, et al. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol, 
2007. 62(2): p. 160-5.
19.  Statland JM, et al. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. 
Neuromuscul Disord, 2013. 23(4): p. 306-12.
20.  Kan HE, et al., Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular 
dystrophy. Neuromuscul Disord, 2009. 19(5): p. 357-62.
21.  Janssen BH, et al., Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR 
detected fat infiltration. PLoS One, 2014. 9(1): p. e85416.
22.  Ricci E, et al., Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation 
between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol, 1999. 45(6): p. 751-7.
23.  Lewis CL and Ferris DP. Walking with increased ankle pushoff decreases hip muscle moments. J Biomech, 2008. 
41(10): p. 2082-9.
24. Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and 
determinants. Age Ageing, 1997. 26(1): p. 15-9.
25.  Judge JO, Davis RB 3rd and Ounpuu S. Step length reductions in advanced age: the role of ankle and hip kinetics. J 
Gerontol A Biol Sci Med Sci, 1996. 51(6): p. M303-12.
26.  Graf A, et al. The effect of walking speed on lower-extremity joint powers among elderly adults who exhibit low 
physical performance. Arch Phys Med Rehabil, 2005. 86(11): p. 2177-83.
27.  Eek MN, Tranberg R and Beckung E, Muscle strength and kinetic gait pattern in children with bilateral spastic CP. 
Gait Posture, 2011. 33(3): p. 333-7.
GAIT PROPULSION IN FSHD
77
4
28.  Olney SJ, et al. Work and power in hemiplegic cerebral palsy gait. Phys Ther, 1990. 70(7): p. 431-8.
29.  Marshall R, Wood G and Nade S. Effects of ankle arthrodesis on walking: kinematic and kinetic studies. Clin 
Biomech (Bristol, Avon), 1990. 5(1): p. 3-8.
30.  Winter DA. Human balance and posture control during standing and walking. Gait Posture, 1995. 3: p. 193-214.
31.  Parvataneni K, Olney SJ and Brouwer B, Changes in muscle group work associated with changes in gait speed of 
persons with stroke. Clin Biomech (Bristol, Avon), 2007. 22(7): p. 813-20.
32.  Tawil R and van der Maarel S. Facioscapulohumeral muscular dystrophy. Muscle & Nerve, 2006. 34(1): p. 1-15

Dynamic stability during level walking and 
obstacle crossing in persons with FSHD
5
Published as:
NHM Rijken, BGM van Engelen, ACH Geurts, V Weerdesteyn. 
Dynamic stability during level walking and obstacle crossing in persons with 
facioscapulohumeral muscular dystrophy
Gait Posture, 2015 Sep; 42(3):295-300
CHAPTER 5
80
Abstract
Patients with facioscapulohumeral muscular dystrophy suffer from progressive skeletal 
muscle weakness, which is associated with an elevated fall risk. To obtain insight into fall 
mechanisms in this patient group, we aimed to assess dynamic stability during level 
walking and obstacle crossing in patients at different disease stages. Ten patients with at 
least some lower extremity weakness were included, of whom six were classified as 
moderately affected and four as mildly affected. Ten healthy controls were also included. 
Level walking at comfortable speed was assessed, as well as crossing a 10 cm high wooden 
obstacle. We assessed forward and lateral dynamic stability, as well as spatiotemporal and 
kinematics variables. During level walking, the moderately affected group demonstrated 
a lower walking speed, which was accompanied by longer step times and smaller step 
lengths, yet dynamic stability was unaffected. When crossing the obstacle, however, the 
moderately affected patients demonstrated reduced forward stability margins during the 
trailing step, which was accompanied by an increased toe clearance and greater trunk 
and hip flexion. This suggests that during level walking, the patients effectively utilized 
compensatory strategies for maintaining dynamic stability, but that the moderately 
affected group lacked the capacity to fully compensate for the greater stability demands 
imposed by obstacle crossing, rendering them unable to maintain optimal stability levels. 
The present results highlight the difficulties that facioscapulohumeral muscular dystrophy 
patients experience in performing this common activity of daily living and may help 
explain their propensity to fall in the forward direction.
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Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary neuromuscular disorder 
leading to progressive muscle weakness. Skeletal muscle weakness leads to posture and 
balance impairments [1, 2] and is related to a five times greater risk of recurrent falls [3]. Falls 
may lead to injuries but also to fear of falling, which causes a vicious circle of physical 
inactivity and secondary ‘disuse’ impacting muscle weakness, general health and quality 
of life [4]. 
Prevention of falls has been studied extensively in the elderly as well as in several groups 
of patients with neurological disorders (e.g. stroke, Parkinson’s disease), but it has not yet 
been addressed in people with FSHD. The design of preventive intervention strategies 
may be informed by research on fall circumstances in people with FSHD. In this population, 
it was found that falls mainly occurred in the forward direction [3]. The predominance of 
forward falls seems counterintuitive, as in general the foot dorsiflexors and the abdominal 
muscles (that protect against backward falls) are affected at earlier disease stages and are 
also more severely affected than the calf and back muscles [5]. We previously demonstrated 
that, as a result of this muscle weakness, people with FSHD indeed have major difficulties 
sustaining balance perturbation in the backward direction as well. Hence, to better 
understand FSHD-specific fall mechanisms and for providing further directions for 
preventive strategies, insight is needed into the biomechanical challenges imposed on 
whole body dynamic stability during activities of daily living, such as walking and stepping 
over a doorstep.
Studies that applied quantitative, instrumented assessments of balance and gait in people 
with FSHD are yet scarce. A few studies on level walking have reported a decreased speed, 
step length and step frequency in persons with FSHD compared to healthy controls [6, 7]. 
Furthermore, the ability of these patients to coordinate upper-body transversal plane 
movements during walking was found to become poorer with disease progression [8]. 
The defective upper-body control may compromise maintenance of dynamic stability. 
This interpretation is supported by a recent study on balance control following external 
perturbations induced by support-surface translations, in which we found that the degree 
of trunk muscle involvement associated strongly with postural instability in the sagittal 
plane [1]. It is yet unknown, however, whether people with FSHD indeed have poorer 
dynamic stability during self-initiated whole-body movements, such as walking, and in 
which stage of the disease these difficulties become manifest. 
In the present study, we aimed to assess dynamic stability during walking in patients with 
various stages of FSHD. In addition, dynamic stability was further challenged by an 
obstacle that had to be crossed [9]. We hypothesized that compared to healthy controls, 
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people with FSHD would demonstrate poorer dynamic stability during level walking. 
Defective dynamic stability was expected to become more apparent when crossing the 
obstacle and with more advanced stages of the disease. Furthermore, based on the 
previous report of frequent forward falls in FSHD, we expected greater impairments in the 
sagittal than in the frontal plane.
Methods
Participants
Ten patients with genetically confirmed FSHD were recruited via the rehabilitation and 
neurology departments of our university hospital. Patients with at least some weakness in 
pelvis or proximal legs were included (clinical severity scores (CSS) 3-4.5 as described by 
Ricci et al. [10]). They were categorized based on mild (CSS = 3) or moderate to severe 
pelvic and proximal leg muscle weakness (CSS ≥ 3.5) [6, 7]. These two groups are further 
referred to as mildly and moderately affected. Specific exclusion criteria were the presence 
of other neurological diseases, severe cardiopulmonary disease, contra-indications for MRI 
and pregnancy. 
 During an intake visit a physiatrist checked the inclusion and exclusion criteria and 
determined the CSS [10]. Upon inclusion, this visit was followed by an MRI scan at the 
same day. The methods and results of these MRIs have been reported elsewhere [11]. For 
the present study, we only used the average proportion of spared muscle tissue (PMT) to 
identify the most affected leg. Gait assessments were performed within 8 weeks after 
inclusion. A control group of similar age and gender distribution was also included. This 
study was approved by the local medical ethical committee. All subjects gave written 
informed consent. 
Protocol
All subjects were asked to walk barefoot over a ten-meter walkway at their self-selected 
comfortable walking speed. Once subjects were accustomed to walking on the walkway, 
three trials of level walking were recorded. Subsequently, a wooden obstacle (h * l * w: 100 
x 40 x 1000mm) was placed in the middle of the walkway [12]. Subjects were instructed to 
step over the obstacle with both the left or right leg leading (three trials each in a random 
order). The starting position was at least 4m in front of the obstacle to allow several steps 
to reach steady-state walking before the obstacle was encountered.  
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Data collection
Reflective markers were placed on the skin according to the PlugInGait full-body model 
(BodyBuilder, Vicon Motion Systems, Lake Forest, CA). Kinematic data were acquired using 
a six-camera Vicon motion analysis system (Vicon MX, Oxford Metrics, Oxford, UK) with a 
sample frequency of 100Hz. Two steady-state gait cycles recorded from the middle 
portion of the walkway were used for analysis. Marker data was filtered (fourth-order 
Butterworth, 6 Hz) and processed with the Vicon Clinical Manager model (VCM) to 
calculate full body kinematics. Centre of mass (CoM) positions were calculated in the 
standard Vicon software as the weighted sum of the 12 body segments defined by the 
Plug-in-Gait model [13, 14]. 
Data analysis
For both level walking and obstacle crossing, walking speed, step length, step width and 
step time were calculated from kinematic data. For obstacle trials, we calculated these 
variables for the pre-crossing step, the leading and the trailing step (Figure 1). In addition, 
toe distance was calculated as the horizontal distance between the toe marker of the 
trailing leg (prior to crossing) and the obstacle. Heel distance was the horizontal distance 
between the obstacle and the heel marker of the leading leg. Leading and trailing (vertical) 
toe clearances were determined as the distance between the obstacle and the toe marker, 
when the toe was above the obstacle marker [15, 16]. At the instants of both leading and 
trailing toe crossing, we also determined sagittal ankle, knee, hip and trunk angles.
To assess dynamic stability, we determined the margins of stability (MoS) according to the 
method of Hof et al. [17, 18]. To this aim, the extrapolated centre of mass (XCoM) was 
calculated as the CoM plus its velocity times a factor √(g/l), with g being the acceleration 
of gravity and l the height of the CoM (0.55 * body height). In the forward direction, the MoS 
was calculated at heel-strike as the position of the heel minus the position of the XCoM. In 
the lateral direction, it was calculated as the smallest distance between the ankle marker 
and the position of the XCoM throughout the stance phase (Figure 1). In previous studies, 
this method has proven sensitive in detecting age- and disease-related reductions in 
dynamic stability [18-22].
Statistical analysis
We compared level walking parameters and toe and heel distances during obstacle 
crossing between groups (mild, moderate, and control) using univariate ANOVAs with 
group as a fixed factor. For the other obstacle-crossing parameters, we added step 
(pre-crossing, leading and trailing) as a within-subjects factor. Bonferroni post-hoc 
correction was used in case of significant effects. Since we found no significant differences 
between obstacle-crossing trials with the most or the least affected leg leading, we used 
the average values for further analysis. 
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Results
Table 1 displays characteristics of all patients and of the control group. Of the ten persons 
with FSHD who were included, all persons performed the level walking trials, but only 
seven were able to complete the obstacle-crossing trials. One person (CSS = 4.5) was 
unable to step over the obstacle. Two persons (CSS = 4) did not perform the obstacle task, 
because the researcher deemed completion of the full protocol (also including other 
tasks) too fatiguing for them. As a result, the moderately affected group comprised six 
patients for level walking, and three for obstacle crossing. The mildly affected group 
existed of four subjects with CSS = 3. All ten controls successfully performed the tasks. No 
falls occurred during either level walking or obstacle crossing. There was a large variability 
in muscle involvement with an average PMT of 60 ± 18%.
Figure 1 Schematic overview of an obstructed walking trial displaying the leading step (Lead), and 
trailing step (Trail). The grey line represents the center of mass trajectory throughout the trial. The black line 
represents the extrapolated centre of mass (XCoM). Stars represent the moments of heel strike. 
Forward margin of stability (F MoS) is determined at heel strike. Lateral margin of stability (L MoS) 
reflects the smallest distance between XCoM and base of support throughout the stance phase. Toe 
distance (TD) is the distance between the toe marker and the obstacle. Heel distance (HD) is the 
distance between the heel marker and the obstacle, determined at foot contact of the leading limb.
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Level walking
Both walking speed and step time were different between groups (F2,17 = 9.77, p = 0.001 
and F2,17 = 5.25, p = 0.017 respectively; table 2). Walking speed was lower in FSHD patients 
than in controls, albeit only significantly different for the moderately affected patients. 
Correspondingly, moderately affected FSHD patients had increased step times. Step length 
was also different between groups; the moderately affected group took smaller steps 
compared to the mildly affected and control groups (F2,17 = 5.40, p = 0.015). No significant 
differences between groups were found in step width or MoS values (F2,17 < 1.2, p > 0.05). 
Obstacle crossing
The walking speed during obstacle crossing tended to be slightly lower than during level 
walking (1.22 ± 0.20 m/s vs. 1.27 ± 0.16 m/s; F2,14 = 4.16, p = 0.061), but the decrease in 
speed was similar between groups (condition * group: F2,14 = 0.35, p = 0.708).
Spatiotemporal parameters
Figure 2 shows the results for the spatiotemporal parameters. Overall, pre-crossing steps 
were significantly narrower and of shorter length and duration compared to leading and 
trailing steps (F2,28 > 16.4, p < 0.01), whereas leading and trailing steps were not significantly 
different from each other (figure 2a-c). These differences in step parameters were similar 
between groups (step * group, F2,28 < 2.0, p > 0.05). 
Table 2   Unobstructed spatiotemporal parameters and margins of stability for different 
groups (average values and confidence intervals).
FSHD
Controls (n=10) Mildly (n=4) Moderately (n=6)
Walking speed (m/s) 1.34 (1.26 - 1.43) 1.24 (1.12 - 1.36) 0.82 (0.42 - 1.23)*#
Step length (cm) 69.3 (65.9 - 72.7) 69.9 (66.3 - 73.5) 52.9 (33.8 - 72.0)*
Step width (cm) 23.4 (21.6 - 25.2) 23.7 (19.4 – 28.0) 25.7 (20.1 - 31.3)
Step time (s) 0.52 (0.50 - 0.54) 0.57 (0.54 - 0.61) 0.72 (0.50 - 0.94)*
Margin of stability (mm)
Forward 101 (89 - 114) 133 (101 - 166) 115 (52 - 177)
Lateral   93 (87 - 100)   87 (54 - 120)   99 (89 - 108)
* Different from controls (p < 0.05)
# Different from mildly affected group (p<0.05)
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In accordance with the results for level walking, step time was different between groups 
(F2,14 = 4.6, p = 0.029), with longer step times for the moderately affected patients compared 
to controls (p = 0.044). 
 Step length and step width were similar between groups (F2,14 ≤ 0.82, p ≥ 0.46). 
Trailing toe clearance was greater than leading toe clearance (172 ± 52mm vs. 149 ± 31 mm; 
F1,14 = 13.8, p = 0.002), but this result was mainly driven by the large trailing toe clearances of 
Figure 2  Step length (a), step width (b), step time (c) and margins of stability in forward (e) and in 
lateral (f) direction of pre-crossing, leading and trailing steps. Toe clearance (d) of leading and trailing leg. 
Results are displayed for the control group, mildly affected and moderately affected patients. 
* Indicates significant difference (p < 0.05) between steps, 
+ Indicates significant difference between groups, 
◊ Indicates significant interaction effects. 
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Figure 3  Sagittal plane kinematics at the moment of crossing of the leading leg and trailing leg. 
Above the plots, stick figures displaying the configuration of one subject of each group at both 
moments of crossing. Solid lines represent controls, dashed lines the mildly affected group, and 
dotted lines the moderately affected group.
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the moderately affected subjects (figure 2d), as demonstrated by a significant step * group 
interaction (F2,14 = 3.88, p = 0.046). Toe distance (276 ± 50mm) and heel distance (263 ± 
61mm) were not different between groups (F2,14 ≤ 1.99, p ≥ 0.17).
Dynamic stability
Forward MoS (figure 2e) differed between steps (F2,28 = 46.3, p < 0.001), but these results 
varied between groups (step * group, F4,28 = 4.78, p < 0.01). All groups demonstrated smaller 
forward MoS values in the trailing compared to the leading step, but this reduction was 
greater in the moderately affected group (73 ± 11mm), compared to the control group 
(33 ± 15 mm, p = 0.008). For lateral MoS (figure 2f), we observed a similar (yet smaller) 
reduction in dynamic stability between the leading and trailing step (step, F2,28 = 6.5, 
p = 0.005), but there were no differences between groups (group, F2,28 = 1.1, p = 0.37).
Kinematics
Hip angles were different between groups, with larger angles for the moderately affected 
patients compared to the controls (F2,14 = 5.74, p = 0.015), particularly in the trailing step 
(step * group, F2,14 = 23.03, p < 0.001) (figure 3). In addition, their larger trailing hip angles 
were accompanied by greater trunk angles in the trailing step (step * group, F2,14 = 3.80, 
p = 0.048). Ankle and knee angles were similar between groups.
Discussion
In the present study, dynamic stability was evaluated in patients with different stages of 
FSHD and compared to healthy controls. Dynamic stability was assessed during level 
walking and during crossing of a small obstacle to challenge maintenance of stability. 
During level walking, gait speed was reduced with greater disease severity. In the 
moderately affected group, we also found increased step times and reduced step lengths. 
In contrast to our expectation, these spatiotemporal differences during level walking were 
not accompanied by poorer dynamic stability. When crossing the obstacle, however, the 
moderately affected patients demonstrated reduced anterior stability margins during the 
trailing step, as hypothesized. This was accompanied by an increased toe clearance and 
greater trunk and hip flexion.
Level walking
The observed reduction in walking speed and increase in step time in our patients concurs 
with previous reports on level walking in people with FSHD [6, 7]. In addition, Iosa et al. 
previously reported increased upper body movements during level walking in a group 
of 13 patients, which was associated with a decrease in walking speed and with greater 
disease severity [8]. These increased upper body movements were interpreted as a sign of 
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instability [6, 8]. In our, albeit small, group of FSHD patients we could not establish these 
presumed impairments in dynamic stability during level walking, despite substantial loss 
of muscle tissue in the trunk as well as the lower extremities (Table 1). In contrast, we 
previously found the same group of patients to indeed have severe postural instability in 
response to support surface perturbations, which was associated with greater trunk 
muscle involvement [1]. Apparently, our patients effectively utilized compensatory 
strategies to maintain dynamic stability during level walking, presumably by reducing 
their step length [23, 24] and walking speed [23, 25, 26]. 
Obstacle crossing
During obstacle crossing, the spatiotemporal outcomes were similar to those for level 
walking, with lower walking speeds and increased step times in FSHD patients, particularly 
in the moderately affected group. In contrast to level walking, when dynamic stability was 
challenged we observed poorer forward stability margins in the moderately affected 
group following the trailing step, despite a decrease in walking speed. Such differences in 
forward stability margins may simply result from modulation of step lengths [24], but we 
did not observe any differences between groups in support of this explanation. As such, 
we expect that the present results rather indicate that the moderately affected group 
lacked the capacity to fully compensate for the greater stability demands imposed by 
obstacle crossing, rendering them unable to maintain optimal stability levels. 
Furthermore, the moderately affected group also exhibited differences in toe clearances. 
In healthy controls and mildly affected patients we found comparable toe clearances 
between the leading and trailing steps, which is in agreement with previous findings [14, 
16]. In contrast to a mere 1-2 cm difference between leading and trailing toe clearance in 
these participants, however, the moderately affected group lifted the foot over the 
obstacle with a 7 cm greater margin for the trailing step. This result could not be explained 
by larger horizontal distances between the foot and the obstacle prior to crossing, as 
reported by Chou and Draganich [15]. Larger toe clearances are usually interpreted as a 
sign of more cautious crossing behavior [16, 27, 28], which may be particularly helpful to 
reduce the risk of tripping during the trailing step when there is no vision of the obstacle. 
In the moderately affected patients, however, such behavior seems inefficient in light of 
their pronounced muscle weakness.  
Alternatively, the differences in hip and trunk kinematics may point at the moderate group 
using a distinct movement strategy to compensate for their reduced ankle plantarflexion 
and knee flexion strength. In parallel with their greater trailing toe clearances, the 
moderate group demonstrated only slightly (and non-significantly) larger trailing knee 
flexion angles compared to the other participants, but their trailing hip flexion angles 
were about 20º larger. These observations are in contrast to the usual movement strategy 
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applied by healthy individuals for achieving a greater trailing toe height, involving a 
greater increase in knee than hip flexion angles [29]. Greater knee flexion angles are 
generally produced by increasing the ankle plantarflexion torque at push-off [29-32], but 
the weak calf muscles of the moderately affected patients may have prevented them from 
exploiting this mechanism during the trailing step. In addition, muscle strength of the 
knee flexors was greatly reduced as well, which presumably limited the utilization of 
active knee flexion as a compensatory mechanism for foot elevation. In contrast, the hip 
flexor muscles were (largely) spared in the moderately affected group, which may explain 
their excessive hip flexion angles for lifting the leg over the obstacle. Their 4.6º increase in 
trunk inclination angles (versus on average 1.2º in the other participants) from leading to 
trailing step would fit well with this hypothesis, as this likely yielded a more favorable 
length of the iliopsoas muscle for generating hip flexion torques during the first half of the 
trailing step [33]. This postulated movement strategy in the moderately affected patients 
for lifting the trailing limb over the obstacle may also explain their reduction in forward 
margins of stability from leading to trailing step. Greater forward trunk lean conceivably 
leads to a more anterior position of the XCoM [34] and - in the absence of step length 
modulation - a smaller margin of stability. This would imply that the moderately affected 
group ‘sacrificed’ forward dynamic stability to be able to cross the 10cm obstacle. On the 
other hand, we cannot rule out the possibility that the observed reduction in forward MoS 
was due to actual balance loss during the obstacle-crossing maneuver. Either way, our 
results demonstrate the difficulties that the moderately affected patients with FSHD 
experience in performing this common activity of daily living and may help explain their 
propensity to fall in the forward direction [3].
Limitations
The small sample size is an obvious limitation of the present study, but is common in 
gait-analysis studies in FSHD (n = 8-16) [6-8,35,36]. Nevertheless, we found statistically 
significant differences in kinematic and dynamic stability measures between mildly and 
moderately affected FSHD patients that seem to be consistent with the observed pattern 
of muscle affliction in these patients. 
 Another limitation relates to the generalizability of our results. As FSHD patients 
typically present with variable patterns of muscle involvement [5], our study population 
may not be representative of the FSHD population at large. Furthermore, our patients had 
rather similar levels of individual muscle affliction between the legs, whereas asymmetric 
involvement is a commonly observed in FSHD [5]. Hence, in this study we could not 
identify whether patients would experience greater difficulties in obstacle crossing when 
leading with the most or with the least affected leg.
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Clinical implications and conclusion
The present results suggest that FSHD patients at moderate disease stages (CSS > 3) may 
not yet show dynamic instability when walking over level ground, but are unable to 
negotiate a relatively small obstacle while maintaining optimal forward stability margins 
in the trailing step. As this task represents a common activity of daily living (e.g. stepping 
over a doorstep), these findings may bear significance with regards to the frequent 
forward falls in people with FSHD. Furthermore, our findings suggest that including more 
challenging tasks into the clinical assessment of disease severity may provide additional 
and meaningful insight into patients’ daily life functioning.
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Abstract
Purpose. To evaluate the construct validity and inter-rater reliability of four simple anti-gravity 
tests in a small group of patients with facioscapulohumeral muscular dystrophy.
Design. Case-control study.
Setting. University Medical Centre.
Participants. Nine patients with various severity levels of FSHD and ten healthy control 
subjects were included.
Interventions. Not applicable
Main Outcome Measures.  A four-point ordinal scale was designed to grade performance 
on four anti-gravity tests: Sit-to-Stance, Stance-to-Sit, Step-up, and Step-down. In addition, 
the 6-minute Walk-Test, 10m walking test, Berg Balance Scale and Timed-up-and-Go were 
administered as conventional tests. Construct validity was determined by linear regression 
analysis using Ricci’s Clinical Severity Score (CSS) as dependent variable. Inter-rater 
agreement was tested using Fleiss’ kappa analysis.
Results. Patients with FSHD performed worse on all four anti-gravity tests compared to 
controls. Stronger correlations were found within than between test categories (anti-gravity 
vs. conventional). The anti-gravity tests revealed the highest explained variance with 
regard to the CSS (R2=0.86, p=0.014). Inter-rater agreement was generally good.
Conclusions. The results of this exploratory study support the construct validity and 
inter-rater reliability of the proposed anti-gravity tests for the assessment of functional 
capacity in patients with FSHD taking into account the use of compensatory strategies. 
Future research should further validate these results in a larger sample of patients with 
FSHD.
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Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most frequent muscle 
diseases [1]. FSHD is a hereditary disorder usually starting with weakness in the facial and 
shoulder muscles, but in many patients it eventually leads to weakness and fatty infiltration 
of trunk, pelvic and leg muscles [2]. Muscle weakness of the trunk, pelvis and lower 
extremities causes characteristic impairments of posture, balance and gait, such as 
anterior pelvic tilt, lumbar hyperlordosis, postural instability (predominantly in the sagittal 
plane) and gait deviations such as foot drop, loss of push-off power, and hip and knee 
instability [3, 4]. As a consequence, it has been reported that patients with FSHD have a 
five times greater risk of sustaining recurrent falls [5]. 
For assessment of disease severity in patients with FSHD, Ricci’s Clinical Severity Score (CSS) 
is most commonly used [6]. This scale is based on strength assessment using manual muscle 
testing (MMT) and takes into account the typical pattern of muscle involvement in FSHD. 
Although MMT has shown to be a valid measure of disease progression in Duchenne muscular 
dystrophy [7, 8], inter-rater reliability is low for several muscles in patients with FSHD [9]. 
Additionally, MMT may not be sensitive enough to detect a gradual loss of muscle function 
during disease progression. Hence, for the clinical assessment of functional capacity as well as 
for research purposes, more sensitive tests are needed [10]. 
In neurological rehabilitation, several functional tests of balance and gait are frequently 
used across various patient groups, such as the 10-meter Walk Test (10mWT) for gait speed, 
the 6-Minute Walk Test (6MWT) for physical endurance, the Timed-up-and-Go test (TUG) for 
dynamic balance and the Berg Balance Scale (BBS) for static and dynamic balance [11-14]. 
Although these tests are indiscriminately applied in patients with muscle disease, they 
allow substantial use of compensatory strategies since the strength of critical trunk, pelvic 
and leg muscles is not specifically challenged [13]. As a consequence, patients with severe 
paresis of these muscles may sometimes still be able to attain acceptable results on 
conventional balance and gait tests, while their true functional capacity is actually worse.
In view of these considerations, we hypothesized that functional tests which challenge muscle 
strength to a greater extent, such as anti-gravity tests, would be more suitable for the 
assessment of functional capacity in patients with FSHD than conventional tests of 
balance and gait. This notion is coherent with the finding that the highest fall incidence in 
FSHD has been observed during tasks such as stair climbing, rising from a chair, and while 
sitting down [5]. Possibly, such tasks restrict the use of compensatory strategies, as a result 
of which they unmask the functional consequences of muscle weakness better than 
conventional tests. 
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Therefore, the goal of the current exploratory study was to evaluate the construct validity 
and inter-rater reliability of four anti-gravity tests in patients with FSHD: Sit-to-Stance, Stance- 
to-Sit, Step-up, and Step-down. To score patients’ capacity with regard to these anti-gravity 
tests, a scale was used – based on other qualitative functional performance scales 
(POMA-B [15], Dynamic gait index [16], Motor Function Measurement [17]) –  that allowed 
grading the use of compensatory strategies. In this way, it was attempted to increase the 
validity of the scoring system. To test construct validity, we compared the anti-gravity 
tests with four conventional balance and gait tests (10mWT, 6MWT, TUG, BBS) and tested 
three hypotheses: (1) patients with FSHD perform worse on the anti-gravity tests than 
healthy controls; (2) the anti-gravity tests and conventional tests show greater within- 
category than between-category associations in patients with FSHD; and (3) associations 
of the CSS with the anti-gravity tests are stronger than with the conventional tests in patients 
with FSHD. Inter-rater reliability was tested by comparing the scores of three observers. 
Methods
Participants and design
Ten adults with genetically confirmed FSHD were recruited via the rehabilitation and 
neurology outpatient departments of our university clinic. We purposely included a wide 
range of disease severities, from patients with mild lower extremity muscle weakness at 
the one end (CSS 3) to severely affected patients who were barely able to walk anymore 
on the other hand (CSS 4.5). A physiatrist determined the CSS [6]. In addition, age, sex, 
weight and height were recorded for each patient. Specific exclusion criteria were: the 
presence of other neurological diseases affecting balance or ambulation, severe cardio-
pulmonary disease, and pregnancy. Ten healthy control subjects who were matched for 
age and gender were additionally recruited. The patients with FSHD performed both the 
anti-gravity tests and the conventional tests as part of a more extensive biomechanical 
assessment of balance and gait [18, 19]. All tests were performed in a standardized order 
under the supervision of the primary investigator (NR): conventional tests were performed 
on the day of the intake (BBS, TUG, 10mWT, 6MWT), whereas anti-gravity tests were 
performed on a different day within 8 weeks after the intake (Step-up, Step-down, 
Sit-to-Stance, Stance-to-Sit). Controls only performed the anti-gravity tests. Participants 
were allowed to take time in between tests whenever they needed rest. The study was 
approved by the regional medical-ethical committee. All participants gave written informed 
consent.
Anti-gravity tests
To perform the Step-up and Step-down tests, a box of 20cm height was used. For the 
former test, participants were instructed to step up twice in a controlled manner, once 
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with the left foot and once with the right foot first. A similar instruction was given for the 
Step-down test. Each test (e.g., Step-up with left foot first) was performed and scored 
twice. For the Sit-to-Stance and Stance-to-Sit tests, the seat height was individually 
adjusted, so that the feet were flat on the ground and the knee angle was 90° when 
sitting. Subjects were instructed to place their hands on their waist and stand up or sit 
down without using their arms. Tests were performed twice for obtaining a score 3 or 2. If 
the test was not possible after two attempts, participants were allowed to use their arms 
during a second pair of trials to obtain a score 1 or 0.  Videos of all anti-gravity tests were 
recorded in both the frontal and sagittal planes using two cameras (Basler A602FC-2; 
Ahrensburg, Germany) at 6.5m distance and 1.25m height. 
Conventional tests
The BBS and TUG were both assessed once in a quiet room. The 10mWT was assessed 
three times at comfortable and three times at maximum velocity, starting from a quiet 
standing position, using a 10m walking track in a quiet corridor. The assessor gave an 
auditory starting signal and a stopwatch was used to measure the time taken to cover the 
10m track. The 6MWT was performed once in a quiet corridor using a walking track of 
25m. Subjects were not allowed to talk during the test and were intermittently informed 
by the assessor about the remaining time. All tests were assessed by NR.
Scoring of the anti-gravity tests
A four-point scale was used for the anti-gravity tests (see table 1). This scale was derived 
from several commonly applied tests to qualitatively grade functional performance 
(POMA-B, Dynamic Gait Index, Motor Function Measurement) with the aim to be able to 
score the use of compensatory strategies (e.g., using the arms for forward propulsion 
while standing up). All videos were independently assessed by three physiotherapists 
who were experienced with treating patients with muscle disease. For each trial, both the 
sagittal and frontal videos were shown twice. Videos of patients and healthy controls were 
shown alternately, starting with a control subject, in the following order: Step-up (left and 
right step), Step-down (left and right step), Sit-to-Stance and Stance-to-Sit. After the 
observers had finished all trials, any disagreement was discussed with the aim to reach 
consensus about the definitive score for each trial. This consensus score was used for 
determining construct validity.
Scoring of the conventional tests
For the 6MWT the distance covered was recorded in meters. The average (comfortable 
and maximum) walking velocity was calculated across the three trials in meters per 
second. The time to perform the TUG was recorded in seconds. The score on the BBS 
could range from 0 to 56. 
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Statistical analysis
The scores of anti-gravity trials were averaged per test and per individual to determine 
construct validity (left and right steps were taken together for the Step-up and Step-down 
tests). Then, average performance on the anti-gravity tests was compared between 
patients and controls using one-way ANOVA. Spearman correlations coefficients were 
calculated both within and between test categories for the patients with FSHD. Linear 
regression analyses were used to predict the individual CSS (dependent variable) based 
on either the anti-gravity or conventional tests (independent variables) in patients with 
FSHD applying backward stepwise exclusion of factors. As for inter-rater reliability, the 
scores of the first trials of each anti-gravity test were used. Inter-rater agreement among 
the three assessors was calculated by regarding the individual scores per assessor using 
Fleiss kappa’s analysis [20]. 
Table 1  Scoring of anti-gravity tests
Sit-to-Stance
3 Is able to stand up in a controlled manner
2 Has difficulty standing up in a controlled manner
1 Is able to rise after several attempts or by using the arms for support or forward propulsion
0 Is not able to rise independently
Stance-to-Sit
3 Is able to sit down in a controlled manner 
2 Has difficulty sitting down in a controlled manner
1 Plumps down, takes support with the hands on the legs, or uses the arms as counterweight
0 Is not able to sit down independently
Step-up
3 Is able to step up in a smooth controlled manner
2 Stepping up requires effort or is associated with balance problems
1 Turns the body, uses circumduction, or uses the arms for support or forward propulsion
0 Is not able to step up independently
Step-down
3 Is able to step down in a controlled manner
2 Stepping down requires effort or is associated with balance problems
1 Drops down, turns the body, or takes support with the hands on the knees
0 Is not able to step down independently
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Results
Participants
Of the ten persons that were included in the biomechanical assessment studies [18, 19], 
one person was not able to perform all functional tests due to fatigue. As a result, nine 
persons with FSHD performed all functional tests and were compared to ten healthy 
controls with regard to the anti-gravity test results. The individual patient characteristics 
are listed in table 2. All listed compensatory mechanisms of the scoring system (score 1) 
were seen among the patients that scored a 1 on the anti-gravity tests. 
Construct validity
The average scores on all anti-gravity tests are displayed in figure 1 for both groups. The FSHD 
group performed significantly worse compared to the control group (Step-up: F1,17 = 20.2, 
p < 0.001, Step-down: F1,17 = 36.4, p < 0.001, Sit-to-Stance: F1,17 = 37.0, p < 0.001, Stance-to-Sit: 
F1,17 = 25.6, p < 0.001). 
 The anti-gravity tests and the conventional tests showed high within-category correlations 
(anti-gravity tests: average rS > 0.85; p < 0.01; conventional tests: average rS > 0.88; p < 0.01), 
whereas the anti-gravity tests did not significantly correlate with the conventional tests 
(average rS = 0.63, p = 0.085) (see table 3). 
 A linear regression model with Step-up, Step-down and Sit-to-Stance as independent 
variables yielded the largest significant explained variance (R2 = 0.86, p = 0.014, adjusted 
R2 = 0.78). Further exclusion of the Step-down test yielded a slightly decreased explained 
variance (R2 = 0.84, p < 0.01, adjusted R2 = 0.79), whereas a model with only the Step-up 
test performed substantially worse (R2 = 0.75, p < 0.01, adjusted R2 = 0.72). For the 
conventional tests, the model was only significant when the BBS alone was used to predict 
the CSS, but yielded a much lower explained variance (R2 = 0.54, p = 0.024, adjusted R2 = 0.47). 
 The difficulty of the three anti-gravity tests included in the best performing model 
showed a clear hierarchy as shown in figure 1: Sit-to-Stance, Step-up, Step-down (from 
most easy to most difficult). When these tests were used in this hierarchical order to 
predict the CSS according to the flowchart in Figure 2, all but one patient (89%) could be 
correctly classified.
Inter-rater reliability
Absolute agreement between three assessors was found in 72% of the Step-up trials (n = 36), 
68% of the Step-down trials (n = 34), 89% of the Sit-to-Stance trials (n = 19) and 84% of 
the Stance-to-Sit trials (n = 19). Three completely different scores were found only once for 
the Step-up and once for the Sit-to-Stance trials. For the Step-up and Step-down tests, 
Fleiss’ kappa values of κ = 0.65 (p < 0.001) and κ = 0.67 (p < 0.001) were found, respectively. 
For the Sit-to-Stance and Stance-to-Sit tests, the Fleiss’ kappa’s were κ = 0.85 (p < 0.001) 
and κ = 0.81 (p < 0.001), respectively.
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Figure 1  Average scores on anti-gravity tests for healthy controls (dark grey bars) and 
patients with FSHD (light grey bars).
Figure 2  Flowchart to predict the CSS based on three anti-gravity tests (Sit-to-Stance, 
Step-up, Step-down).
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Discussion
The goal of the present exploratory study was to evaluate the construct validity and 
inter-rater reliability of four anti-gravity tests in a small group of FSHD patients. To this end, 
the anti-gravity tests  – Step-up, Step-down, Sit-to-Stance, Stance-to-Sit – were compared 
to four conventional functional tests of balance and gait capacity (10mWT, 6MWT, TUG, 
BBS) using a new ordinal scoring system that allows grading the use of compensatory 
mechanisms. Construct validity of the anti-gravity tests was supported by clear group 
differences compared to healthy controls who were matched for age and gender. More 
importantly, our hypotheses that anti-gravity tests would show greater within-category 
correlations than between-category correlations with the conventional tests and that the 
anti-gravity tests would be stronger associated with Ricci’s CSS than the conventional tests 
were corroborated by the results. In addition, the inter-rater reliability of the antigravity 
tests was shown to be good. 
Construct validity
Currently, conventional tests are indiscriminately used in patients with muscle disease for 
the functional assessment of their balance and gait capacity. Although these tests may 
have some value for assessing the ultimate functional performance of individual patients, 
they allow massive use of compensatory strategies as the strength of critical trunk, pelvic 
and leg muscles is not specifically challenged [13]. As a consequence, these conventional 
tests easily overestimate the true functional capacities of patients with muscle disease, 
such as FSHD, and lack the sensitivity to discriminate between subjects and to identify 
functional change within subjects across time. The results of the current study clearly 
showed that, in comparison with the conventional balance and gait tests, the reported 
anti-gravity tests were much stronger associated with clinical disease severity as assessed 
with the CSS [6], which was based on manual muscle testing. This is an intuitive result, as 
the CSS incorporates ‘getting up from a chair’ as a critical item in the scoring system. 
Remarkably, however, the CSS scores 3 to 4.5 could accurately be predicted in all but one 
patient by simply using three of the anti-gravity tests in a hierarchical order: Sit-to-Stance, 
Step-up, and Step-down. This finding strongly supports the construct validity of the 
anti-gravity tests for the functional assessment of mobility capacity in patients with FSHD. 
Apart from the use of gravity as a natural way of imposing muscle resistance, the good 
construct validity seems to be related to the fact that the use of compensatory mechanism 
was explicitly scored by assigning a score 1 in each of the anti-gravity tests. 
The clinical value of the reported anti-gravity tests is further supported by previous results from 
our group indicating that anti-gravity activities such as stair climbing and chair transfers 
are common causes of falls in patients with FSHD [5]. Hence, it may well be that anti-gravity 
tests are better able to identify patients with increased fall risk than conventional tests of 
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balance and gait capacity, but this should be investigated in future studies. Likewise, 
although a good construct validity suggests that the reported anti-gravity tests may also 
be used to monitor disease progression in patients with FSHD, their sensitivity to change 
needs to be established in a longitudinal design and compared to manual muscle testing. 
In patients with other neuromuscular diseases, the Motor Function Measure (MFM) has 
been shown to be sensitive to disease progression, probably because it takes into account 
the use of compensatory mechanisms [21]. Yet, the MFM did not show sufficient sensitivity 
in people with FSHD during a one year follow-up [21], indicating that better functional 
measures of gross motor capacity with good validity and sensitivity are needed in these 
patients.
Inter-rater reliability
Although Fleiss’ kappa has been designed for analyzing categorical data (instead of 
ordinal data as used in this study) obtained by more than two observers, we still chose this 
type of analysis since a weighted Fleiss’ kappa does not exist. Because the difference in 
grading between observers was more than 2 in merely two trials, a weighted Fleiss’ kappa 
would probably have led to similar results. The inter-rater agreement of the anti-gravity 
tests was found to be ‘substantial’ for the Step-up and Step-down tests and ‘almost 
perfect’ for the Sit-to-Stance and ‘Stance-to-Sit’ tests [22]. Only in two trials, the three 
assessors completely disagreed. It must be acknowledged, however, that all raters were 
experienced with treating patients with muscle disease. Still, the amount of training 
needed for ‘naïve’ physiotherapists to obtain similar results seems to be relatively small. 
The inter-rater agreement was, nevertheless, not perfect, especially not for the Step-up 
and Step-down tests, which implies that further improvement is possible by either 
extending the training or adjusting the scoring system. Because manual muscle tests 
typically assess peak isometric muscle strength during a very short time period, it is well 
conceivable that a comparison of reliability between manual muscle tests and functional 
anti-gravity tests will be in favor of the latter, because muscle force has to be controlled for 
a longer time period in a more coordinated way. This natural feature of functional tests 
may also add to their sensitivity to change, but this assumption should be tested in future 
research. Future studies including many more patients and raters, taking into account the 
influence of disease severity and rater experience, may use (many-facet) Rasch analysis 
[23] to transform the ordinal character of the proposed anti-gravity tests into interval 
scales to optimize their sensitivity to change.
Study limitations
An obvious limitation of the present exploratory study is the relatively small number of 
patients and assessors. Nonetheless, these patients were carefully selected for having a 
CSS between 3 and 4.5 to obtain an optimal variation in the severity of balance and gait 
problems. Hence, we anticipate that a study including a larger sample of FSHD patients 
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with essentially the same variation in disease severity would yield similar results. People 
with a CSS lower than 3 were expected to hardly have any such problems, whereas those 
with a score 5 would have been unable to perform the anti-gravity tests. Another limitation 
of our study is its cross-sectional design that did not allow us to investigate the sensitivity 
to change of the anti-gravity tests. Furthermore, we did not determine their intra-rater or 
test-retest reliability. 
Conclusion
The four proposed anti-gravity tests – Step-up, Step-down, Sit-to-Stance, Stance-to-Sit –, 
combined with a new four-point scale that allows grading the use of compensatory 
mechanisms, were found to have excellent construct validity regarding the functional 
assessment of gross motor capacity in a relatively small group of patients with FHSD as 
well as good inter-rater reliability. The first three tests could accurately predict Ricci’s 
clinical severity scores 3 to 4.5, whereas the conventional balance and gait tests showed a 
much weaker relationship with the CSS. These results point toward the notion that 
conventional tests may be less suitable to assess functional capacities in patients with 
FSHD. However, larger studies should be conducted to confirm these results. Future 
research should focus on the sensitivity to change of the proposed anti-gravity tests 
compared to conventional balance and gait tests and to manual muscle testing.
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Summary
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common hereditary 
muscular disorder, with an estimated prevalence of 1:8,500 in the Netherlands [1]. FSHD is 
characterized by progressive, mostly descending (face-schoulders-legs), weakness of 
eventually all skeletal muscles. Because a causative treatment is not available, it remains 
important to focus on symptomatic treatment (rehabilitation) to minimize the consequences 
of muscles weakness and to compensate for functional limitations. 
 Patients with FSHD often experience postural problems as soon as trunk and/or lower 
extremity muscles become involved. When muscle weakness is present at several body 
segments, complex alterations of static (standing) and dynamic (walking) balance occur 
that increase the risk of falls. It has been shown that falls in FSHD mainly occur in the 
forward direction and in the home situation (e.g. while climbing stairs or rising from a 
chair) [2]. However, balance and gait deviations are still poorly understood. It remains 
unclear what fall mechanisms are into play and which muscle weakness is most critical for 
the increased occurrence of falls. Biomechanical studies of balance and/or mobility are 
still scarce in patients with FSHD. Especially the effects of selective muscle involvement on 
balance and mobility have been disregarded.
 The development of optimal rehabilitation strategies calls for understanding of all 
aspects and mechanisms underlying decreased postural control, walking capacity and 
dynamic balance control in persons with FSHD. In the studies that constitute this thesis, it 
was aimed to further our understanding of the selective pattern of individual muscle 
involvement in patients with FSHD, and to gain insight into the mechanisms underlying 
the balance and mobility problems that are experienced by these patients.  
Chapter 1 is the general introduction and provides background information on FSHD. 
It gives a short overview of the clinical picture of FSHD and discusses the problems that 
are experienced by the patients regarding balance and mobility. 
In this chapter the most important research questions of this thesis are introduced:
1. What is the total body pattern of individual muscle involvement in FSHD and is the 
degree of muscle involvement associated with genetic defect size?
2. Which muscle weakness is most critical for loss of sagittal-plane postural control in FSHD?
3. What is the association of ankle plantarflexor involvement with gait propulsion in 
FSHD and what compensatory gait strategies are used?
4. To what extent is dynamic postural stability affected during normal level walking and 
obstructed walking in FSHD?
5. What is the added clinical value of anti-gravity tests next to conventional tests for 
functional assessment of mobility in FSHD?
The general introduction ends with a description of the outline of this thesis. 
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Research question 1: What is the total body pattern of individual muscle involvement 
in FSHD and is the degree of muscle involvement associated with genetic defect size?
The aim of chapter 2 was to identify the total body pattern of individual muscle 
involvement in a large group of patients with FSHD to better understand postural and 
movement disabilities. Additionally, we studied whether residual D4Z4 repeat array length, 
adjusted for age and gender, could predict the degree of muscle involvement. Total body 
computed tomography scans of 70 patients were used to assess the degree of fatty 
infiltration of 42 muscles from neck to ankle level on a semi-quantitative scale. Groups of 
muscles that highly correlated regarding the presence of fatty infiltration were identified 
using factor analysis. Strong correlations between the amount of fatty infiltration in 
groups of muscles and the forces that could be generated by these muscles were found. 
This indicates that the pattern of fatty infiltration also represents the pattern of muscle 
weakness. Trunk muscles were most frequently affected. Of these, back extensors were 
more frequently affected than previously reported. Asymmetry in muscle involvement 
was seen in 45% of the muscles that were infiltrated with fat. The right-sided upper 
extremity showed significantly higher scores for fat infiltration compared to the left side, 
which could not be explained by handedness. Linear regression analysis was performed 
using muscle fatty infiltration as the dependent variable and D4Z4 repeat length, age and 
gender as independent variables. This analysis revealed that for the trunk, the lower 
extremity and also for the whole body the D4Z4-repeat length explained a significant 
amount of the fatty infiltration found. It was possible to explain 29% of the fat infiltration 
based on D4Z4 repeat length, corrected for age and gender. Based on these results it was 
concluded that frequent occurrence of fat infiltration in the back extensors, in addition to 
the abdominal muscles, emphasizes the extent of trunk involvement, which may have a 
profound impact on postural control even in otherwise mildly affected patients.
Research question 2: Which muscle weakness is most critical for loss of sagittal-plane 
postural control in FSHD?
In chapter 3 it was aimed to determine whether the affliction of trunk or lower limb 
muscles is ultimately most critical for the loss of sagittal-plane postural control in patients 
with FSHD. This was analyzed by studying the responses to sagittal-plane platform 
translations in both the forward and backward direction in a group of ten patients with 
various severity levels of FSHD and ten healthy controls. Stepping thresholds were 
determined and kinematic responses and centre-of-mass displacements to external 
perturbations were assessed using three-dimensional motion analysis. Magnetic resonance 
imaging was used to determine the amount of fatty infiltration of trunk and lower extremity 
muscles. It was hypothesized that trunk muscle involvement would be more critical than 
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lower extremity muscle involvement. Stepping thresholds in both forward and backward 
directions were decreased in patients compared to controls. In patients, significant 
correlations were found for fatty infiltration of the ventral muscles with the backward 
stepping threshold and for fatty infiltration of the dorsal muscles with the forward 
stepping threshold. Fatty infiltration of the rectus abdominis and the back extensors 
explained the largest part of the variance in backward and forward stepping threshold, 
respectively. Centre-of-mass displacements were dependent on intensity and direction of 
perturbation. Kinematic analysis revealed predominant ankle strategies, except in patients 
with lumbar hyperlordosis. All together, the results of this study indicated that trunk 
muscle involvement is most critical for loss of sagittal-plane postural balance in patients 
with facioscapulohumeral muscular dystrophy. This is valuable information that can be 
used to identify patients that are prone to falls. 
Research question 3: What is the association of ankle plantarflexor involvement with 
gait propulsion in FSHD and what compensatory gait strategies are used?
In chapter 4 the effect of ankle plantarflexor involvement on gait propulsion and the use 
of compensatory hip strategies were studied in FSHD. If calf muscles are unable to exert 
sufficient plantarflexion power to maintain walking speed (‘push-off’), an exaggerated hip 
flexion moment is commonly used through increased recruitment of the hip flexors (‘pull 
off’). Such a shift was also hypothesized to occur in patients with FSHD since the calf 
muscles may show early fatty infiltration, whereas iliopsoas muscles are often spared for a 
longer time. In this context also the gluteus maximus muscles are important as they may 
be used to increase hip extension power. In the current study, MRI was used to assess the 
percentage of unaffected calf, iliopsoas and gluteus maximus muscles. Walking speed and 
joint powers were analyzed in ten patients with FSHD at comfortable and maximum 
walking speed to determine the contribution of ankle plantarflexor, hip flexor and hip 
extensor power to gait propulsion. Associations between muscle morphology, power 
generation and gait speed were assessed. The results showed that ankle plantarflexor 
power was the only factor that uniquely contributed to the explained variance of 
comfortable (R2=80%) and maximum (R2=86%) walking speed. Although the iliopsoas 
muscles were largely unaffected, they appeared to be sub-maximally recruited. From 
these results it was concluded that the natural compensatory strategy for calf weakness 
was insufficiently used by patients with FSHD. This may be related to poor trunk stability, 
resulting in a disproportionate effect of calf muscle involvement on gait speed in patients 
with FSHD. 
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Research question 4: To what extent is dynamic postural stability affected during 
normal level walking and obstructed walking in FSHD?
Chapter 5 aimed to assess dynamic stability during level walking and obstacle crossing in 
patients with different severity levels of FSHD, to obtain insight into fall mechanisms in this 
patient group. Forward and lateral dynamic stability were assessed, as well as spatiotemporal 
and kinematic variables, during level walking and walking while crossing an obstacle of 10 
cm height. Ten patients with at least some lower extremity weakness were included, of 
whom six were classified as ‘moderately affected’ and four as ‘mildly affected’. Ten healthy 
controls were also included. During level walking, the moderately affected group demonstrated 
a lower walking speed, which was accompanied by longer step times and smaller step 
lengths, yet dynamic stability was unaffected. When crossing the obstacle, however, the 
moderately affected patients demonstrated reduced forward stability margins during 
the trailing step, which was accompanied by increased toe clearance and greater trunk 
and hip flexion. This suggests that during level walking, the patients effectively utilized 
compensatory strategies for maintaining dynamic stability, but that the task requirements 
for obstacle crossing exceeded the residual capacity of the moderately affected patients, 
rendering them unable to maintain optimal stability levels. These present results highlight 
the difficulties that FSHD patients experience in performing this common activity of daily 
living and may help explain the propensity of these patients to fall in the forward direction.
Research question 5: What is the added clinical value of anti-gravity tests next to 
conventional tests for functional assessment of mobility in FSHD?
In chapter 6 the construct validity and inter-rater reliability of four simple anti-gravity 
performance tests (Sit-to-Stance, Stance-to-Sit, Step-up and Step-down) in patients with 
facioscapulohumeral muscular dystrophy (FSHD) were evaluated. For the functional 
assessment of mobility capacity in patients with FSHD valid, reliable and sensitive tests are 
needed that go beyond manual muscle testing and conventional tests of balance and gait 
to monitor disease progression and response to treatment. In particular, these tests should 
take into account the use of compensatory strategies. A four-point ordinal scale was 
designed to grade performance on the four anti-gravity tests. In addition, the 6-minute 
Walk-Test, 10-meter Walking Test, Berg Balance Scale and Timed-Up-and-Go were administered 
as conventional tests. Nine patients with various severity levels of FSHD and ten healthy 
control subjects were included. Patients with FSHD performed worse on all four anti- 
gravity tests compared to controls. Stronger correlations were found within than between 
test categories (anti-gravity vs. conventional). The anti-gravity tests revealed the highest 
explained variance with regard to Ricci’s Clinical Severity Scale (CSS) (R2 = 0.86, p = 0.014). 
Fleiss’ kappa values for inter-rater agreement were generally good. The results support the 
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construct validity and inter-rater reliability of the proposed anti-gravity tests for the 
functional assessment of mobility capacity in patients with FSHD taking into account the 
use of compensatory strategies. Future research should further establish the clinimetric 
properties of the proposed anti-gravity tests, particularly their sensitivity to change.
General discussion
Until it is possible to stop or reverse the progressive infiltration of fatty tissue in skeletal 
muscles, the main focus of treatment in patients with FSHD is on rehabilitation, providing 
them with strategies and aids to support their functional capacities and to prevent them 
from falling as a consequence of muscle weakness. The results of this thesis further our 
understanding of the total body pattern of individual muscle weakness and its relation to 
the balance and mobility problems that are experienced by patients in different stages of 
FSHD. However, also new questions arose regarding these issues that require further 
attention and discussion.
Muscle imaging in FSHD 
To investigate the total body pattern of individual muscle involvement and its associations 
with balance and mobility problems, muscle imaging was used. Currently, muscle imaging 
in muscular disorders is mainly applied for research purposes [3-5], which reveal an 
increasing contribution of full body MRI scanning to the differential diagnosis of muscle 
diseases, instead of invasive muscle biopsies [4-6]. In the clinic, muscle involvement is still 
commonly assessed by manual muscle testing. It may, nevertheless, be valuable to include 
muscle imaging in the standard care for monitoring purposes or as a tool to improve the 
functional diagnosis to support rehabilitation strategies. Both MRI and ultrasound imaging 
are harmless methods that can be used to evaluate muscle affliction. Several pros and 
cons of muscle imaging can be listed. 
Pros of muscle imaging:
-   Identification of individual muscle involvement
In contrast to the clinical assessment of muscle weakness, identification of individual 
muscle involvement is possible using muscle imaging. For example, this thesis highlights 
the importance of frequent trunk muscle involvement in FSHD, which is hard to recognize 
clinically. Thus, muscle imaging contributes to a better functional diagnosis to understand 
the postural and gait problems in these patients. Because of the strong relationship 
between fatty infiltration and muscle strength, even a semi-quantitative measure of fatty 
infiltration can be used to estimate muscle strength in FSHD. This is valuable, since manual 
muscle testing is highly assessor dependent. Therefore, muscle imaging can contribute to 
our understanding of the balance and mobility problems in individual patients and assist 
in choosing the optimal rehabilitation strategy or orthotic device. 
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-  Monitoring disease progression
The possibility to objectively assess individual muscle involvement makes muscle imaging 
a good measure of disease progression at the muscular level. In addition, muscle imaging 
can be used to evaluate the effectiveness of (future) interventions that are aimed to 
decelerate fatty infiltration rate. Tawil et al. have recently stressed the importance of 
objective measures of disease progression [7]. With regular muscle imaging, the 
monitoring of disease severity can possibly be more reliably performed for both clinical 
and research purposes.  
Cons of muscle imaging:
-  Time and cost consumption 
Currently, important reasons for not regularly using MRI in the clinic are the economic and 
time aspects. The use of MRI has grown exponentially and the technique has been 
improved in a way that the applications of MRI become tremendous. However, the time 
to perform MRI is still relatively long, ranging from 20 minutes for a simple protocol up to 
more than an hour for full body imaging, without taking into account the time to assess 
the images. This is also reflected in the costs of an MR examination. 
Ultrasound imaging is less costly and usually less time consuming. However, a 
representative examination of fatty infiltration of the body may also take approximately 90 
minutes. 
-  Problems with grading of muscle involvement
Although imaging will reveal even small amounts of muscle fatty infiltration, standardized 
quantification of muscle involvement remains complex. The objective assessment of 
muscle involvement requires a standardized measure of muscle affliction [4, 5]. In the 
current thesis grading was done both semi-quantitatively using a four-point scale and 
quantitatively by calculating the percentage of remaining muscle tissue. For a general 
picture of the affected muscles a semi-quantitative score may be sufficient, whereas for 
monitoring disease progression a more sensitive, quantitative measure is needed. In the 
current thesis, the percentage of remaining muscle tissue was performed at the level of 
the thickest cross-sectional area only. For accurately monitoring disease progression or 
treatment effects muscle affliction at more levels and in different planes is desired.
-  Inter-individual variation in muscle size 
FSHD does not only lead to fatty infiltration of muscles. The process of muscle impairment 
involves an inflammatory phase as well as muscle atrophy [3].  There is increasing evidence 
that determination of muscle involvement is not only reflected by the amount of fatty 
infiltration. The degree of muscle atrophy and the presence of inflammation should be 
taken into account for an optimal representation of muscle involvement. While 
inflammation can be assessed using a different sequence of MR imaging, atrophy is more 
difficult to determine. The cross-sectional area of a muscle is not only dependent on the 
amount of atrophy due to the disease, but also on age and gender and the amount of 
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(strength) training that has been done [8]. Thus, except for extreme cases, muscle atrophy 
can only be detected when the muscle cross-sectional area is measured more than once. 
Besides visible or quantified [3] involvement of muscle by fatty infiltration and atrophy, 
there is preliminary evidence for the notion that normally appearing muscle fibres can 
already be weakened in patients with FSHD [9].  
In conclusion, muscle imaging in patients with FSHD is especially useful when it is 
quantified [3] in a standardized manner and performed more frequently throughout the 
time course of the disease. When used in a proper way, it can serve as an objective 
measure of individual muscle involvement to support the functional diagnosis of mobility 
problems and to monitor disease progression.
Evolving insights in the pattern of muscle involvement in FSHD 
Factor analysis of CT data in a large group of patients with FSHD allowed the identification 
of groups of muscles that become affected at a certain stage of the disease. The 
identification of frequently involved as well as spared muscles is not only valuable for 
functional diagnosis, but also furthers our knowledge of the pathophysiology that 
underlies the unique clinical picture of FSHD. The most interesting and valuable findings 
are the following. 
-   Trunk muscles, and specifically the back extensors, are frequently affected. This 
information is new, probably because trunk muscles are difficult to test clinically. As the 
case description in Box 3 (see the Introduction of this thesis) already pointed out, 
problems that are experienced by persons with FSHD cannot always be understood 
without the objective assessment of muscle involvement. Awareness of the possibility 
of early trunk muscle weakness may contribute to a better understanding of the postural 
and gait problems in FSHD. The relevance of trunk muscle involvement for balance and 
mobility becomes apparent in the studies of this thesis, where trunk muscle weakness 
was related to disorders of sagittal-plane posture and balance and, possibly also, to 
impaired gait propulsion.
-   It was found that the hamstrings and rectus femoris muscles constitute a cluster of 
muscles that commonly show fatty infiltration, whereas the other quadriceps muscles 
are still unaffected. The reason for this unique distribution of muscle involvement 
remains elusive. It may be related to embryological genesis, but it may also be related to 
a functional difference. Both the hamstrings and the rectus femoris are biarticular 
muscles that may be more sensitive to fatty infiltration compared to monoarticular 
muscles, such as the vastus muscles. An important difference between mono- and 
biarticular muscles is that biarticular muscles have a unique role in controlling the 
distribution of net moments about individual joints and, thus, contribute to mechanical 
energy transfer between joints [10-12]. Furthermore, Hof showed that monoarticular 
muscles generate little work in the transverse plane compared to biarticular muscles 
CHAPTER 7
122
[13]. Whether these functional differences may predispose biarticular muscles to 
become infiltrated with fat in FSHD remains to be elucidated, particularly because the 
early involvement of the tibialis anterior muscles in these patients does not support this 
assumption 
-   Although previous studies emphasized the specific early affliction of the semimembra-
nosus [14], factor analysis of the CT data indicated that all hamstrings muscles are 
similarly affected. This is an important finding in the context of lumbar hyperlordosis. 
Weak hamstrings in combination with weak abdominal muscles may easily lead to an 
anterior tilt of the pelvis that is passively stabilized by the spine, forcing the lumbar spine 
in hyperlordosis [15]. 
-   Asymmetric fatty infiltration was present in a larger proportion (45%) than previously 
reported [14, 16]. Only recently, a comparable percentage of asymmetry (37,5%) was 
found in an MRI study of 37 patients, but unfortunately the authors did not report the 
direction of asymmetry [17]. In our CT study, a clear right-sided asymmetry was found. It 
appeared that the direction of asymmetry was not related to handedness, which does 
not support the overuse theory [18]. Whether the right body side is more affected due 
to genetic, functional, or anatomical/developmental mechanisms needs further investigation. 
Unfortunately, it was not possible to assess the effect of asymmetric weakness on 
balance and mobility problems due to the small number of patients in the biomechanical 
studies. Biomechanical analyses in combination with muscle imaging in larger patient 
groups are necessary to identify the influence of asymmetric fatty infiltration of muscles 
on balance and mobility capacity in patients with FSHD. 
-   Muscle fatty infiltration could be explained by genetic defect size, corrected for age and 
gender. However, the low percentage of explained variance indicates that there must be 
other than genetic factors influencing the severity of FSHD. Within the work of this thesis 
it was not possible to identify any other determinants of disease severity than gender. 
Previously, penetrance of FSHD was shown to be higher in males compared to females 
[19-21]. Surprisingly, the CT study revealed that among affected persons the detrimental 
effect of a certain D4Z4 repeat length on fat infiltration and associated muscle weakness 
was stronger in females than in males of the same age. Hence, it can be concluded that 
if females with FSHD become symptomatic, the disease seems to progress faster. 
Possibly, gender may also influence the pathophysiological mechanism of muscle fatty 
infiltration. 
Although the current thesis provides valuable data on the total body pattern of individual 
muscle involvement in FSHD, the design of the CT study was not optimal. Because of its 
cross-sectional nature, the pattern of muscle involvement was established by the clustered 
occurrence of affected muscles in groups of patients. The wide range of disease severity 
and the relatively large number of participants allowed the use of this method. However, 
actual (progression of) individual muscle involvement should preferably be investigated 
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using a longitudinal design, which would provide data on the true sequence(s) of muscle 
affliction in FSHD. This should then be done using MRI or ultrasound imaging, because of 
its harmless nature compared to CT scanning.
Postural stability in FSHD 
Both trunk and lower extremity muscles acting in the sagittal plane are important for 
maintaining balance in this plane of control [22, 23]. Previous studies on postural control 
in FSHD have mainly focused on lower extremity muscles. It was shown that distal leg 
muscle weakness was more critical for causing sagittal plane postural instability than 
proximal leg muscle weakness [24]. This finding was explained by the fact that the lower 
leg muscles are the prime movers of the ankle strategy underlying the ‘inverted pendulum’ 
response in the sagittal plane [23, 25]. However, a prerequisite for a successful ‘inverted 
pendulum’ response to recover from a perturbation is sufficient stability of the knee, the 
hip and the trunk [23, 25]. Regardless of the postural strategies used by the patients with 
FSHD, the resultant stepping threshold was decreased compared to healthy controls. 
Remarkably, the strongest relation between fatty infiltration and sagittal plane stepping 
threshold was found for the trunk muscles. Trunk muscle weakness may, thus, play a 
larger role than previously thought in the occurrence of falls in FSHD. How can this be 
understood?
Previous studies on postural control in healthy subjects have already emphasized the 
critical role of trunk muscles to recover from balance perturbations [23, 26, 27]. Indeed, the 
trunk muscles have an essential role in the execution of both the ankle and the hip 
strategy, the latter being the most important alternative for the ankle strategy to keep the 
feet in place, whereas the lower leg muscles are merely critical for the ankle strategy [23, 
27]. Thus, when the lower leg muscles are weak, the ankle strategy in both directions is 
seriously affected, but a hip strategy may still be executed. However, when the trunk 
muscles are weak, both the ankle and the hip strategy will be affected, leaving a stepping 
response as a last resort strategy to maintain balance.
The applied postural strategy to withstand body perturbations is not only dependent on 
the biomechanical constraints. There can be different preferences for either an ankle or a 
hip strategy among healthy persons to respond to balance perturbations [23]. In persons 
with FSHD, this preference will probably be related to the muscles that are affected and to 
intrinsic factors such as fear of falling [28]. However, the currently studied patient group 
was too small to investigate the influence of such individual factors in patients with FSHD. 
The postural strategy used to recover from a perturbation is also dependent on the 
amount of body inclination towards the direction of perturbation at the moment of 
perturbation [29, 30]. Hence, a random order was applied for the direction of forward and 
backward perturbations to control for this influence. Nevertheless, we cannot completely 
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rule out an influence of initial body inclination, since posture was not determined at the 
moment of perturbation. 
Although a direct link between muscle weakness and increased fall risk has not been 
demonstrated experimentally, epidemiological studies have suggested such an association 
[2, 31]. In this thesis, it was not possible to examine relations between the involvement 
of trunk muscles and the actual occurrence of falls because of the small patient group. 
In addition, the cross-sectional design would only have allowed a retrospective assessment 
of falls, which is notoriously unreliable. In the current thesis, the participants were perturbed on 
the Radboud Falls Simulator to obtain information about their ability to recover from small 
perturbations. Obviously, these small perturbations did not provide information about 
their ability to execute stepping responses. In daily life falls will only occur when, besides 
the feet-in-place responses, also the stepping responses fail. Hence, future research in 
patients with FSHD should focus on the influence of leg versus trunk muscle involvement 
on the execution of stepping responses as well as using larger perturbation intensities 
than applied in this thesis. Fortunately, the Radboud Falls Simulator is able to impose such 
perturbations, which allows us to analyze the subsequent occurrence and quality of the 
steps taken. In this thesis, only sagittal plane balance was investigated, as previous studies 
pointed out that balance problems in patients with FSHD are most evident in the anterior- 
posterior direction. Yet, in daily life, balance disturbances rarely occur strictly in the sagittal 
plane. Hence, future research should also investigate balance responses in the frontal plane.
The finding that trunk muscle weakness is most critical for postural instability bears 
valuable clinical information. Clinicians often see FSHD patients who suffer from typical 
problems with their ‘core stability’. The results of this thesis indicate that those patients 
may suffer from trunk muscle involvement, even though they may not experience loss of 
trunk muscle strength themselves. Possibly, when they become prone to falling, these 
patients may profit from specific training to improve the frequency, speed and quality of 
their stepping responses. Because the results of this thesis showed that the more severe 
patients may use a ‘passive strategy’ upon body perturbations to maintain their feet in 
place, these patients might profit from a dynamic (flexible) trunk orthosis to reduce the 
load on their spinal ligaments and residual trunk muscles. 
Gait propulsion in FSHD 
A reduced walking speed in persons with FSHD has previously been related to a decreased 
ankle plantarflexion power [32]. In accordance to this, it was found in this thesis that both 
comfortable and maximum walking speed were highly correlated to the proportion 
preserved calf muscle and the ankle plantarflexion power. It was, however, expected that 
when calf muscle weakness was present, hip compensatory strategies would be recruited 
because of the typical sparing of the iliopsoas and gluteal muscles. This is a common 
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compensatory mechanism seen in several patients groups when calf muscles are affected 
[33-37]. Surprisingly, the patients with FSHD who suffered from calf muscle weakness did 
not seem to use this common compensatory mechanism. Although a substantial instantaneous 
increase in hip flexion power was possible in some patients, the proportion preserved 
iliopsoas muscle or hip flexion power did not contribute to the explained variance of 
either comfortable or maximum walking speed, suggesting that they did not compensate 
by using a ‘pull-off’ strategy. One explanation for this result may be related to trunk muscle 
weakness in our patient sample. It is likely that a consistent increase in hip flexion power 
during walking would challenge the core stability in patients with trunk muscle weakness 
too much. Indeed, a ‘pull-off’ strategy requires the recruitment of the iliopsoas muscles, 
which originate from multiple lumbar vertebrae. Increased recruitment of these muscles 
would aggravate anterior tilt of the pelvis as well as lumbar hyperlordosis, which would be 
insufficiently counteracted by the abdominal muscles. Another explanation may be that, 
in the patients with a lumbar hyperlordosis the iliopsoas muscles are insufficiently able to 
contract due to relative shortening of these muscles as a consequence of the abnormal 
lumbar and pelvic posture. Future studies should try to shed light on these hypotheses. 
Possibly, supporting core stability during walking may enable the use of a ‘pull-off’ strategy 
in patients with spared iliopsoas muscles. Another focus for future studies would be to 
further investigate the possible compensatory role of the gluteus maximus muscle in gait 
propulsion. Our patient sample did not show a clear increase in hip extension power either, 
even though the proportion preserved gluteus maximus was above 75% for the majority 
of the patients with FSHD. The reasons for this insufficient compensation remain elusive.
Based on the results from this thesis, clinicians should be aware of the relatively large 
impact of impaired calf muscle strength on gait propulsion in patients with FSHD, particularly 
in those with concomitant trunk muscle weakness. As a consequence, ankle-foot orthoses 
(AFOs) that are often prescribed to compensate for weakness of the foot dorsiflexors in 
FSHD should interfere with ankle plantarflexion power as minimally as possible. Hence, 
dynamic AFOs are strongly preferred over more rigid AFOs, if indicated at all. Indeed, the 
functional consequences of foot drop (e.g. risk of tripping) should be balanced against the 
side effects of AFOs (loss of ankle dynamics) based on individual muscle involvement, gait 
characteristics, and relevant personal activities. Gait analysis and muscle imaging may 
support such (shared) clinical decision-making.
Dynamic stability in FSHD 
Margins of stability are increasingly used to investigate postural (in)stability during 
dynamic balance and gait tasks. A lower margin of stability reflects a smaller distance 
between the extrapolated centre of mass and the base of support, which corresponds to 
a less stable situation [38, 39]. Recently, Iosa et al. (2010) reported increased trunk sway 
during gait, indicative of dynamic instability [40]. A significant increase in trunk sway was 
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found in the forward direction, mainly in patients with a CSS score 2.5 or higher [40]. 
The subjects included in the present thesis had a CSS score > 2.5, which means that they 
were likely to have a larger trunk sway during walking as well. However, their margins of 
stability during level walking in both the forward and lateral directions did not differ from 
healthy controls. Thus, regardless of their amount of trunk sway during gait, the patients 
recruited a successful obstacle avoidance strategy. The increased trunk sway as reported 
by Iosa et al. [40] may be a direct consequence of trunk muscle weakness, but may also be 
a compensatory mechanism for pelvic or lower extremity weakness to remain dynamically 
stable. To disentangle these hypotheses, further research is necessary including muscle 
imaging of the trunk and lower extremity muscles in combination with measurements of 
full body kinematics during level walking and obstacle avoidance. 
During obstacle crossing, differences in dynamic stability between patient groups became 
apparent. A decreased forward dynamic stability during crossing of the trailing leg was 
found only for the moderately affected group. This was accompanied by increased toe 
clearance and a larger forward trunk flexion angle. The moderately affected patients seemed to 
‘sacrifice’ forward dynamic stability to be able to cross the 10 cm obstacle. In daily life, level 
walking without any obstacles or challenges is rare. Although our data were collected in a 
laboratory situation, the size of the applied obstacle can be compared with, for instance, 
daily encountered doorsteps. Thus, our results underscore the difficulties that moderately 
affected patients with FSHD experience while performing common activities of daily life. 
This conclusion supports the findings of Horlings et al., who indicated that the majority of 
falls in patients with FSHD occur in familiar places and under familiar circumstances [2]. 
The results of this thesis help to explain the propensity of persons with FSHD to fall in the 
forward direction. If they systematically sacrifice their forward margin of stability to cross 
obstacles, they may increase their risk of falling in the forward direction. Thus, they should 
be informed about (and possibly trained to use) alternative strategies to negotiate 
obstacles. The results of this thesis also indicate that patients need be challenged by 
complex avoidance tasks to reveal dynamic instability. 
Functional assessment of mobility capacity in FSHD
As already mentioned, there is a need for more objective measures to monitor the 
progression of FSHD at the muscular level. Yet, it may even be more relevant to monitor 
disease progression at the functional level. For instance, in Duchenne muscular dystrophy, 
the Motor Function Measure has shown to be sensitive to disease progression [41, 42], but 
this measure did not appear to be sensitive enough to the natural progression in FSHD 
during one year [43]. Conventional clinical tests of balance and gait capacity (e.g. 10m 
Walking Test) did not show to be sensitive enough either to detect progression of selective 
muscle involvement in FSHD [17]. Hence, valid, reliable and sensitive functional tests of 
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mobility capacity for patients with FSHD are urgently needed that go beyond the 
conventional tests of balance and gait to monitor functional disease progression and 
possible response to treatment. It was found that simple anti-gravity tests (Step-up, 
Step-down, Sit-to-Stance and Stance-to-Sit), using an ordinal grading system that allows 
scoring the use of compensatory mechanisms, may be promising in this respect. 
Currently, functional incapacities of persons with FSHD may be underestimated clinically 
when using conventional balance and gait tests, as these tests do not require a substantial 
amount of muscle strength and typically allow ample use of compensatory mechanisms. 
In contrast, the proposed anti-gravity tests do challenge muscle strength to a substantial 
degree, while the proposed grading system controls for the use of compensatory trunk 
and arm movements. The observed correlation among the different anti-gravity tests and 
the observed strong correlation with Ricci’s CSS support their construct validity, while the 
good inter-rater agreement supports their reliability. Nevertheless, further research is 
necessary to validate these tests in a larger population of patients with FSHD to further 
establish their capacity to discriminate between various severity levels and to show their 
sensitivity to change across time. It would also be interesting to investigate their use in 
patients with other neuromuscular disorders. Additionally, the relationship between the 
performance on the anti-gravity tests and the actual occurrence of falls should be assessed 
to further establish their clinical value. In this perspective, it is promising that the proposed 
anti-gravity tests were selected based on their correspondence to activities that put 
patients with FSHD at risk of falling, such as stair climbing and making transfers [2]. 
Clinical recommendations
The results of the current thesis have led to new insights regarding balance and mobility 
capacity problems in patients with FSHD. Based on these results several clinical recom-
mendations can be made.
- During physical examination of patients with FSHD, more attention should be paid to 
trunk muscle involvement, not only of the abdominal muscles but also of the paraspinal 
muscles considering their importance for postural control.
- During physical examination of patients with FSHD, manual muscle testing should, 
whenever possible, be accompanied by palpation and/or inspection of the muscles of 
interest to identify affliction of individual (parts of) muscles, as specific structures within 
muscle groups such as the hamstrings and quadriceps can be affected in isolation. 
- Muscle imaging can support a proper functional diagnosis in patients with FSHD and 
should, thus, be considered by rehabilitation specialists when providing patients with 
functional advice and when prescribing physiotherapy, occupational therapy or 
orthotic interventions.
- Muscle imaging may also be used by neurologists and rehabilitation specialists to 
monitor disease progression and the response to behavioural interventions. For those 
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patients who seem to be functionally limited by trunk muscle involvement, dynamic 
trunk orthoses may be tried to support their core stability during daily life balance and 
gait tasks. Inevitably, however, such orthoses will have side effects as well, particularly 
during activities that require flexible movements of the trunk such as turning, bending, 
and rolling over when lying. 
- FSHD patients who suffer from tripping and increased fall risk as a result of (unilateral of 
bilateral) foot drop may be prescribed dynamic ankle-foot orthoses, taking into account 
their effect on residual ankle plantarflexion power. A possible detrimental effect on gait 
propulsion should be balanced against a beneficial effect on foot elevation and 
placement, especially in patients with trunk muscle involvement.
- Selected groups of FSHD patients may profit from specific forms of training to optimize 
the use of compensatory (spared) muscle groups for gait propulsion, such as the 
iliopsoas and gluteus maximus muscles. 
- Well-selected patients may also profit from the training of optimal gait avoidance 
strategies for negotiating daily life obstacle to minimize their risk of (forward) falls.   
- For physiotherapists involved in the rehabilitation of patients with FSHD, it is important 
to be aware of the most common balance and mobility problems in these patients. 
They should also be aware of the pitfalls when using conventional functional tests of 
balance and gait, which may lead to overestimation of functional mobility capacities. 
More challenging capacity tests are needed to reveal dynamic instability and estimate 
fall risk. 
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Facioscapulohumerale dystrofie (FSHD) is een van de meest voorkomende erfelijke spier- 
ziekten, met een geschatte prevalentie van 1:8500 in Nederland [1]. FSHD wordt gekenmerkt 
door een progressieve, meestal cranio-caudaal verlopende (gelaat-schouders- benen) zwakte 
van uiteindelijk alle skeletspieren. Omdat een oorzakelijke behandeling niet beschikbaar is, 
blijft symptomatische behandeling (revalidatie) essentieel om de gevolgen van de spier- 
zwakte te verminderen en ter compensatie van functionele beperkingen.
 Patiënten met FSHD ervaren vaak houdingsproblemen zodra romp- en/of beenspieren 
verzwakt raken. Wanneer spierzwakte aanwezig is in verschillende lichaamsdelen ontstaan 
complexe veranderingen van statische (sta-) en dynamische (loop-)balans, wat leidt tot 
een verhoogd valrisico. Onderzoek heeft aangetoond dat vallen bij mensen met FSHD 
voornamelijk optreedt in de voorwaartse richting en hoofdzakelijk in de thuissituatie (bijv. 
tijdens traplopen of opstaan  uit een stoel) [2]. Balans- en loopproblemen worden echter 
nog steeds slecht begrepen. Het blijft onduidelijk welke valmechanismen een rol spelen en 
welke spierzwakte het meest kritisch is voor de verhoogde valincidentie. Biomechanische 
balans- en/of looponderzoeken zijn nog steeds schaars bij patiënten met FSHD. Vooral de 
effecten van selectieve spierzwakte op houdingsregulatie en loopvaardigheid zijn onderbelicht.
 De ontwikkeling van optimale revalidatiestrategieën vereist kennis van alle aspecten 
en mechanismen die ten grondslag liggen aan de verminderde houdingsregulatie, loop-
capaciteit en dynamisch stabiliteit bij personen met FSHD. De studies die dit proefschrift 
vormen hadden tot doel om onze kennis van het selectieve vervettings-patroon bij 
patiënten met FSHD te bevorderen, en om inzicht te krijgen in de mechanismen die ten 
grondslag liggen aan de balans- en mobiliteitsproblemen die worden ervaren door deze 
patiënten.
Hoofdstuk 1 vormt de algemene inleiding en geeft achtergrondinformatie over FSHD. 
Het geeft een kort overzicht van het klinische beeld van FSHD en bespreekt de problemen 
die worden ervaren door patiënten met betrekking tot hun balans en mobiliteit.
In dit hoofdstuk worden de belangrijkste onderzoeksvragen van dit proefschrift geïntroduceerd:
1. Wat is het patroon van individuele spiervervetting van het totale lichaam bij mensen 
met FSHD en is de mate van spiervervetting geassocieerd met de grootte van het 
genetisch defect?
2. Welke spierzwakte is het meest kritisch voor het verlies van houdingsregulatie in het 
sagittale vlak bij mensen met FSHD?
3. Wat is de associatie tussen kuitspiervervetting en de propulsie tijdens het lopen bij 
mensen met FSHD en welke compenserende loopstrategieën worden gebruikt?
4. In hoeverre is de dynamische balans aangetast tijdens normaal lopen en tijdens het 
lopen over obstakels bij mensen met FSHD?
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5. Wat is de toegevoegde waarde van anti-zwaartekracht testen naast conventionele 
testen voor de functionele beoordeling van mobiliteit bij mensen met FSHD?
De algemene inleiding eindigt met een beschrijving van de hoofdlijnen van dit proefschrift.
Onderzoeksvraag 1: Wat is het patroon van individuele spiervervetting van het totale 
lichaam bij mensen met FSHD en is de mate van spiervervetting geassocieerd met de 
grootte van het genetisch defect?
Het doel van hoofdstuk 2 was om het totale lichaamspatroon van individuele spierzwakte 
te identificeren in een grote groep patiënten met FSHD teneinde houdings- en beweging-
sproblemen beter te begrijpen. Daarnaast werd onderzocht of de grootte van de genetische 
afwijking (weergegeven middels de resterende D4Z4-repeat lengte), gecorrigeerd voor 
leeftijd en geslacht, de mate van spiervervetting kan voorspellen. Computer Tomografie 
(CT scan) van het hele lichaam bij 70 patiënten werd gebruikt om de mate van vervetting 
van 42 spieren van nek tot enkels te evalueren op een semi-kwantitatieve schaal. 
Spiergroepen die sterk correleerden wat betreft de aanwezigheid van vervetting werden 
geïdentificeerd door middel van factoranalyse. Er bleken sterke correlaties te bestaan 
tussen de hoeveelheid vervetting in de spieren en de kracht die gegenereerd kon worden 
door deze spieren. Het patroon van vervetting reflecteert dus ook het patroon van 
spierzwakte. De rompspieren waren het vaakst aangedaan. Verder bleek dat de rugspieren 
vaker waren aangedaan dan eerder werd gerapporteerd. Asymmetrie in spieraantasting 
werd waargenomen in 45% van de spieren die waren vervet. De rechterzijde van de bovenste 
extremiteit vertoonde significant hogere scores voor vervetting dan de linkerzijde, wat 
niet kon worden verklaard op basis van de voorkeurshand. Lineaire regressieanalyse werd 
uitgevoerd met spiervervetting als afhankelijke variabele en D4Z4-repeat lengte, leeftijd 
en geslacht als onafhankelijke variabelen. De D4Z4-repeat lengte bleek een significant 
deel van de spiervervetting te verklaren in zowel de onderste extremiteiten als de romp, 
en daardoor ook van het hele lichaam. Het was mogelijk om 29% van de vervetting te 
verklaren op basis van D4Z4-repeat lengte, gecorrigeerd voor leeftijd en geslacht. Uit deze 
resultaten werd geconcludeerd dat het veelvuldig vóórkomen van vervetting van de rug- 
spieren, naast aantasting van de buikspieren, de mate van betrokkenheid van de romp 
benadrukt. Deze betrokkenheid van de romp kan een grote invloed hebben op de houdings-
regulatie, zelfs bij mild aangedane patiënten.
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Onderzoeksvraag 2: Welke spierzwakte is het meest kritisch voor het verlies van 
houdingsregulatie in het sagittale vlak bij mensen met FSHD?
In hoofdstuk 3 was het doel te bepalen welke spieraantasting het meest kritisch is voor 
het verlies van houdingsregulatie in het sagittale-vlak bij patiënten met FSHD; vervetting 
van de rompspieren of van de onderste extremiteit? Dit werd geanalyseerd door het 
bestuderen van de reacties van het lichaam op opgelegde platformverschuivingen in het 
sagittale vlak, in zowel de voorwaartse als achterwaartse richting. Hiervoor werd een 
groep van tien FSHD patiënten met verschillende mate van ziekte-ernst geïncludeerd 
evenals een groep van tien gezonde controles. De stapdrempels werden bepaald en 
kinematische reacties op externe verstoringen werden beoordeeld met behulp van 
drie-dimensionale bewegingsanalyse. Magnetic Resonance Imaging (MRI) werd gebruikt 
om de hoeveelheid vervetting van spieren in de romp en de onderste extremiteiten te 
bepalen. De hypothese was dat vervetting van de rompspieren kritischer is voor de houd-
ingsregulatie dan vervetting van de beenspieren. In vergelijking met de controles bleken 
de stapdrempels in zowel de voorwaartse als achterwaartse richting verminderd te zijn bij 
de patiënten. Bij de patiënten werden significante correlaties gevonden tussen vervetting 
van de buikspieren en achterwaartse stapdrempel en tussen vervetting van de rugspieren 
en voorwaartse stapdrempel. Vervetting van de rectus abdominis en de erector spinae 
verklaarde het grootste deel van de variantie in respectievelijk de achter- en voorwaartse 
stapdrempel. Verplaatsing van het massamiddelpunt was afhankelijk van de intensiteit en 
de richting van de verstoring. Uit kinematische analyse van de reacties van het lichaam 
bleek dat overheersend enkelstrategieën werden gebruikt, behalve bij patiënten met een 
lumbale hyperlordose. Uit de resultaten van dit experiment blijkt dat de betrokkenheid 
van rompspieren het meest kritisch is voor het verlies van houdingsregulatie in het 
sagittale vlak bij patiënten met FSHD. Dit is belangrijke informatie die kan worden gebruikt 
om patiënten te identificeren die een verhoogd risico hebben om te vallen.
Onderzoeksvraag 3: Wat is de associatie tussen kuitspiervervetting en de propulsie 
tijdens het lopen bij mensen met FSHD en welke compenserende loopstrategieën 
worden gebruikt?
 
In hoofdstuk 4 wordt het effect van vervetting van de kuitspieren op de propulsie tijdens 
het lopen bestudeerd bij mensen met FSHD. Hierin werd het gebruik van compenserende 
heupstrategieën meegenomen. Als de kuitspieren niet in staat zijn om voldoende 
plantairflexie in de enkel te genereren om de loopsnelheid te behouden (‘push-off’), 
wordt vaak een vergroot heupflexiemoment (‘pull off’) gebruikt. Dit vergrote moment kan 
worden gegenereerd door rekrutering van de heupflexoren. Een dergelijke verschuiving 
werd ook verwacht bij patiënten met FSHD, omdat de kuitspieren vaak in een vroege fase 
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vervet zijn, terwijl de iliopsoas spier vaak lang gespaard blijft. Ook de gluteus maximus 
spier kan een belangrijke rol spelen, omdat deze spier gebruikt kan worden om het heup-
extensiemoment te vergroten. In het huidige onderzoek werd MRI gebruikt om het 
percentage onaangetast spierweefsel van de kuit, iliopsoas en gluteus maximus te 
beoordelen. Loopsnelheid en gewrichtsvermogen werden geanalyseerd tijdens lopen op 
comfortabele en maximale loopsnelheid bij tien patiënten met FSHD. Dit werd gedaan 
om de bijdragen van het geleverd vermogen door de enkelplantairflexoren, heupflexoren 
en heupextensoren aan de loopsnelheid te bepalen. Associaties tussen vervetting, 
geleverd vermogen en loopsnelheid werden beoordeeld. De loopsnelheid bij mensen 
met FSHD was verlaagd ten opzichte van de normale loopsnelheid bij gezonde leef-
tijdsgenoten. De resultaten toonden aan dat het geleverd vermogen door de kuitspieren 
de enige factor was die uniek bijdroeg aan de verklaarde variantie van de comfortabele 
(R2 = 80%) en maximale  loopsnelheid (R2 = 86%). Hoewel de iliopsoas spieren grotendeels 
onaangetast waren, bleken ze sub-maximaal aangesproken. Uit deze resultaten werd 
geconcludeerd dat de natuurlijke compensatiestrategie voor kuitzwakte onvoldoende 
werd gebruikt bij patiënten met FSHD. Dit was wellicht gerelateerd aan een slechte romp-
stabiliteit, waardoor een onevenredig effect van kuitspierzwakte op de loopsnelheid 
werd gevonden bij patiënten met FSHD.
Onderzoeksvraag 4: In hoeverre is de dynamische balans aangetast tijdens normaal 
lopen en tijdens het lopen over obstakels bij mensen met FSHD?
Hoofdstuk 5 is gericht op het beoordelen van de dynamische stabiliteit tijdens normaal 
lopen en het lopen over obstakels bij patiënten met verschillende gradaties van FSHD om 
inzicht te krijgen in de valmechanismen bij deze groep patiënten. Voorwaartse en zijwaartse 
dynamische stabiliteit, spatiotemporele en kinematische variabelen werden beoordeeld 
tijdens gewoon lopen en lopen over een obstakel van 10 cm hoogte. Tien patiënten met 
spierzwakte in de onderste extremiteiten werden geïncludeerd, van wie er zes werden 
geclassificeerd als ‘matig aangedaan’ en vier als ‘mild aangedaan’. Daarnaast werden tien 
gezonde controles geïncludeerd. Tijdens gewoon lopen liet de matig aangedane groep 
een lagere loopsnelheid zien, die gepaard ging met langere staptijden en kleinere 
staplengtes, terwijl de dynamische stabiliteit onaangetast bleef. Bij het lopen over het 
obstakel lieten de matig aangedane patiënten verminderde voorwaartse stabiliteitsmarges 
zien tijdens de ’trailing’ stap (de stap waarbij het achterste been over het obstakel stapt), 
hetgeen gepaard ging met het hoger optillen van het dit been en een toegenomen 
romp- en heupflexie. Dit suggereert dat de patiënten tijdens normaal lopen compensatie-
strategieën aanwendden om hun dynamische stabiliteit effectief te handhaven, maar dat 
het lopen over een obstakel de restcapaciteit van de matig aangedane patiënten 
overschreed, waardoor ze niet in staat waren  optimale stabiliteit te handhaven. De huidige 
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resultaten benadrukken de problemen die FSHD patiënten ervaren tijdens het uitvoeren 
van een simpele activiteit van het dagelijks leven. Deze resultaten kunnen helpen te verklaren 
waarom deze patiënten een verhoogd risico hebben om te vallen in de voorwaartse 
richting.
Onderzoeksvraag 5: Wat is de toegevoegde waarde van anti-zwaartekracht testen 
naast conventionele testen voor de functionele beoordeling van mobiliteit bij mensen 
met FSHD?  
In hoofdstuk 6 werden de constructvaliditeit en de inter-beoordelaarbetrouwbaarheid 
van vier eenvoudige anti-zwaartekracht testen (Zit-tot-Stand, Stand-tot-Zit, Opstappen, 
Afstappen) geëvalueerd bij patiënten met FSHD. Voor de functionele beoordeling van 
mobiliteit in deze groep zijn valide, betrouwbare en gevoelige testen nodig die verder 
gaan dan het manueel schatten van spierkracht en het conventioneel testen van balans- 
en loopvaardigheid. Deze testen zouden meer inzicht moeten geven in de klinische ziekte-
progressie en de effecten van behandeling. Daarnaast zouden ze gevoelig moeten zijn 
voor het gebruik van compensatiestrategieën. Hiertoe werd een 4-punts (ordinale) schaal 
ontworpen om de prestaties op de vier anti-zwaartekracht testen te scoren. Ter vergelijking 
werden de volgende conventionele testen afgenomen: 6-minuten looptest, 10-meter 
looptest, Berg Balance Schaal en Timed-Up-and-Go test. Negen patiënten met verschillende 
gradaties van FSHD en tien gezonde controlepersonen werden geïncludeerd. De patiënten 
met FSHD presteerden slechter op alle vier de anti-zwaartekracht testen in vergelijking 
met de gezonde controles. Binnen test-categorieën werden sterkere correlaties gevonden 
dan tussen test-categorieën (anti-zwaartekracht versus conventioneel). De anti- zwaartekracht 
testen samen verklaarden het hoogste percentage variantie van Ricci’s Clinical Severity 
Scale (CSS) (R2 = 0.86, p = 0.014). Fleiss’ kappawaarden voor inter-beoordelaarovereenkomst 
waren in het algemeen goed. De resultaten onderbouwen de constructvaliditeit en inter- 
beoordelaarbetrouwbaarheid van de voorgestelde anti-zwaartekracht testen voor de 
klinische evaluatie van mobiliteit bij patiënten met FSHD, waarbij deze ook rekening 
houden met het gebruik van compensatiestrategieën. Toekomstig onderzoek moet 
gericht zijn op de verdere onderbouwing van de klinimetrische eigenschappen van de 
voorgestelde anti-zwaartekracht testen, vooral wat betreft hun sensitiviteit voor verandering.
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Dankwoord
Dit is dan de plek waar ik mijn dank uit mag spreken naar de mensen die waardevol zijn 
geweest voor mij tijdens mijn promotieonderzoek. De afgelopen 5 jaar heb ik veel tijd en 
energie gestopt in mijn promotie. Toch had ik dit project zeker niet alleen tot een goed einde 
kunnen brengen. Veel mensen hebben hier in meer of mindere mate aan bijgedragen.
De tijd die ik heb besteed aan mijn promotieonderzoek bestaat uit 3 verschillende parttime 
aanstellingen aangevuld met wat eigen tijd. In 2010 begon ik als junior onderzoeker aan een 
onderzoek van één jaar, gesubsidieerd door de FSHD Stichting. Na verloop van tijd bleek dat 
uit de verzamelde data veel meer informatie te halen was dan vooraf gedacht. Om voldoende 
tijd te hebben de data optimaal te kunnen gebruiken, heeft de FSHD Stichting twee keer een 
verlenging van het onderzoek gefinancierd. Als eerste wil ik daarom de FSHD Stichting 
bedanken voor de mogelijkheid om dit onderzoek te doen en het vertrouwen in onze groep 
om twee keer te verlengen. Ik hoop dat dit proefschrift een waardevolle toevoeging is aan 
de kennis over beweegproblemen bij FSHD en dat ik daarmee een bijdrage kan leveren aan 
de kwaliteit van leven van mensen met FSHD. Ook V!GO wil ik graag bedanken voor de 
financiële steun bij de laatste aanstelling.
Ik wil graag de proefpersonen bedanken die vrijwillig uren bij mij in het lab hebben door- 
gebracht. Ik weet dat ik veel van jullie vroeg en dat het voor sommigen een zware opgave 
was. Bedankt voor jullie geduld en inzet, maar ook voor de gezelligheid. Indrukwekkend om 
jullie persoonlijke verhalen te horen. Respect voor de manier waarop jullie je leven inrichten 
en omgaan met de lichamelijke beperkingen als gevolg van FSHD. 
Ook de gezonde controleproefpersonen wil ik graag bedanken voor hun inzet en vrijwillige 
bijdrage aan de wetenschap en de resultaten in dit boek.
Sander, Baziel en Vivian, wat heb ik veel van jullie geleerd! Jullie waren voor mij een mooie 
combinatie (co)promotoren, zowel voor wat betreft jullie kennis, als ook de manier van werken 
en begeleiden.
Sander, ik bewonder je om je kennis, je analytisch vermogen en discipline. Bedankt voor 
telkens weer je snelle en uitgebreide feedback op mijn stukken, hier heb ik veel van geleerd. 
Dat kwam duidelijk tot uiting in de afnemende tijd en moeite die het kostte om de artikelen 
gepubliceerd te krijgen.
Baziel, jouw kennis over het ziektebeeld en je klinische ervaring met de patiënten waren onmisbaar. 
Ook hielp je me om af en toe weer even boven mijn onderzoek te gaan staan. De momenten 
waarop we filosofeerden over onderzoek en andere onderwerpen waren waardevol. Daarnaast 
ben ik je heel dankbaar voor je persoonlijke aandacht, ik kon jouw kamer niet binnenlopen 
zonder dat we het even hadden over hoe het echt met me ging. Bedankt daarvoor.
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Vivian, bedankt voor je begeleiding als copromotor. We hebben veel lange overleggen 
gehad waarin we resultaten analyseerden en discussieerden over wat er nu daadwerkelijk 
gebeurde in het lichaam van de proefpersonen. Onder jouw supervisie ben ik erin geslaagd 
dit proefschrift te schrijven. Ik bewonder je discipline en de manier waarop je de afgelopen 
jaren alle balletjes hebt weten hoog te houden. En wat heb je me soms verbaasd met je 
bizarre geheugen!
Joyce en Chantal bedankt voor de waardevolle intervisies in de periode dat we alle drie op 
de afdeling revalidatie werkten. Het was fijn om gevoelens en onderzoeks-frustraties te 
kunnen delen, om daarna weer met beide benen op de grond gezet te worden. Jullie kritische 
commentaar en adviezen waren waardevol. Ook was het heerlijk om buiten kantooruren samen 
het hoofd leeg te maken. Hanneke en Lotte, bedankt voor de gezellige tijd en aandacht voor 
ook niet-werkgerelateerde zaken, ook tijdens de afgelopen anderhalf jaar als ik weer eens 
voor afspraak op de afdeling was. Arjen, bedankt voor de momenten waarop we onze resultaten 
of voortgang bespraken onder het genot van een koffie en de gezellige thuiswerkdagen in 
de afgelopen anderhalf jaar. Jos, Jasper en Nicole, dank jullie wel voor de praktische hulp en 
het delen van jullie kennis over FSHD. Roland en Geert, bedankt voor jullie hulp. Ik was niet 
altijd geduldig, maar jullie technische ondersteuning heb ik zeer op prijs gesteld.
Alle andere directe (oud)collega onderzoekers van de revalidatie, Merel, Mariska, Frank, Lars, 
Roos, Ellen, Katrijn, Mariëlle, bedankt voor de hulp op onderzoekstechnisch vlak tijdens de 
OZO’s en de labmeetings, maar ook daarbuiten. En natuurlijk ook voor leuke periode in het 
Radboud met de vele koffie momenten en de leuke uitjes. 
Mijn kamergenootjes wil ik in het bijzonder noemen. Digna, Sjoerd, Jorik en in het eerste jaar 
ook Mark. In onze kamer werd hard gewerkt, maar was ook ruimte voor een grap of een mooi 
verhaal. We hebben veel van elkaar gezien en meegemaakt in de jaren dat we samen dagelijks een 
kamer deelden. Dank jullie wel voor jullie hulp en adviezen op alle vlakken. Mark en Sjoerd, 
bedankt voor jullie heerlijke nuchtere instelling en waardevolle hulp bij Matlab problemen. 
Jorik, je ging als een speer. Bedankt voor je frisse wind en de onderonsjes vanachter onze 
computers. Digna, bedankt voor je hulp en adviezen. Ik bewonder je drive, je geduld en 
eindeloze luisterende oor. 
Annemieke, we hebben de eerste jaren samen op de afdeling gewerkt. Je was altijd bereid 
om je kennis en ervaring te delen en advies te geven. Leuk dat we ook na jouw promotie veel 
contact hebben gehouden. Dankjewel dat je mijn paranimf wil zijn.
Elly vd Kooi, Barbara Jansen, Saskia Lassche, Karlien Mul, Nicole Voet, Hanneke Deenen en 
Nicol Voermans, als experts op gebied van FSHD zijn jullie waardevol geweest op de momenten 
waarin we resultaten deelden en interpreteerden en elkaar daarmee tot hulp waren. 
Collega’s van de sint Maartenskliniek, op de vrijdagen heb ik met veel plezier bij jullie gewerkt. 
Het was een mooie afwisseling in de week. Noel, Sanne, Lise, Cheriel, Astrid, Marianne, Koen, 
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Bart, Brenda, Niki, Petra, Amber, Janneke, Thomas, Agnes, Peter, Miranda, Michiel en andere 
(oud)collega’s van de research, bedankt voor de leuke tijd. 
Lieve vrienden, ook jullie wil ik graag bedanken voor jullie eindeloze interesse in de voortgang 
van mijn onderzoek en jullie luisterend oor als het even wat minder soepel liep. Jullie zijn 
heel waardevol voor mij!
Frederike en Mirelle, ik ben heel blij dat we elkaar nog steeds zien, ondanks dat we al lang 
niet meer samenwonen en steeds verder uit elkaar verhuizen. Bedankt voor jullie eindeloze 
interesse en vertrouwen. Lief dat jullie zo attent zijn en altijd met me meeleven. 
Lindy, SanneK, Loes, SanneF, Marjan en Karin, jullie weten als geen ander wat het is om 
promotie onderzoek te doen. Toch leuk dat ik de eerste ben die het afrond. Al zal de volgende 
promotie niet lang op zich laten wachten, toch Lindy?!  Ik ben blij dat we elkaar nog regelmatig 
zien, en die jaarlijkse weekendjes weg gaan we er zeker in houden. Jullie zijn toppers! 
Carlijn, Samantha, Iris en Cees jullie zijn waardevolle vrienden die altijd voor me klaar staan. 
Daarvoor ben ik jullie heel dankbaar. 
Noor, naast dat je al heel lang een goede vriendin bent heb je ook de kaft van dit proefschrift 
ontworpen. Dankjewel, het is prachtig geworden!
Anita, dankjewel dat je me kennis hebt laten maken met de opleiding biomedische 
wetenschappen. Als jij niet zo enthousiast was geweest had ik hier waarschijnlijk niet gestaan. 
Ik vind het leuk dat je nu ook mijn paranimf wil zijn. 
Roelof en Sylva, schoonfamilie en alle andere mensen om mij heen die regelmatig informeren 
naar de voortgang, dank voor jullie interesse en aandacht.
De atletiekbaan is altijd de plek geweest waar ik zowel mijn energie kwijt kon als deze weer 
opdoen. Ik wil al mijn trainingsmaatjes bedanken voor de fijne uren op de baan. Linsie en 
Nathalie in het bijzonder, met jullie heb ik ook vele werk-gerelateerde frustraties en successen 
gedeeld. Frank, bedankt voor je eindeloze vertrouwen, geduld en aandacht, je keek soms 
dwars door mij heen. Je hebt me geholpen vele hordes te nemen.
Pap en mam, jullie hebben altijd achter me gestaan in mijn keuzes. Pap, mijn onderzoekende 
karakter heb ik van jou, ook al laat jij die kant van jezelf thuis weinig zien. Ik vind het leuk dat 
ik, soort van, in je voetsporen ben getreden en dat we in de afgelopen jaren zelfs parttime 
collega’s zijn geweest. Ik geloof dat je stiekem best trots op me bent. Mam, dank je dat je 
altijd tijd voor me hebt, zelfs als ik alleen maar loop te klagen. Je bent een lieverd! 
Lieve Ilse en Esther, ook al zien we elkaar niet zo vaak, het is altijd goed. Ik ben trots op jullie. 
Ik heb in de afgelopen jaren minder tijd voor jullie gehad dan ik zou willen. Dankjewel voor 
al jullie begrip en steun.  
Hans, ik ben ontzettend blij dat ik jou ben tegengekomen. Je was precies wat ik nodig had 
en dat ben je nog steeds. Dank je voor je eindeloze vertrouwen in mij. Dit is voor altijd!
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Noortje Rijken was born in Nijmegen, the Netherlands on the 31st of August 1984 and has 
spend her childhood in Wijchen. In 2001 she completed her secondary education (HAVO) 
at the MaasWaal college in Wijchen and started studying Medical Imaging and Radiation 
Therapy at the Fontys Hogeschool Eindhoven. After obtaining her bachelor of Health 
Science in 2005 she started working as a radiographer in the Elkerliek hospital in Helmond. 
In 2007 she started the Master programme Biomedical Science at the Radboud Univerity 
Nijmegen with the specialization Human Movement Science. During her master course 
she went to the Institute of Health and Biomedical Innovation of the Queensland University 
of Technology in Brisbane, Australia for a five-month internship in orthopedic research. In 
2009 she started her final 9-month internship at the research department of the st. 
Maartenskliniek in Nijmegen, the Netherlands. During this internship she studied effects 
of neuromodulation on ostructed walking in patients with chronic pain. 
 After graduation in 2010, Noortje started as a PhD student working at the rehabilitation 
department of the Radboud University Medical Centre Nijmegen. Simultaneously she 
worked as a researcher at the St. Maartenskliniek on the Fusion project, investigating 
potential applications of a new ambulant 3D movement analysis system in healthcare. 
Both in the St. Maartenskliniek as well as in the rehabilitation department of the Radboud 
UMC she was, for a certain period of time, responsible for the technical support and the 
reports of gait analysis of outpatients. During her PhD trajectory, she investigated which 
muscles are responsible for common balance and gait disabilities in patients with FSHD. 
Throughout the first year she also picked up the analysis of a large existing CT dataset to 
unravel the typical pattern of muscle involvement in FSHD. Currently she is working at the 
Research Centre of Saxion university of applied science in Enschede as the projectmanager 
of a project focussing on the application of existing and new technological systems and 
materials in (elite) sports. 
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Noortje Rijken werd geboren in Nijmegen, Nederland op 31 augustus 1984 en heeft haar 
jeugd doorgebracht in Wijchen. In 2001 voltooide ze de HAVO op het Maaswaal College 
in Wijchen en begon ze met de studie Medische Beeldvormende en Radiotherapeutische 
Technieken aan de Fontys Hogeschool Eindhoven. Na het behalen van haar Bachelor 
diploma in 2005 begon ze als radiodiagnostisch laborant op de afdeling radiologie van 
het Elkerliek ziekenhuis in Helmond. In 2007 begon ze met de masteropleiding Biomedische 
Wetenschappen aan de Radboud Universiteit in Nijmegen met de specialisatie Human 
Movement Science. Tijdens haar masteropleiding ging ze naar het Institute of Health and 
Biomedical Innovation van de Queensland University of Technology in Brisbane, Australië 
voor een vijf maanden durende stage in orthopedisch onderzoek. In 2009 begon ze haar 
afstudeer stage bij de onderzoeksafdeling van de st. Maartenskliniek in Nijmegen, Nederland. 
Tijdens deze stage bestudeerde ze de effecten van neuromodulatie op lopen bij patiënten 
met chronische pijn. 
 Na haar afstuderen in 2010, is Noortje begonnen als promovendus bij de afdeling 
revalidatie van het Radboud UMC. Tegelijkertijd werkte ze ook als onderzoeker bij de 
St. Maartenskliniek in het Fusion project, waarvoor ze mogelijke toepassingen onderzocht 
in de gezondheidszorg voor een nieuw ambulant 3D bewegingsanalysesysteem. Zowel 
in de St. Maartenskliniek, alsmede bij de revalidatie afdeling van het Radboud UMC was ze, 
voor een bepaalde periode, verantwoordelijk voor de technische ondersteuning en 
analyse van het gangpatroon analyses van poliklinische patiënten. Tijdens haar promotie 
traject onderzocht ze welke spieren verantwoordelijk zijn voor de typische balans en 
loopproblemen bij mensen met FSHD. Gedurende het eerste jaar analyseerde ze ook een 
grote bestaande CT dataset van mensen met FSHD om het patroon van spiervervetting 
te ontrafelen. Momenteel is zij werkzaam bij het lectoraat Ambient Intelligence van de 
Saxion Hogeschool in Enschede, waar ze projectleider is van een project gericht op het 
toepassen van bestaande en nieuwe technologische systemen en materialen in de (top)
sport.
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